{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:29:54Z","timestamp":1790501394113,"version":"4.1.0"},"reference-count":450,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:00:00Z","timestamp":1642204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402442"],"award-info":[{"award-number":["81402442"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-021-08892-z","type":"journal-article","created":{"date-parts":[[2022,1,15]],"date-time":"2022-01-15T00:04:35Z","timestamp":1642205075000},"page":"284-320","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Mesenchymal Stem Cell\u2013Based Therapy as a New Approach for the Treatment of Systemic Sclerosis"],"prefix":"10.1007","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3355-0124","authenticated-orcid":false,"given":"Xiufen","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,15]]},"reference":[{"key":"8892_CR1","doi-asserted-by":"publisher","unstructured":"Maria AT, Maumus M, Le Quellec A,\u00a0Jorgensen C,\u00a0Noel D,\u00a0Guilpain P (2017) Adipose-derived mesenchymal stem cells in autoimmune disorders: state of the art and perspectives for systemic sclerosis. Clin Rev Allergy Immunol 52:234\u2013259. [pii] https:\/\/doi.org\/10.1007\/s12016-016-8552-9","DOI":"10.1007\/s12016-016-8552-9"},{"key":"8892_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00296-012-2486-1","volume":"33","author":"AA Topal","year":"2013","unstructured":"Topal AA, Dhurat RS (2013) Scleroderma therapy: Clinical overview of current trends and future perspective. Rheumatol Int 33:1\u201318. https:\/\/doi.org\/10.1007\/s00296-012-2486-1","journal-title":"Rheumatol Int"},{"key":"8892_CR3","doi-asserted-by":"publisher","unstructured":"Pattanaik\u00a0D, Brown\u00a0M, Postlethwaite\u00a0BC, Postlethwaite\u00a0AE (2015) Pathogenesis of Systemic Sclerosis. Front Immunol 6:272.\u00a0https:\/\/doi.org\/10.3389\/fimmu.2015.00272","DOI":"10.3389\/fimmu.2015.00272"},{"key":"8892_CR4","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.3389\/fimmu.2018.02013","volume":"9","author":"J Peltzer","year":"2018","unstructured":"Peltzer J, Aletti M, Frescaline N, Busson E, Lataillade JJ, Martinaud C (2018) Mesenchymal stromal cells based therapy in systemic sclerosis: rational and challenges. Front Immunol 9:2013. https:\/\/doi.org\/10.3389\/fimmu.2018.02013","journal-title":"Front Immunol"},{"key":"8892_CR5","doi-asserted-by":"publisher","first-page":"4569826","DOI":"10.1155\/2019\/4569826","volume":"2019","author":"A Sierra-Sepulveda","year":"2019","unstructured":"Sierra-Sepulveda A, Esquinca-Gonzalez A, Benavides-Suarez SA, Sordo-Lima DE, Caballero-Islas AE, Cabral-Castaneda AR, Rodriguez-Reyna TS (2019) Systemic sclerosis pathogenesis and emerging therapies, beyond the fibroblast. Biomed Res Int 2019:4569826. https:\/\/doi.org\/10.1155\/2019\/4569826","journal-title":"Biomed Res Int"},{"key":"8892_CR6","doi-asserted-by":"publisher","unstructured":"Ntelis\u00a0K, Bogdanos D, Dimitroulas\u00a0T, Sakkas\u00a0L, Daoussis\u00a0D (2019) Platelets in systemic sclerosis: the missing link connecting vasculopathy, autoimmunity, and fibrosis? Curr Rheumatol Rep 21:15.\u00a0[pii] https:\/\/doi.org\/10.1007\/s11926-019-0815-z10.1007\/s11926-019-0815-z","DOI":"10.1007\/s11926-019-0815-z10.1007\/s11926-019-0815-z"},{"key":"8892_CR7","doi-asserted-by":"publisher","unstructured":"Ingegnoli F, Ughi\u00a0N, Mihai\u00a0C (2018) Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis. Best Pract Res Clin Rheumatol 32:223\u2013240.\u00a0[pii] S1521-6942(18)30042-1 https:\/\/doi.org\/10.1016\/j.berh.2018.08.005","DOI":"10.1016\/j.berh.2018.08.005"},{"key":"8892_CR8","doi-asserted-by":"publisher","unstructured":"Mayes\u00a0MD, Lacey\u00a0JV Jr, Beebe-Dimmer\u00a0J, Gillespie\u00a0BW, Cooper\u00a0B, Laing\u00a0TJ, Schottenfeld\u00a0\u00a0D (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48:2246- 2255.\u00a0https:\/\/doi.org\/10.1002\/art.11073","DOI":"10.1002\/art.11073"},{"key":"8892_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/BOR.0000000000000214","volume":"27","author":"PS Ramos","year":"2015","unstructured":"Ramos PS, Silver RM, Feghali-Bostwick CA (2015) Genetics of systemic sclerosis: recent advances. Curr Opin Rheumatol 27:521\u2013529. https:\/\/doi.org\/10.1097\/BOR.0000000000000214","journal-title":"Curr Opin Rheumatol"},{"key":"8892_CR10","doi-asserted-by":"publisher","unstructured":"Rubio-Rivas M, Moreno\u00a0R, Corbella\u00a0X (2017) Occupational and environmental scleroderma Systematic review and meta-analysis. Clin Rheumatol 36:569\u2013582.\u00a0[pii] https:\/\/doi.org\/10.1007\/s10067-016-3533-110.1007\/s10067-016-3533-1","DOI":"10.1007\/s10067-016-3533-110.1007\/s10067-016-3533-1"},{"key":"8892_CR11","unstructured":"Freire\u00a0M, Rivera\u00a0A, Sopena\u00a0B, Tolosa Vilella\u00a0C, Guillen-Del Castillo\u00a0A, Colunga Arguelles D, Callejas Rubio\u00a0JL, Rubio Rivas\u00a0M, Trapiella Martinez\u00a0L, Todoli Parra\u00a0JA, Rodriguez Carballeira\u00a0M, Iniesta Arandia\u00a0N, Garcia Hernandez\u00a0FJ, Egurbide Arberas\u00a0MV, Saez Comet\u00a0L, Vargas Hitos\u00a0JA, Rios Blanco\u00a0JJ, Marin Ballve A, Pla Salas\u00a0X, Madronero Vuelta\u00a0AB, Ruiz Munoz M, Fonollosa Pla\u00a0V, Simeon Aznar\u00a0CP (2017) Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review. Clin Exp Rheumatol 35 Suppl 106:89\u201397.\u00a0[pii] 11910"},{"key":"8892_CR12","doi-asserted-by":"publisher","unstructured":"Tsou PS,\u00a0Sawalha AH (2017) Unfolding the pathogenesis of scleroderma through genomics and epigenomics. J Autoimmun 83:73\u201394.\u00a0[pii] S0896-8411(17)30325-6 https:\/\/doi.org\/10.1016\/j.jaut.2017.05.004","DOI":"10.1016\/j.jaut.2017.05.004"},{"key":"8892_CR13","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.3389\/fimmu.2018.02452","volume":"9","author":"A van Caam","year":"2018","unstructured":"van Caam A, Vonk M, van den Hoogen F, van Lent P, van der Kraan P (2018) Unraveling SSc pathophysiology; the myofibroblast. Front Immunol 9:2452. https:\/\/doi.org\/10.3389\/fimmu.2018.02452","journal-title":"Front Immunol"},{"key":"8892_CR14","doi-asserted-by":"publisher","unstructured":"Distler O, Cozzio A (2016) Systemic sclerosis and localized scleroderma\u2013current concepts and novel targets for therapy. Semin Immunopathol 38:87\u2013 95.\u00a0[pii]\u00a0https:\/\/doi.org\/10.1007\/s00281-015-0551-z10.1007\/s00281-015-0551-z","DOI":"10.1007\/s00281-015-0551-z10.1007\/s00281-015-0551-z"},{"key":"8892_CR15","doi-asserted-by":"publisher","unstructured":"Furue M, Mitoma C, Mitoma H,\u00a0Tsuji G, Chiba T, Nakahara T, Uchi H, Kadono T (2017) Pathogenesis of systemic sclerosis-current concept and emerging treatments. Immunol Res 65:790\u2013797.\u00a0[pii] https:\/\/doi.org\/10.1007\/s12026-017-8926-y10.1007\/s12026-017-8926-y","DOI":"10.1007\/s12026-017-8926-y10.1007\/s12026-017-8926-y"},{"key":"8892_CR16","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1111\/1756-185X.13203","volume":"20","author":"K Morrisroe","year":"2017","unstructured":"Morrisroe K, Stevens W, Proudman S, Nikpour M (2017) A systematic review of the epidemiology, disease characteristics and management of systemic sclerosis in Australian adults. Int J Rheum Dis 20:1728\u20131750. https:\/\/doi.org\/10.1111\/1756-185X.13203","journal-title":"Int J Rheum Dis"},{"key":"8892_CR17","doi-asserted-by":"publisher","unstructured":"Ahmed S,\u00a0Misra DP, Agarwal\u00a0V (2019) Interleukin-17 pathways in systemic sclerosis-associated fibrosis. Rheumatol Int 39:1135\u20131143.\u00a0[pii] https:\/\/doi.org\/10.1007\/s00296-019-04317-510.1007\/s00296-019-04317-5","DOI":"10.1007\/s00296-019-04317-510.1007\/s00296-019-04317-5"},{"key":"8892_CR18","doi-asserted-by":"publisher","unstructured":"Asano Y, Takahashi T, Saigusa\u00a0R (2019) Systemic sclerosis: Is the epithelium a missing piece of the pathogenic puzzle? J Dermatol Sci 94:259\u2013265.\u00a0[pii] S0923-1811(19)30100-8 https:\/\/doi.org\/10.1016\/j.jdermsci.2019.04.007","DOI":"10.1016\/j.jdermsci.2019.04.007"},{"key":"8892_CR19","doi-asserted-by":"publisher","unstructured":"Ferreli C, Gasparini\u00a0G, Parodi\u00a0A, Cozzani E, Rongioletti\u00a0F, Atzori\u00a0L (2017) Cutaneous manifestations of scleroderma and scleroderma-like disorders: a comprehensive review. Clin Rev Allergy Immunol 53:306\u2013336 [pii]\u00a0https:\/\/doi.org\/10.1007\/s12016-017-8625-410.1007\/s12016-017-8625-4","DOI":"10.1007\/s12016-017-8625-410.1007\/s12016-017-8625-4"},{"key":"8892_CR20","doi-asserted-by":"publisher","unstructured":"Bhattacharyya S, Varga J (2018) Endogenous ligands of TLR4 promote unresolving tissue fibrosis: implications for systemic sclerosis and its targeted therapy. Immunol Lett 195:9\u201317. [pii] S0165-2478(17)30321-8 https:\/\/doi.org\/10.1016\/j.imlet.2017.09.011","DOI":"10.1016\/j.imlet.2017.09.011"},{"key":"8892_CR21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s12016-012-8347-6","volume":"45","author":"J Voswinkel","year":"2013","unstructured":"Voswinkel J, Francois S, Simon JM, Benderitter M, Gorin NC, Mohty M, Fouillard L, Chapel A (2013) Use of mesenchymal stem cells (MSC) in chronic inflammatory fistulizing and fibrotic diseases: a comprehensive review. Clin Rev Allergy Immunol 45:180\u2013192. https:\/\/doi.org\/10.1007\/s12016-012-8347-6","journal-title":"Clin Rev Allergy Immunol"},{"key":"8892_CR22","doi-asserted-by":"publisher","unstructured":"Volkmann\u00a0ER, Varga\u00a0J (2019) Emerging targets of disease-modifying therapy for systemic sclerosis. Nat Rev Rheumatol 15:208\u2013224.\u00a0[pii] https:\/\/doi.org\/10.1038\/s41584-019-0184-z10.1038\/s41584-019-0184-z","DOI":"10.1038\/s41584-019-0184-z10.1038\/s41584-019-0184-z"},{"key":"8892_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/BOR.0b013e32834aa45f","volume":"23","author":"RK Burt","year":"2011","unstructured":"Burt RK, Milanetti F (2011) Hematopoietic stem cell transplantation for systemic sclerosis: history and current status. Curr Opin Rheumatol 23:519\u2013529. https:\/\/doi.org\/10.1097\/BOR.0b013e32834aa45f","journal-title":"Curr Opin Rheumatol"},{"key":"8892_CR24","doi-asserted-by":"publisher","unstructured":"Laar\u00a0JM, van\u00a0Naraghi K, Tyndall\u00a0A (2015) Haematopoietic stem cell transplantation for poor-prognosis systemic sclerosis. Rheumatology (Oxford) 54:2126\u20132133.\u00a0[pii] https:\/\/doi.org\/10.1093\/rheumatology\/kev117kev117","DOI":"10.1093\/rheumatology\/kev117kev117"},{"key":"8892_CR25","doi-asserted-by":"publisher","unstructured":"Del Papa N, Pignataro\u00a0F, Zaccara\u00a0E, Maglione\u00a0W, Minniti\u00a0A (2018) Autologous hematopoietic stem cell transplantation for treatment of systemic sclerosis. Front Immunol 9:2390.\u00a0https:\/\/doi.org\/10.3389\/fimmu.2018.02390","DOI":"10.3389\/fimmu.2018.02390"},{"key":"8892_CR26","doi-asserted-by":"publisher","unstructured":"van Laar JM, Farge\u00a0D, Sont\u00a0JK, Naraghi\u00a0K, Marjanovic\u00a0Z, Larghero\u00a0J, Schuerwegh\u00a0AJ, Marijt\u00a0EW, Vonk\u00a0MC, Schattenberg\u00a0AV, Matucci-Cerinic\u00a0M, Voskuyl\u00a0AE, van de\u00a0Loosdrecht AA, Daikeler\u00a0T, Kotter\u00a0I, Schmalzing\u00a0M, Martin\u00a0T, Lioure\u00a0B, Weiner\u00a0SM, Kreuter\u00a0A, Deligny\u00a0C, Durand\u00a0JM, Emery P, Machold\u00a0KP, Sarrot-Reynauld\u00a0F, Warnatz\u00a0K, Adoue\u00a0DF, Constans\u00a0J, Tony\u00a0HP,\u00a0Del Papa N, Fassas\u00a0A, Himsel\u00a0A, Launay\u00a0D,\u00a0 Lo Monaco\u00a0A, Philippe\u00a0P, Quere\u00a0I, Rich\u00a0E, Westhovens\u00a0R, Griffiths\u00a0B, Saccardi\u00a0R, Hoogen\u00a0FH, van den Fibbe\u00a0WE, Socie\u00a0G, Gratwohl\u00a0A, Tyndall\u00a0A (2014) Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: a randomized clinical trial. JAMA 311:2490\u20132498.\u00a0[pii] https:\/\/doi.org\/10.1001\/jama.2014.63681883019","DOI":"10.1001\/jama.2014.63681883019"},{"key":"8892_CR27","doi-asserted-by":"publisher","unstructured":"Sullivan\u00a0KM, Goldmuntz\u00a0EA, Keyes-Elstein\u00a0L, McSweeney\u00a0PA, Pinckney\u00a0A, Welch\u00a0B, Mayes\u00a0MD, Nash\u00a0RA, Crofford\u00a0LJ, Eggleston\u00a0B, Castina\u00a0S, Griffith\u00a0LM, Goldstein\u00a0JS, Wallace\u00a0D, Craciunescu\u00a0O, Khanna\u00a0D, Folz\u00a0RJ, Goldin\u00a0J, St Clair\u00a0EW, Seibold\u00a0JR, Phillips\u00a0K, Mineishi\u00a0S, Simms\u00a0RW, Ballen\u00a0K, Wener\u00a0MH, Georges\u00a0GE, Heimfeld\u00a0S, Hosing\u00a0C, Forman\u00a0S, Kafaja\u00a0S, Silver\u00a0RM, Griffing\u00a0L, Storek\u00a0J, LeClercq\u00a0S, Brasington\u00a0R, Csuka\u00a0ME, Bredeson\u00a0C, Keever-Taylor\u00a0C, Domsic\u00a0RT, Kahaleh\u00a0MB, Medsger\u00a0T, Furst\u00a0DE (2018) Myeloablative autologous stem-cell transplantation for severe scleroderma. N Engl J Med 378:35\u201347.\u00a0[pii] https:\/\/doi.org\/10.1056\/NEJMoa170332710.1056\/nejmoa1703327","DOI":"10.1056\/NEJMoa170332710.1056\/nejmoa1703327"},{"key":"8892_CR28","doi-asserted-by":"publisher","unstructured":"Burt\u00a0RK, Shah\u00a0SJ, Dill V, Grant\u00a0T, Gheorghiade\u00a0M, Schroeder\u00a0J, Craig\u00a0R, Hirano\u00a0I, Marshall\u00a0K, Ruderman\u00a0E, Jovanovic\u00a0B, Milanetti\u00a0F, Jain\u00a0S, Boyce\u00a0K, Morgan\u00a0A, Carr\u00a0J, Barr\u00a0W (2011) Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial. Lancet 378:498\u2013506.\u00a0[pii]\u00a0S0140-6736(11)60982-3 https:\/\/doi.org\/10.1016\/S0140-6736(11)60982-3","DOI":"10.1016\/S0140-6736(11)60982-3"},{"key":"8892_CR29","doi-asserted-by":"publisher","unstructured":"Pawlak-Bus\u00a0K, Schmidt\u00a0W, Olejarz\u00a0M, Czyz\u00a0A, Komarnicki\u00a0M, Leszczynski\u00a0P (2019) Autologous hematopoietic stem cell transplant for progressive diffuse systemic sclerosis: procedural success and clinical outcome in 5-year follow-up. Reumatologia 57:50\u201354.\u00a0[pii] https:\/\/doi.org\/10.5114\/reum.2019.8324083240","DOI":"10.5114\/reum.2019.8324083240"},{"key":"8892_CR30","doi-asserted-by":"publisher","unstructured":"Shouval\u00a0R, Furie\u00a0N, Raanani\u00a0P, Nagler\u00a0A, Gafter-Gvili\u00a0A (2018) Autologous hematopoietic stem cell transplantation for systemic sclerosis: a systematic review and meta-analysis. Biol Blood Marrow Transplant 24:937\u2013944.\u00a0[pii] S1083-8791(18)30036-3 https:\/\/doi.org\/10.1016\/j.bbmt.2018.01.020","DOI":"10.1016\/j.bbmt.2018.01.020"},{"key":"8892_CR31","doi-asserted-by":"publisher","unstructured":"Kowal-Bielecka\u00a0O, Fransen\u00a0J, Avouac\u00a0J, Becker\u00a0M, Kulak\u00a0A, Allanore\u00a0Y, Distler\u00a0O, Clements\u00a0P, Cutolo\u00a0M, Czirjak\u00a0L, Damjanov\u00a0N, Galdo\u00a0F, Del Denton\u00a0CP, Distler\u00a0JHW, Foeldvari\u00a0I, Figelstone\u00a0K, Frerix\u00a0M, Furst\u00a0DE, Guiducci\u00a0S, Hunzelmann\u00a0N, Khanna D, Matucci-Cerinic\u00a0M, Herrick\u00a0AL, Hoogen\u00a0F, van den Laar JM, van Riemekasten G, Silver\u00a0R, Smith\u00a0V, Sulli\u00a0A, Tarner\u00a0I, Tyndall\u00a0A, Welling\u00a0J, Wigley\u00a0F, Valentini\u00a0G, Walker\u00a0UA, Zulian\u00a0F, Muller-Ladner\u00a0U (2017) Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 76:1327\u20131339.\u00a0[pii]\u00a0https:\/\/doi.org\/10.1136\/annrheumdis-2016-209909annrheumdis-2016-209909","DOI":"10.1136\/annrheumdis-2016-209909annrheumdis-2016-209909"},{"key":"8892_CR32","doi-asserted-by":"publisher","unstructured":"de Vries-Bouwstra\u00a0JK, Allanore Y, Matucci-Cerinic\u00a0M, Balbir-Gurman A (2020) Worldwide expert agreement on updated recommendations for the treatment of systemic sclerosis. J Rheumatol 47:249\u2013254.\u00a0[pii] https:\/\/doi.org\/10.3899\/jrheum.181173jrheum.181173","DOI":"10.3899\/jrheum.181173jrheum.181173"},{"key":"8892_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11926-008-0032-7","volume":"10","author":"JM van Laar","year":"2008","unstructured":"van Laar JM, Tyndall A (2008) Cellular therapy of systemic sclerosis. Curr Rheumatol Rep 10:189\u2013194. https:\/\/doi.org\/10.1007\/s11926-008-0032-7","journal-title":"Curr Rheumatol Rep"},{"key":"8892_CR34","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/01.bor.0000434669.32150.ac","volume":"25","author":"JM van Laar","year":"2013","unstructured":"van Laar JM, Sullivan K (2013) Stem cell transplantation in systemic sclerosis. Curr Opin Rheumatol 25:719\u2013725. https:\/\/doi.org\/10.1097\/01.bor.0000434669.32150.ac","journal-title":"Curr Opin Rheumatol"},{"key":"8892_CR35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/BOR.0000000000000541","volume":"30","author":"J Spierings","year":"2018","unstructured":"Spierings J, van Rhijn-Brouwer FCC, van Laar JM (2018) Hematopoietic stem-cell transplantation in systemic sclerosis: an update. Curr Opin Rheumatol 30:541\u2013547. https:\/\/doi.org\/10.1097\/BOR.0000000000000541","journal-title":"Curr Opin Rheumatol"},{"key":"8892_CR36","unstructured":"Host\u00a0L, Nikpour\u00a0M, Calderone\u00a0A, Cannell\u00a0P, Roddy\u00a0J (2017) Autologous stem cell transplantation in systemic sclerosis: a systematic review. Clin Exp Rheumatol 35 Suppl 106:198\u2013207.\u00a0[pii] 11512"},{"key":"8892_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/sccaa.s5282","volume":"2","author":"W Xiong","year":"2009","unstructured":"Xiong W, Derk CT (2009) Treatment of systemic sclerosis: potential role for stem cell transplantation. Stem Cells Cloning 2:1\u20139. https:\/\/doi.org\/10.2147\/sccaa.s5282","journal-title":"Stem Cells Cloning"},{"key":"8892_CR38","doi-asserted-by":"publisher","unstructured":"Turse\u00a0EP, Dailey\u00a0FE, Naseer\u00a0M, Partyka\u00a0EK, Bragg\u00a0JD, Tahan\u00a0V (2018) Stem cells for luminal, fistulizing, and perianal inflammatory bowel disease: A comprehensive updated review of the literature. Stem Cells Cloning 11:95\u2013113.\u00a0[pii] https:\/\/doi.org\/10.2147\/SCCAA.S135414sccaa-11-095","DOI":"10.2147\/SCCAA.S135414sccaa-11-095"},{"key":"8892_CR39","doi-asserted-by":"publisher","unstructured":"Dazzi\u00a0F,\u00a0Laar van JM,\u00a0Cope A, Tyndall\u00a0A (2007) Cell therapy for autoimmune diseases. Arthritis Res Ther 9:206. [pii] ar2128 https:\/\/doi.org\/10.1186\/ar2128","DOI":"10.1186\/ar2128"},{"key":"8892_CR40","doi-asserted-by":"publisher","unstructured":"Cras\u00a0A, Farge\u00a0D, Carmoi\u00a0T, Lataillade\u00a0JJ, Wang\u00a0DD, Sun\u00a0L (2015) Update on mesenchymal stem cell-based therapy in lupus and scleroderma. Arthritis Res Ther 17\u2013301.\u00a0[pii] https:\/\/doi.org\/10.1186\/s13075-015-0819-710.1186\/s13075-015-0819-7","DOI":"10.1186\/s13075-015-0819-710.1186\/s13075-015-0819-7"},{"key":"8892_CR41","doi-asserted-by":"publisher","unstructured":"Reinders\u00a0ME, Fibbe\u00a0WE, Rabelink\u00a0TJ (2010) Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation. Nephrol Dial Transplant 25:17\u201324.\u00a0[pii] https:\/\/doi.org\/10.1093\/ndt\/gfp552gfp552","DOI":"10.1093\/ndt\/gfp552gfp552"},{"key":"8892_CR42","doi-asserted-by":"publisher","unstructured":"Shi\u00a0Y, Su\u00a0J, Roberts\u00a0AI, Shou\u00a0P, Rabson\u00a0AB, Ren\u00a0G (2012) How mesenchymal stem cells interact with tissue immune responses. Trends Immunol 33:136\u2013143.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.it.2011.11.004S1471-4906(11)00200-6","DOI":"10.1016\/j.it.2011.11.004S1471-4906(11)00200-6"},{"key":"8892_CR43","first-page":"381","volume":"16","author":"AJ Friedenstein","year":"1966","unstructured":"Friedenstein AJ, Piatetzky S II, Petrakova KV (1966) Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol 16:381\u2013390","journal-title":"J Embryol Exp Morphol"},{"key":"8892_CR44","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1365-2184.1970.tb00347.x","volume":"3","author":"AJ Friedenstein","year":"1970","unstructured":"Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393\u2013403. https:\/\/doi.org\/10.1111\/j.1365-2184.1970.tb00347.x","journal-title":"Cell Tissue Kinet"},{"key":"8892_CR45","first-page":"267","volume":"4","author":"AJ Friedenstein","year":"1976","unstructured":"Friedenstein AJ, Gorskaja JF, Kulagina NN (1976) Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4:267\u2013274","journal-title":"Exp Hematol"},{"key":"8892_CR46","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jor.1100090504","volume":"9","author":"AI Caplan","year":"1991","unstructured":"Caplan AI (1991) Mesenchymal stem cells. J Orthop Res 9:641\u2013650. https:\/\/doi.org\/10.1002\/jor.1100090504","journal-title":"J Orthop Res"},{"key":"8892_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143\u2013147. https:\/\/doi.org\/10.1126\/science.284.5411.143","journal-title":"Science"},{"key":"8892_CR48","doi-asserted-by":"publisher","unstructured":"Dominici\u00a0M, Blanc Le\u00a0K, Mueller\u00a0I, Slaper-Cortenbach I, Marini\u00a0F, Krause\u00a0D, Deans\u00a0R,\u00a0 Keating\u00a0A, Prockop\u00a0D, Horwitz\u00a0E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315\u2013317.\u00a0[pii] Q2183N8UT042W62H https:\/\/doi.org\/10.1080\/14653240600855905","DOI":"10.1080\/14653240600855905"},{"key":"8892_CR49","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726\u2013736. https:\/\/doi.org\/10.1038\/nri2395","journal-title":"Nat Rev Immunol"},{"key":"8892_CR50","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/stem.269","volume":"28","author":"HK Salem","year":"2010","unstructured":"Salem HK, Thiemermann C (2010) Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 28:585\u2013596. https:\/\/doi.org\/10.1002\/stem.269","journal-title":"Stem Cells"},{"key":"8892_CR51","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1002\/jcb.24166","volume":"113","author":"DG Phinney","year":"2012","unstructured":"Phinney DG (2012) Functional heterogeneity of mesenchymal stem cells: implications for cell therapy. J Cell Biochem 113:2806\u20132812. https:\/\/doi.org\/10.1002\/jcb.24166","journal-title":"J Cell Biochem"},{"key":"8892_CR52","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/cyto.a.22313","volume":"83","author":"M Corselli","year":"2013","unstructured":"Corselli M, Crisan M, Murray IR, West CC, Scholes J, Codrea F, Khan N, Peault B (2013) Identification of perivascular mesenchymal stromal\/stem cells by flow cytometry. Cytometry A 83:714\u2013720. https:\/\/doi.org\/10.1002\/cyto.a.22313","journal-title":"Cytometry A"},{"key":"8892_CR53","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2298\/sarh1304178t","volume":"141","author":"D Trivanovic","year":"2013","unstructured":"Trivanovic D, Kocic J, Mojsilovic S, Krstic A, Ilic V, Djordjevic IO, Santibanez JF, Jovcic G, Terzic M, Bugarski D (2013) Mesenchymal stem cells isolated from peripheral blood and umbilical cord Wharton\u2019s jelly. Srp Arh Celok Lek 141:178\u2013186. https:\/\/doi.org\/10.2298\/sarh1304178t","journal-title":"Srp Arh Celok Lek"},{"key":"8892_CR54","doi-asserted-by":"publisher","first-page":"6726185","DOI":"10.1155\/2018\/6726185","volume":"2018","author":"J Steens","year":"2018","unstructured":"Steens J, Klein D (2018) Current strategies to generate human mesenchymal stem cells in vitro. Stem Cells Int 2018:6726185. https:\/\/doi.org\/10.1155\/2018\/6726185","journal-title":"Stem Cells Int"},{"key":"8892_CR55","doi-asserted-by":"publisher","unstructured":"Berebichez-Fridman\u00a0R, Montero-Olvera\u00a0PR (2018) Sources and clinical applications of mesenchymal stem cells: State-of-the-art review Sultan Qaboos. Univ Med J 18:e264\u2013e277.\u00a0[pii] https:\/\/doi.org\/10.18295\/squmj.2018.18.03.002squmj1808-e264-277","DOI":"10.18295\/squmj.2018.18.03.002squmj1808-e264-277"},{"key":"8892_CR56","doi-asserted-by":"publisher","first-page":"5373294","DOI":"10.1155\/2018\/5373294","volume":"2018","author":"K Shah","year":"2018","unstructured":"Shah K, Zhao AG, Sumer H (2018) New approaches to treat osteoarthritis with mesenchymal stem cells. Stem Cells Int 2018:5373294. https:\/\/doi.org\/10.1155\/2018\/5373294","journal-title":"Stem Cells Int"},{"key":"8892_CR57","doi-asserted-by":"publisher","unstructured":"Abdallah\u00a0BM, Kassem\u00a0M (2008) Human mesenchymal stem cells: from basic biology to clinical applications. Gene Ther 15:109\u2013116.\u00a0[pii] 3303067 https:\/\/doi.org\/10.1038\/sj.gt.3303067","DOI":"10.1038\/sj.gt.3303067"},{"key":"8892_CR58","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/sctm.17-0129","volume":"6","author":"RM Samsonraj","year":"2017","unstructured":"Samsonraj RM, Raghunath M, Nurcombe V, Hui JH, van Wijnen AJ, Cool SM (2017) Concise review: Multifaceted characterization of human mesenchymal stem cells for use in regenerative medicine. Stem Cells Transl Med 6:2173\u20132185. https:\/\/doi.org\/10.1002\/sctm.17-0129","journal-title":"Stem Cells Transl Med"},{"key":"8892_CR59","doi-asserted-by":"publisher","unstructured":"Bochev\u00a0I, Elmadjian\u00a0G, Kyurkchiev\u00a0D, Tzvetanov\u00a0L, Altankova\u00a0I, Tivchev\u00a0P, Kyurkchiev\u00a0S (2008) Mesenchymal stem cells from human bone marrow or adipose tissue differently modulate mitogen-stimulated B-cell immunoglobulin production in vitro. Cell Biol Int 32:384\u2013393.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.cellbi.2007.12.007S1065-6995(08)00006-1","DOI":"10.1016\/j.cellbi.2007.12.007S1065-6995(08)00006-1"},{"key":"8892_CR60","doi-asserted-by":"publisher","unstructured":"Jang\u00a0S, Cho\u00a0HH, Cho\u00a0YB, Park\u00a0JS, Jeong\u00a0HS (2010) Functional neural differentiation of human adipose tissue-derived stem cells using bFGF and forskolin BMC. Cell Biol 11\u201325.\u00a0[pii] https:\/\/doi.org\/10.1186\/1471-2121-11-251471-2121-11-25","DOI":"10.1186\/1471-2121-11-251471-2121-11-25"},{"key":"8892_CR61","doi-asserted-by":"publisher","unstructured":"Ullah\u00a0I, Subbarao\u00a0RB, Rho\u00a0GJ (2015) Human mesenchymal stem cells - current trends and future prospective. Biosci Rep 35.\u00a0[pii] BSR20150025 https:\/\/doi.org\/10.1042\/BSR20150025e00191","DOI":"10.1042\/BSR20150025e00191"},{"key":"8892_CR62","doi-asserted-by":"publisher","unstructured":"Fujita\u00a0Y, Kadota\u00a0T, Araya\u00a0J, Ochiya\u00a0T, Kuwano\u00a0K (2018) Clinical application of mesenchymal stem cell-derived extracellular vesicle-based therapeutics for inflammatory lung diseases. J Clin Med 7\u00a0E355 [pii] https:\/\/doi.org\/10.3390\/jcm7100355jcm7100355","DOI":"10.3390\/jcm7100355jcm7100355"},{"key":"8892_CR63","doi-asserted-by":"publisher","unstructured":"Gugjoo\u00a0MB, Amarpal\u00a0C, Wani V,\u00a0 Dhama K, Sharma GT (2018) Mesenchymal stem cell research in veterinary medicine. Curr Stem Cell Res Ther 13:645\u2013657.\u00a0[pii] https:\/\/doi.org\/10.2174\/1574888X13666180517074444CSCR-EPUB-90485","DOI":"10.2174\/1574888X13666180517074444CSCR-EPUB-90485"},{"key":"8892_CR64","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1634\/stemcells.22-3-377","volume":"22","author":"J Oswald","year":"2004","unstructured":"Oswald J, Boxberger S, Jorgensen B, Feldmann S, Ehninger G, Bornhauser M, Werner C (2004) Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells 22:377\u2013384. https:\/\/doi.org\/10.1634\/stemcells.22-3-377","journal-title":"Stem Cells"},{"key":"8892_CR65","doi-asserted-by":"publisher","unstructured":"Cipriani\u00a0P, Guiducci\u00a0S, Miniati\u00a0I, Cinelli\u00a0M, Urbani\u00a0S, Marrelli\u00a0A, Dolo\u00a0V, Pavan\u00a0A, Saccardi\u00a0R, Tyndall\u00a0A, Giacomelli\u00a0R, Cerinic\u00a0MM (2007) Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis. Arthritis Rheum 56:1994\u20132004.\u00a0https:\/\/doi.org\/10.1002\/art.22698","DOI":"10.1002\/art.22698"},{"key":"8892_CR66","doi-asserted-by":"publisher","unstructured":"Phinney DG, Prockop\u00a0DJ (2007) Concise review: mesenchymal stem\/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair\u2013current views. Stem Cells 25:2896\u20132902.\u00a0[pii] 2007-0637 https:\/\/doi.org\/10.1634\/stemcells.2007-0637","DOI":"10.1634\/stemcells.2007-0637"},{"key":"8892_CR67","doi-asserted-by":"publisher","first-page":"4357865","DOI":"10.1155\/2018\/4357865","volume":"2018","author":"W Chen","year":"2018","unstructured":"Chen W, Yu Y, Ma J, Olsen N, Lin J (2018) Mesenchymal stem cells in primary Sjogren\u2019s syndrome: prospective and challenges. Stem Cells Int 2018:4357865. https:\/\/doi.org\/10.1155\/2018\/4357865","journal-title":"Stem Cells Int"},{"key":"8892_CR68","first-page":"101","volume":"55","author":"Zemel\u2019ko, VI, Kozhukharova, IB, Ale","year":"2013","unstructured":"Zemel\u2019ko, VI, Kozhukharova, IB, Alekseenko, LL, Domnina, AP, Reshetnikova, GF, Puzanov, MV, Dmitrieva, RI, Grinchuk, TM, Nikol\u2019skii, NN, and Anisimov, SV, (2013) Neurogenic potential of human mesenchymal stem cells isolated from bone marrow, adipose tissue and endometrium: a comparative study. Tsitologiia 55:101\u2013110","journal-title":"Tsitologiia"},{"key":"8892_CR69","doi-asserted-by":"publisher","unstructured":"Aurich\u00a0H, Sgodda\u00a0M, Kaltwasser\u00a0P, Vetter\u00a0M, Weise\u00a0A, Liehr\u00a0T, Brulport\u00a0M, Hengstler\u00a0JG, Dollinger\u00a0MM, Fleig\u00a0WE, Christ\u00a0B (2009) Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo. Gut 58:570\u2013581.\u00a0[pii] https:\/\/doi.org\/10.1136\/gut.2008.154880gut.2008.154880","DOI":"10.1136\/gut.2008.154880gut.2008.154880"},{"key":"8892_CR70","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/524756","volume":"2015","author":"H Shen","year":"2015","unstructured":"Shen H, Wang Y, Zhang Z, Yang J, Hu S, Shen Z (2015) Mesenchymal stem cells for cardiac regenerative therapy: optimization of cell differentiation strategy. Stem Cells Int 2015:524756. https:\/\/doi.org\/10.1155\/2015\/524756","journal-title":"Stem Cells Int"},{"key":"8892_CR71","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/675103","volume":"2015","author":"SJ Hashemian","year":"2015","unstructured":"Hashemian SJ, Kouhnavard M, Nasli-Esfahani E (2015) Mesenchymal stem cells: rising concerns over their application in treatment of type one diabetes mellitus. J Diabetes Res 2015:675103. https:\/\/doi.org\/10.1155\/2015\/675103","journal-title":"J Diabetes Res"},{"key":"8892_CR72","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3389\/fphys.2018.01323","volume":"9","author":"M Fan","year":"2018","unstructured":"Fan M, Zhang J, Xin H, He X, Zhang X (2018) Current perspectives on role of MSC in renal pathophysiology. Front Physiol 9:1323. https:\/\/doi.org\/10.3389\/fphys.2018.01323","journal-title":"Front Physiol"},{"key":"8892_CR73","doi-asserted-by":"publisher","unstructured":"Jayaram\u00a0P, Ikpeama\u00a0U, Rothenberg\u00a0JB, Malanga\u00a0GA (2019) Bone marrow-derived and adipose-derived mesenchymal stem cell therapy in primary knee osteoarthritis: a narrative review. PM R 11:177\u2013191.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.pmrj.2018.06.019S1934-1482(18)30377-0","DOI":"10.1016\/j.pmrj.2018.06.019S1934-1482(18)30377-0"},{"key":"8892_CR74","doi-asserted-by":"publisher","unstructured":"Quimby JM (2019) Stem cell therapy. Vet Clin North Am Small Anim Pract 49 223\u2013231.\u00a0[pii] S0195-5616(18)30128-1 https:\/\/doi.org\/10.1016\/j.cvsm.2018.10.001","DOI":"10.1016\/j.cvsm.2018.10.001"},{"key":"8892_CR75","doi-asserted-by":"publisher","unstructured":"Caplan\u00a0AI, Sorrell\u00a0JM (2015) The MSC curtain that stops the immune system. Immunol Lett 168:136\u2013139.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.imlet.2015.06.005S0165-2478(15)00103-0","DOI":"10.1016\/j.imlet.2015.06.005S0165-2478(15)00103-0"},{"key":"8892_CR76","doi-asserted-by":"publisher","unstructured":"Gazdic\u00a0M, Volarevic\u00a0V, Arsenijevic\u00a0N, Stojkovic\u00a0M (2015) Mesenchymal stem cells: a friend or foe in immune-mediated diseases. Stem Cell Rev Rep 11:280\u2013287.\u00a0https:\/\/doi.org\/10.1007\/s12015-014-9583-3","DOI":"10.1007\/s12015-014-9583-3"},{"key":"8892_CR77","doi-asserted-by":"publisher","unstructured":"Jiang\u00a0Y, Jahagirdar\u00a0BN, Reinhardt\u00a0RL, Schwartz\u00a0RE, Keene\u00a0CD, Ortiz-Gonzalez\u00a0XR, Reyes\u00a0M, Lenvik\u00a0T, Lund\u00a0T, Blackstad\u00a0M, Du\u00a0J, Aldrich\u00a0S, Lisberg\u00a0A, Low\u00a0WC, Largaespada\u00a0DA, Verfaillie\u00a0CM (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418:41\u201349.\u00a0[pii] https:\/\/doi.org\/10.1038\/nature00870nature00870","DOI":"10.1038\/nature00870nature00870"},{"key":"8892_CR78","doi-asserted-by":"publisher","unstructured":"Guiducci S, Porta\u00a0F, Saccardi\u00a0R, Guidi\u00a0S, Ibba-Manneschi\u00a0L, Manetti\u00a0M, Mazzanti\u00a0B,\u00a0Dal Pozzo\u00a0S, Milia\u00a0AF, Bellando-Randone\u00a0S, Miniati\u00a0I, Fiori\u00a0G, Fontana R,\u00a0Amanzi L,\u00a0 Braschi\u00a0F, Bosi\u00a0A, Matucci-Cerinic\u00a0M (2010) Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report. Ann Intern Med 153:650\u2013654.\u00a0[pii] https:\/\/doi.org\/10.7326\/0003-4819-153-10-201011160-00007153\/10\/650","DOI":"10.7326\/0003-4819-153-10-201011160-00007153\/10\/650"},{"key":"8892_CR79","doi-asserted-by":"publisher","unstructured":"Christopeit\u00a0M, Schendel\u00a0M, Foll\u00a0J, Muller\u00a0LP, Keysser\u00a0G, Behre\u00a0G (2008) Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L. Leukemia 22:1062\u20131064.\u00a0[pii] 2404996 https:\/\/doi.org\/10.1038\/sj.leu.2404996","DOI":"10.1038\/sj.leu.2404996"},{"key":"8892_CR80","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1002\/art.30431","volume":"63","author":"G Keyszer","year":"2011","unstructured":"Keyszer G, Christopeit M, Fick S, Schendel M, Taute BM, Behre G, Muller LP, Schmoll HJ (2011) Treatment of severe progressive systemic sclerosis with transplantation of mesenchymal stromal cells from allogeneic related donors: report of five cases. Arthritis Rheum 63:2540\u20132542. https:\/\/doi.org\/10.1002\/art.30431","journal-title":"Arthritis Rheum"},{"key":"8892_CR81","doi-asserted-by":"publisher","unstructured":"Granel\u00a0B, Daumas\u00a0A, Jouve\u00a0E, Harle\u00a0JR, Nguyen\u00a0PS, Chabannon\u00a0C, Colavolpe\u00a0N, Reynier\u00a0JC, Truillet\u00a0R, Mallet\u00a0S, Baiada\u00a0A, Casanova\u00a0D, Giraudo\u00a0L, Arnaud L, Veran\u00a0J,\u00a0 Sabatier\u00a0F, Magalon\u00a0G (2015) Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: an open-label phase I trial. Ann Rheum Dis 74:2175\u20132182.\u00a0[pii] https:\/\/doi.org\/10.1136\/annrheumdis-2014-205681annrheumdis-2014-205681","DOI":"10.1136\/annrheumdis-2014-205681annrheumdis-2014-205681"},{"key":"8892_CR82","doi-asserted-by":"publisher","unstructured":"Wehbe\u00a0T, Abi Saab\u00a0M, Abi Chahine\u00a0N, Margossian T (2016) Mesenchymal stem cell therapy for refractory scleroderma: A Report of 2 cases. Stem Cell Investig 3\u201348.\u00a0[pii] https:\/\/doi.org\/10.21037\/sci.2016.09.03sci-03-2016.09.03","DOI":"10.21037\/sci.2016.09.03sci-03-2016.09.03"},{"key":"8892_CR83","doi-asserted-by":"publisher","unstructured":"Chen PM, Yen\u00a0ML, Liu\u00a0KJ, Sytwu\u00a0HK, Yen\u00a0BL (2011)\u00a0Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. J Biomed Sci 18\u201349.\u00a0[pii]\u00a0 https:\/\/doi.org\/10.1186\/1423-0127-18-491423-0127-18-49","DOI":"10.1186\/1423-0127-18-491423-0127-18-49"},{"key":"8892_CR84","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1089\/scd.2011.0722","volume":"21","author":"M Strioga","year":"2012","unstructured":"Strioga M, Viswanathan S, Darinskas A, Slaby O, Michalek J (2012) Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells. Stem Cells Dev 21:2724\u20132752. https:\/\/doi.org\/10.1089\/scd.2011.0722","journal-title":"Stem Cells Dev"},{"key":"8892_CR85","doi-asserted-by":"publisher","unstructured":"Hass\u00a0R, Kasper\u00a0C, Bohm\u00a0S, Jacobs\u00a0R (2011) Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal 9\u201312.\u00a0[pii]\u00a0 https:\/\/doi.org\/10.1186\/1478-811X-9-121478-811X-9-12","DOI":"10.1186\/1478-811X-9-121478-811X-9-12"},{"key":"8892_CR86","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/978-1-61779-815-3_30","volume":"879","author":"M Camassola","year":"2012","unstructured":"Camassola M, de Macedo Braga LM, Chagastelles PC, Nardi NB (2012) Methodology, biology and clinical applications of human mesenchymal stem cells. Methods Mol Biol 879:491\u2013504. https:\/\/doi.org\/10.1007\/978-1-61779-815-3_30","journal-title":"Methods Mol Biol"},{"key":"8892_CR87","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1242\/jcs.02932","volume":"119","author":"L da Silva Meirelles","year":"2006","unstructured":"da Silva Meirelles L, Chagastelles PC, Nardi NB (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119:2204\u20132213.\u00a0[pii] jcs.02932 https:\/\/doi.org\/10.1242\/jcs.02932","journal-title":"J Cell Sci"},{"key":"8892_CR88","doi-asserted-by":"publisher","unstructured":"Kern\u00a0S, Eichler\u00a0H, Stoeve\u00a0J, Kluter\u00a0H, Bieback\u00a0K (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24:1294\u20131301.\u00a0[pii] 2005-03421 https:\/\/doi.org\/10.1634\/stemcells.2005-0342","DOI":"10.1634\/stemcells.2005-0342"},{"key":"8892_CR89","doi-asserted-by":"publisher","first-page":"288","DOI":"10.4252\/wjsc.v6.i3.288","volume":"6","author":"HT Liao","year":"2014","unstructured":"Liao HT, Chen CT (2014) Osteogenic potential: comparison between bone marrow and adipose-derived mesenchymal stem cells. World J Stem Cells 6:288\u2013295. https:\/\/doi.org\/10.4252\/wjsc.v6.i3.288","journal-title":"World J Stem Cells"},{"key":"8892_CR90","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/dgd.12049","volume":"55","author":"M Konno","year":"2013","unstructured":"Konno M, Hamabe A, Hasegawa S, Ogawa H, Fukusumi T, Nishikawa S, Ohta K, Kano Y, Ozaki M, Noguchi Y, Sakai D, Kudoh T, Kawamoto K, Eguchi H, Satoh T, Tanemura M, Nagano H, Doki Y, Mori M, Ishii H (2013) Adipose-derived mesenchymal stem cells and regenerative medicine. Dev Growth Differ 55:309\u2013318. https:\/\/doi.org\/10.1111\/dgd.12049","journal-title":"Dev Growth Differ"},{"key":"8892_CR91","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40001-017-0258-9","volume":"22","author":"S Schneider","year":"2017","unstructured":"Schneider S, Unger M, van Griensven M, Balmayor ER (2017) Adipose-derived mesenchymal stem cells from liposuction and resected fat are feasible sources for regenerative medicine. Eur J Med Res 22:17.\u00a0[pii] https:\/\/doi.org\/10.1186\/s40001-017-0258-910.1186\/s40001-017-0258-9","journal-title":"Eur J Med Res"},{"key":"8892_CR92","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1634\/stemcells.21-1-105","volume":"21","author":"YA Romanov","year":"2003","unstructured":"Romanov YA, Svintsitskaya VA, Smirnov VN (2003) Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 21:105\u2013110. https:\/\/doi.org\/10.1634\/stemcells.21-1-105","journal-title":"Stem Cells"},{"key":"8892_CR93","doi-asserted-by":"publisher","unstructured":"Bieback\u00a0K, Kern\u00a0S, Kluter\u00a0H, Eichler\u00a0H (2004) Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22:625\u2013634.\u00a0[pii] 22\/4\/625 https:\/\/doi.org\/10.1634\/stemcells.22-4-625","DOI":"10.1634\/stemcells.22-4-625"},{"key":"8892_CR94","doi-asserted-by":"publisher","unstructured":"Mennan\u00a0C, Brown\u00a0S, McCarthy\u00a0H, Mavrogonatou\u00a0E, Kletsas\u00a0D, Garcia\u00a0J, Balain\u00a0B,\u00a0 Richardson\u00a0J, Roberts\u00a0S (2016) Mesenchymal stromal cells derived from whole human umbilical cord exhibit similar properties to those derived from Wharton\u2019s jelly and bone marrow FEBS. Open Bio 6:1054\u20131066.\u00a0[pii] https:\/\/doi.org\/10.1002\/2211-5463.12104FEB412104","DOI":"10.1002\/2211-5463.12104FEB412104"},{"key":"8892_CR95","doi-asserted-by":"publisher","unstructured":"Lee\u00a0OK, Kuo\u00a0TK, Chen\u00a0WM, Lee\u00a0KD, Hsieh\u00a0SL, Chen\u00a0TH (2004) Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 103:1669\u20131675.\u00a0[pii] https:\/\/doi.org\/10.1182\/blood-2003-05-16702003-05-1670","DOI":"10.1182\/blood-2003-05-16702003-05-1670"},{"key":"8892_CR96","doi-asserted-by":"publisher","unstructured":"Miao\u00a0Z, Jin\u00a0J, Chen\u00a0L, Zhu\u00a0J, Huang\u00a0W, Zhao\u00a0J, Qian\u00a0H, Zhang\u00a0X (2006) Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Cell Biol Int 30:681\u2013687.\u00a0[pii] S1065-6995(06)00088-6 https:\/\/doi.org\/10.1016\/j.cellbi.2006.03.009","DOI":"10.1016\/j.cellbi.2006.03.009"},{"key":"8892_CR97","doi-asserted-by":"publisher","unstructured":"In \u2018t Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE, Kanhai HH (2004) Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22:1338\u20131345.\u00a0[pii] 22\/7\/1338 https:\/\/doi.org\/10.1634\/stemcells.2004-0058","DOI":"10.1634\/stemcells.2004-0058"},{"key":"8892_CR98","doi-asserted-by":"publisher","unstructured":"Li\u00a0L, Wang\u00a0D, Zhou\u00a0J, Cheng\u00a0Y, Liang\u00a0T, Zhang\u00a0G (2015) Characteristics of human amniotic fluid mesenchymal stem cells and their tropism to human ovarian cancer. PLoS One 10:e0123350.\u00a0[pii] https:\/\/doi.org\/10.1371\/journal.pone.0123350PONE-D-14-47125","DOI":"10.1371\/journal.pone.0123350PONE-D-14-47125"},{"key":"8892_CR99","doi-asserted-by":"publisher","unstructured":"Baulier\u00a0E, Favreau\u00a0F, Corf Le\u00a0A, Jayle\u00a0C, Schneider\u00a0F, Goujon\u00a0JM, Feraud\u00a0O, Bennaceur-Griscelli\u00a0A, Hauet\u00a0T, Turhan\u00a0AG (2014) Amniotic fluid-derived mesenchymal stem cells prevent fibrosis and preserve renal function in a preclinical porcine model of kidney transplantation. Stem Cells Transl Med 3 809\u2013820.\u00a0[pii] https:\/\/doi.org\/10.5966\/sctm.2013-0186sctm.2013-0186","DOI":"10.5966\/sctm.2013-0186sctm.2013-0186"},{"key":"8892_CR100","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1182\/blood.v98.8.2396","volume":"98","author":"C Campagnoli","year":"2001","unstructured":"Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM (2001) Identification of mesenchymal stem\/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98:2396\u20132402. https:\/\/doi.org\/10.1182\/blood.v98.8.2396","journal-title":"Blood"},{"key":"8892_CR101","doi-asserted-by":"publisher","unstructured":"Wang\u00a0XJ, Xiang\u00a0BY, Ding\u00a0YH, Chen\u00a0L, Zou\u00a0H, Mou\u00a0XZ, Xiang\u00a0C (2017) Human menstrual blood-derived mesenchymal stem cells as a cellular vehicle for malignant glioma gene therapy. Oncotarget 8:58309\u201358321.\u00a0[pii] https:\/\/doi.org\/10.18632\/oncotarget.1762117621","DOI":"10.18632\/oncotarget.1762117621"},{"key":"8892_CR102","doi-asserted-by":"publisher","unstructured":"Gargett\u00a0CE, Schwab\u00a0KE, Zillwood\u00a0RM, Nguyen\u00a0HP, Wu\u00a0D (2009) Isolation and culture of epithelial progenitors and mesenchymal stem cells from human endometrium. Biol Reprod 80:1136\u20131145. [pii] https:\/\/doi.org\/10.1095\/biolreprod.108.075226biolreprod.108.075226","DOI":"10.1095\/biolreprod.108.075226biolreprod.108.075226"},{"key":"8892_CR103","doi-asserted-by":"publisher","unstructured":"Tomar\u00a0GB, Srivastava\u00a0RK, Gupta\u00a0N, Barhanpurkar\u00a0AP, Pote\u00a0ST, Jhaveri\u00a0HM, Mishra\u00a0GC,\u00a0 Wani\u00a0MR (2010) Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicine. Biochem Biophys Res Commun 393:377\u2013383.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.bbrc.2010.01.126S0006-291X(10)00191-9","DOI":"10.1016\/j.bbrc.2010.01.126S0006-291X(10)00191-9"},{"key":"8892_CR104","doi-asserted-by":"publisher","unstructured":"Huang\u00a0GT, Gronthos\u00a0S, Shi\u00a0S (2009) Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J Dent Res 88:792\u2013806.\u00a0[pii] https:\/\/doi.org\/10.1177\/002203450934086788\/9\/792","DOI":"10.1177\/002203450934086788\/9\/792"},{"key":"8892_CR105","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1089\/ten.tec.2008.0031","volume":"14","author":"BC Perry","year":"2008","unstructured":"Perry BC, Zhou D, Wu X, Yang FC, Byers MA, Chu TM, Hockema JJ, Woods EJ, Goebel WS (2008) Collection, cryopreservation, and characterization of human dental pulp-derived mesenchymal stem cells for banking and clinical use. Tissue Eng Part C Methods 14:149\u2013156. https:\/\/doi.org\/10.1089\/ten.tec.2008.0031","journal-title":"Tissue Eng Part C Methods"},{"key":"8892_CR106","doi-asserted-by":"publisher","unstructured":"Galipeau J, Sensebe\u00a0L (2018) Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell 22:824\u2013833.\u00a0[pii] S1934-5909(18)30222-4 https:\/\/doi.org\/10.1016\/j.stem.2018.05.004","DOI":"10.1016\/j.stem.2018.05.004"},{"key":"8892_CR107","doi-asserted-by":"publisher","unstructured":"Poltavtseva\u00a0RA, Poltavtsev\u00a0AV, Lutsenko\u00a0GV, Svirshchevskaya\u00a0EV (2019) Myths, reality and future of mesenchymal stem cell therapy. Cell Tissue Res 375:563\u2013574.\u00a0[pii] https:\/\/doi.org\/10.1007\/s00441-018-2961-410.1007\/s00441-018-2961-4","DOI":"10.1007\/s00441-018-2961-410.1007\/s00441-018-2961-4"},{"key":"8892_CR108","doi-asserted-by":"publisher","unstructured":"Baksh\u00a0D, Yao\u00a0R, Tuan\u00a0RS (2007) Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25:1384\u20131392.\u00a0[pii] 2006-0709 https:\/\/doi.org\/10.1634\/stemcells.2006-0709","DOI":"10.1634\/stemcells.2006-0709"},{"key":"8892_CR109","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1089\/scd.2013.0016","volume":"22","author":"H Wegmeyer","year":"2013","unstructured":"Wegmeyer H, Broske AM, Leddin M, Kuentzer K, Nisslbeck AK, Hupfeld J, Wiechmann K, Kuhlen J, von Schwerin C, Stein C, Knothe S, Funk J, Huss R, Neubauer M (2013) Mesenchymal stromal cell characteristics vary depending on their origin. Stem Cells Dev 22:2606\u20132618. https:\/\/doi.org\/10.1089\/scd.2013.0016","journal-title":"Stem Cells Dev"},{"key":"8892_CR110","doi-asserted-by":"publisher","unstructured":"Zhang\u00a0J, Chen\u00a0J (2017) Bone tissue regeneration - application of mesenchymal stem cells and cellular and molecular mechanisms. Curr Stem Cell Res Ther 12:357\u2013364.\u00a0[pii] https:\/\/doi.org\/10.2174\/1574888X11666160921121555CSCRT-EPUB-78467","DOI":"10.2174\/1574888X11666160921121555CSCRT-EPUB-78467"},{"key":"8892_CR111","doi-asserted-by":"publisher","first-page":"8329174","DOI":"10.1155\/2018\/8329174","volume":"2018","author":"T Sultana","year":"2018","unstructured":"Sultana T, Lee S, Yoon HY, Lee JI (2018) Current status of canine umbilical cord blood-derived mesenchymal stem cells in veterinary medicine. Stem Cells Int 2018:8329174. https:\/\/doi.org\/10.1155\/2018\/8329174","journal-title":"Stem Cells Int"},{"key":"8892_CR112","doi-asserted-by":"publisher","first-page":"8570","DOI":"10.1002\/jcp.27833","volume":"234","author":"L Aghebati-Maleki","year":"2019","unstructured":"Aghebati-Maleki L, Dolati S, Zandi R, Fotouhi A, Ahmadi M, Aghebati A, Nouri M, Kazem Shakouri S, Yousefi M (2019) Prospect of mesenchymal stem cells in therapy of osteoporosis: a review. J Cell Physiol 234:8570\u20138578. https:\/\/doi.org\/10.1002\/jcp.27833","journal-title":"J Cell Physiol"},{"key":"8892_CR113","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/j.1582-4934.2011.01335.x","volume":"16","author":"HT Chen","year":"2012","unstructured":"Chen HT, Lee MJ, Chen CH, Chuang SC, Chang LF, Ho ML, Hung SH, Fu YC, Wang YH, Wang HI, Wang GJ, Kang L, Chang JK (2012) Proliferation and differentiation potential of human adipose-derived mesenchymal stem cells isolated from elderly patients with osteoporotic fractures. J Cell Mol Med 16:582\u2013593. https:\/\/doi.org\/10.1111\/j.1582-4934.2011.01335.x","journal-title":"J Cell Mol Med"},{"key":"8892_CR114","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/jcb.20904","volume":"99","author":"R Izadpanah","year":"2006","unstructured":"Izadpanah R, Trygg C, Patel B, Kriedt C, Dufour J, Gimble JM, Bunnell BA (2006) Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem 99:1285\u20131297. https:\/\/doi.org\/10.1002\/jcb.20904","journal-title":"J Cell Biochem"},{"key":"8892_CR115","doi-asserted-by":"publisher","unstructured":"Ikegame\u00a0Y, Yamashita\u00a0K, Hayashi\u00a0S, Mizuno\u00a0H, Tawada\u00a0M, You\u00a0F, Yamada\u00a0K, Tanaka\u00a0Y, Egashira\u00a0Y, Nakashima\u00a0S, Yoshimura\u00a0S, Iwama T (2011) Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. Cytotherapy 13:675\u2013685.\u00a0[pii] https:\/\/doi.org\/10.3109\/14653249.2010.549122S1465-3249(11)70547-3","DOI":"10.3109\/14653249.2010.549122S1465-3249(11)70547-3"},{"key":"8892_CR116","doi-asserted-by":"publisher","unstructured":"Dmitrieva\u00a0RI, Minullina\u00a0IR, Bilibina\u00a0AA, Tarasova\u00a0OV, Anisimov SV, Zaritskey\u00a0AY (2012) Bone marrow- and subcutaneous adipose tissue-derived mesenchymal stem cells: differences and similarities. Cell Cycle 11:377\u2013383.\u00a0[pii] https:\/\/doi.org\/10.4161\/cc.11.2.1885818858","DOI":"10.4161\/cc.11.2.1885818858"},{"key":"8892_CR117","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/cbf.1488","volume":"26","author":"Y Zhu","year":"2008","unstructured":"Zhu Y, Liu T, Song K, Fan X, Ma X, Cui Z (2008) Adipose-derived stem cell: a better stem cell than BMSC. Cell Biochem Funct 26:664\u2013675. https:\/\/doi.org\/10.1002\/cbf.1488","journal-title":"Cell Biochem Funct"},{"key":"8892_CR118","doi-asserted-by":"publisher","first-page":"8490489","DOI":"10.1155\/2018\/8490489","volume":"2018","author":"Y Nam","year":"2018","unstructured":"Nam Y, Rim YA, Lee J, Ju JH (2018) Current therapeutic strategies for stem cell-based cartilage regeneration. Stem Cells Int 2018:8490489. https:\/\/doi.org\/10.1155\/2018\/8490489","journal-title":"Stem Cells Int"},{"key":"8892_CR119","doi-asserted-by":"publisher","unstructured":"Fazzina\u00a0R, Iudicone\u00a0P, Fioravanti\u00a0D, Bonanno\u00a0G, Totta\u00a0P, Zizzari\u00a0IG, Pierelli\u00a0L (2016) Potency testing of mesenchymal stromal cell growth expanded in human platelet lysate from different human tissues. Stem Cell Res Ther 7\u2013122.\u00a0[pii] https:\/\/doi.org\/10.1186\/s13287-016-0383-310.1186\/s13287-016-0383-3","DOI":"10.1186\/s13287-016-0383-310.1186\/s13287-016-0383-3"},{"key":"8892_CR120","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10616-012-9428-3","volume":"64","author":"TT Sibov","year":"2012","unstructured":"Sibov TT, Severino P, Marti LC, Pavon LF, Oliveira DM, Tobo PR, Campos AH, Paes AT, Amaro E Jr, FG L, Moreira-Filho CA (2012) Mesenchymal stem cells from umbilical cord blood: parameters for isolation, characterization and adipogenic differentiation. Cytotechnology 64:511\u2013521. https:\/\/doi.org\/10.1007\/s10616-012-9428-3","journal-title":"Cytotechnology"},{"key":"8892_CR121","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s10616-014-9718-z","volume":"67","author":"R Secunda","year":"2015","unstructured":"Secunda R, Vennila R, Mohanashankar AM, Rajasundari M, Jeswanth S, Surendran R (2015) Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study. Cytotechnology 67:793\u2013807. https:\/\/doi.org\/10.1007\/s10616-014-9718-z","journal-title":"Cytotechnology"},{"key":"8892_CR122","doi-asserted-by":"publisher","unstructured":"Wang\u00a0S, Zhu\u00a0R, Li\u00a0H, Li\u00a0J, Han\u00a0Q, Zhao\u00a0RC (2019) Mesenchymal stem cells and immune disorders: from basic science to clinical transition. Front Med 13:138\u2013151.\u00a0[pii] https:\/\/doi.org\/10.1007\/s11684-018-0627-y10.1007\/s11684-018-0627-y","DOI":"10.1007\/s11684-018-0627-y10.1007\/s11684-018-0627-y"},{"key":"8892_CR123","doi-asserted-by":"publisher","unstructured":"Li\u00a0CY, Wu\u00a0XY, Tong\u00a0JB, Yang\u00a0XX, Zhao\u00a0JL, Zheng\u00a0QF, Zhao\u00a0GB, Ma\u00a0ZJ (2015) Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under xeno-free conditions for cell therapy. Stem Cell Res Ther 6\u201355.\u00a0[pii] https:\/\/doi.org\/10.1186\/s13287-015-0066-510.1186\/s13287-015-0066-5","DOI":"10.1186\/s13287-015-0066-510.1186\/s13287-015-0066-5"},{"key":"8892_CR124","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/jcp.26904","volume":"234","author":"K Roszek","year":"2018","unstructured":"Roszek K, Wujak M (2018) How to influence the mesenchymal stem cells fate? Emerging role of ectoenzymes metabolizing nucleotides. J Cell Physiol 234:320\u2013334. https:\/\/doi.org\/10.1002\/jcp.26904","journal-title":"J Cell Physiol"},{"key":"8892_CR125","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1089\/scd.2007.0217","volume":"17","author":"L Peng","year":"2008","unstructured":"Peng L, Jia Z, Yin X, Zhang X, Liu Y, Chen P, Ma K, Zhou C (2008) Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem Cells Dev 17:761\u2013773. https:\/\/doi.org\/10.1089\/scd.2007.0217","journal-title":"Stem Cells Dev"},{"key":"8892_CR126","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1089\/ten.2006.0118","volume":"13","author":"H Afizah","year":"2007","unstructured":"Afizah H, Yang Z, Hui JH, Ouyang HW, Lee EH (2007) A comparison between the chondrogenic potential of human bone marrow stem cells (BMSCs) and adipose-derived stem cells (ADSCs) taken from the same donors. Tissue Eng 13:659\u2013666. https:\/\/doi.org\/10.1089\/ten.2006.0118","journal-title":"Tissue Eng"},{"key":"8892_CR127","doi-asserted-by":"publisher","unstructured":"Niemeyer\u00a0P, Fechner\u00a0K, Milz\u00a0S, Richter\u00a0W, Suedkamp\u00a0NP, Mehlhorn\u00a0AT, Pearce\u00a0S, Kasten\u00a0P (2010) Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma. Biomaterials 31:3572\u20133579.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.biomaterials.2010.01.085S0142-9612(10)00117-1","DOI":"10.1016\/j.biomaterials.2010.01.085S0142-9612(10)00117-1"},{"key":"8892_CR128","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4274\/tjh.2016.0171","volume":"34","author":"E Karaoz","year":"2017","unstructured":"Karaoz E, Demircan PC, Erman G, Gungorurler E, Eker Sariboyaci A (2017) Comparative analyses of immunosuppressive characteristics of bone-marrow, Wharton\u2019s jelly, and adipose tissue-derived human mesenchymal stem cells. Turk J Haematol 34:213\u2013225. https:\/\/doi.org\/10.4274\/tjh.2016.0171","journal-title":"Turk J Haematol"},{"key":"8892_CR129","doi-asserted-by":"publisher","unstructured":"Yousefi\u00a0F, Arab\u00a0FL, Saeidi\u00a0K, Amiri\u00a0H, Mahmoudi\u00a0M (2019) Various strategies to improve efficacy of stem cell transplantation in multiple sclerosis: focus on mesenchymal stem cells and neuroprotection. J Neuroimmunol 328:20\u201334.\u00a0[pii] S0165-5728(18)30470-3 https:\/\/doi.org\/10.1016\/j.jneuroim.2018.11.015","DOI":"10.1016\/j.jneuroim.2018.11.015"},{"key":"8892_CR130","doi-asserted-by":"publisher","unstructured":"Amable\u00a0PR, Teixeira\u00a0MV, Carias\u00a0RB, Granjeiro\u00a0JM, Borojevic\u00a0R (2014) Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton\u2019s jelly. Stem Cell Res Ther 5\u201353.\u00a0[pii] https:\/\/doi.org\/10.1186\/scrt442scrt442","DOI":"10.1186\/scrt442scrt442"},{"key":"8892_CR131","doi-asserted-by":"publisher","first-page":"2406462","DOI":"10.1155\/2018\/2406462","volume":"2018","author":"AS Ansari","year":"2018","unstructured":"Ansari AS, Yazid MD, Sainik N, Razali RA, Saim AB, Idrus RBH (2018) Osteogenic induction of Wharton\u2019s jelly-derived mesenchymal stem cell for bone regeneration: a systematic review. Stem Cells Int 2018:2406462. https:\/\/doi.org\/10.1155\/2018\/2406462","journal-title":"Stem Cells Int"},{"key":"8892_CR132","doi-asserted-by":"publisher","unstructured":"Kim\u00a0WS, Park\u00a0BS, Kim\u00a0HK, Park\u00a0JS, Kim\u00a0KJ, Choi\u00a0JS, Chung\u00a0SJ, Kim\u00a0DD, Sung\u00a0JH (2008) Evidence supporting antioxidant action of adipose-derived stem cells: protection of human dermal fibroblasts from oxidative stress. J Dermatol Sci 49:133\u2013142.\u00a0[pii] S0923-1811(07)00286-1 https:\/\/doi.org\/10.1016\/j.jdermsci.2007.08.004","DOI":"10.1016\/j.jdermsci.2007.08.004"},{"key":"8892_CR133","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1517\/14712590903039684","volume":"9","author":"WS Kim","year":"2009","unstructured":"Kim WS, Park BS, Sung JH (2009) The wound-healing and antioxidant effects of adipose-derived stem cells. Expert Opin Biol Ther 9:879\u2013887. https:\/\/doi.org\/10.1517\/14712590903039684","journal-title":"Expert Opin Biol Ther"},{"key":"8892_CR134","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4055\/cios.2018.10.3.271","volume":"10","author":"YZ Jin","year":"2018","unstructured":"Jin YZ, Lee JH (2018) Mesenchymal stem cell therapy for bone regeneration. Clin Orthop Surg 10:271\u2013278. https:\/\/doi.org\/10.4055\/cios.2018.10.3.271","journal-title":"Clin Orthop Surg"},{"key":"8892_CR135","doi-asserted-by":"publisher","unstructured":"Meza-Zepeda\u00a0LA, Noer\u00a0A, Dahl\u00a0JA, Micci\u00a0F, Myklebost\u00a0O, Collas\u00a0P (2008) High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence. J Cell Mol Med 12:553\u2013563.\u00a0[pii] https:\/\/doi.org\/10.1111\/j.1582-4934.2007.00146.xJCMM146","DOI":"10.1111\/j.1582-4934.2007.00146.xJCMM146"},{"key":"8892_CR136","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/03946320130260S102","volume":"26","author":"C Bellotti","year":"2013","unstructured":"Bellotti C, Stanco D, Ragazzini S, Romagnoli L, Martella E, Lazzati S, Marchetti C, Donati D, Lucarelli E (2013) Analysis of the karyotype of expanded human adipose-derived stem cells for bone reconstruction of the maxillo-facial region. Int J Immunopathol Pharmacol 26:3\u20139. https:\/\/doi.org\/10.1177\/03946320130260S102","journal-title":"Int J Immunopathol Pharmacol"},{"key":"8892_CR137","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/812693","volume":"2012","author":"PC Baer","year":"2012","unstructured":"Baer PC, Geiger H (2012) Adipose-derived mesenchymal stromal\/stem cells: tissue localization, characterization, and heterogeneity. Stem Cells Int 2012:812693. https:\/\/doi.org\/10.1155\/2012\/812693","journal-title":"Stem Cells Int"},{"key":"8892_CR138","doi-asserted-by":"publisher","first-page":"8947548","DOI":"10.1155\/2018\/8947548","volume":"2018","author":"SL Francis","year":"2018","unstructured":"Francis SL, Duchi S, Onofrillo C, Di Bella C, Choong PFM (2018) Adipose-derived mesenchymal stem cells in the use of cartilage tissue engineering: the need for a rapid isolation procedure. Stem Cells Int 2018:8947548. https:\/\/doi.org\/10.1155\/2018\/8947548","journal-title":"Stem Cells Int"},{"key":"8892_CR139","doi-asserted-by":"publisher","unstructured":"Damia\u00a0E, Chicharro\u00a0D, Lopez\u00a0S, Cuervo\u00a0B, Rubio\u00a0M, Sopena\u00a0JJ, Vilar\u00a0JM, Carrillo\u00a0JM (2018) Adipose-derived mesenchymal stem cells: are they a good therapeutic strategy for osteoarthritis?. Int J Mol Sci 19 E1926.\u00a0[pii] https:\/\/doi.org\/10.3390\/ijms19071926ijms19071926","DOI":"10.3390\/ijms19071926ijms19071926"},{"key":"8892_CR140","doi-asserted-by":"publisher","unstructured":"Mitchell\u00a0JB, McIntosh\u00a0K, Zvonic\u00a0S, Garrett\u00a0S, Floyd\u00a0ZE, Kloster\u00a0A, Halvorsen\u00a0Y, Storms\u00a0DR, Goh\u00a0B, Kilroy\u00a0G, Wu\u00a0X, Gimble\u00a0JM (2006) Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells 24:376\u2013385.\u00a0[pii] 2005-0234 https:\/\/doi.org\/10.1634\/stemcells.2005-0234","DOI":"10.1634\/stemcells.2005-0234"},{"key":"8892_CR141","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1002\/jbm.a.36089","volume":"105","author":"GI Im","year":"2017","unstructured":"Im GI (2017) Bone marrow-derived stem\/stromal cells and adipose tissue-derived stem\/stromal cells: their comparative efficacies and synergistic effects. J Biomed Mater Res A 105:2640\u20132648. https:\/\/doi.org\/10.1002\/jbm.a.36089","journal-title":"J Biomed Mater Res A"},{"key":"8892_CR142","doi-asserted-by":"publisher","unstructured":"Ivanova-Todorova\u00a0E, Bochev\u00a0I, Mourdjeva\u00a0M, Dimitrov\u00a0R, Bukarev\u00a0D, Kyurkchiev\u00a0S,\u00a0 Tivchev\u00a0P, Altunkova\u00a0I, Kyurkchiev\u00a0DS (2009) Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells. Immunol Lett 126:37\u201342.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.imlet.2009.07.010S0165-2478(09)00185-0","DOI":"10.1016\/j.imlet.2009.07.010S0165-2478(09)00185-0"},{"key":"8892_CR143","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12015-012-9365-8","volume":"9","author":"M Al-Nbaheen","year":"2013","unstructured":"Al-Nbaheen M, Vishnubalaji R, Ali D, Bouslimi A, Al-Jassir F, Megges M, Prigione A, Adjaye J, Kassem M, Aldahmash A (2013) Human stromal (mesenchymal) stem cells from bone marrow, adipose tissue and skin exhibit differences in molecular phenotype and differentiation potential. Stem Cell Rev Rep 9:32\u201343. https:\/\/doi.org\/10.1007\/s12015-012-9365-8","journal-title":"Stem Cell Rev Rep"},{"key":"8892_CR144","doi-asserted-by":"publisher","unstructured":"Shi\u00a0Y, Wang\u00a0Y, Li\u00a0Q, Liu\u00a0K, Hou\u00a0J, Shao\u00a0C (2018) Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol 14:493\u2013507.\u00a0[pii] https:\/\/doi.org\/10.1038\/s41581-018-0023-510.1038\/s41581-018-0023-5","DOI":"10.1038\/s41581-018-0023-510.1038\/s41581-018-0023-5"},{"key":"8892_CR145","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3389\/fimmu.2018.01658","volume":"9","author":"L Yan","year":"2018","unstructured":"Yan L, Zheng D, Xu RH (2018) Critical role of tumor necrosis factor signaling in mesenchymal stem cell-based therapy for autoimmune and inflammatory diseases. Front Immunol 9:1658. https:\/\/doi.org\/10.3389\/fimmu.2018.01658","journal-title":"Front Immunol"},{"key":"8892_CR146","doi-asserted-by":"publisher","unstructured":"Djouad\u00a0F, Bony\u00a0C, Haupl\u00a0T, Uze\u00a0G, Lahlou\u00a0N, Louis-Plence\u00a0P, Apparailly\u00a0F, Canovas\u00a0F, Reme\u00a0T, Sany\u00a0J, Jorgensen\u00a0C, Noel\u00a0D (2005) Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal stem cells. Arthritis Res Ther 7:1304\u20131315.\u00a0[pii] ar1827 https:\/\/doi.org\/10.1186\/ar1827","DOI":"10.1186\/ar1827"},{"key":"8892_CR147","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/jcb.25395","volume":"117","author":"YJ Jeon","year":"2016","unstructured":"Jeon YJ, Kim J, Cho JH, Chung HM, Chae JI (2016) Comparative analysis of human mesenchymal stem cells derived from bone marrow, placenta, and adipose tissue as sources of cell therapy. J Cell Biochem 117:1112\u20131125. https:\/\/doi.org\/10.1002\/jcb.25395","journal-title":"J Cell Biochem"},{"key":"8892_CR148","doi-asserted-by":"publisher","first-page":"560","DOI":"10.3389\/fimmu.2015.00560","volume":"6","author":"P Mattar","year":"2015","unstructured":"Mattar P, Bieback K (2015) Comparing the immunomodulatory properties of bone marrow, adipose tissue, and birth-associated tissue mesenchymal stromal cells. Front Immunol 6:560. https:\/\/doi.org\/10.3389\/fimmu.2015.00560","journal-title":"Front Immunol"},{"key":"8892_CR149","doi-asserted-by":"publisher","unstructured":"Maria\u00a0AT, Toupet\u00a0K, Maumus\u00a0M, Fonteneau\u00a0G,\u00a0Le Quellec A, Jorgensen\u00a0C, Guilpain\u00a0P, Noel\u00a0D (2016) Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis. J Autoimmun 70:31\u201339.\u00a0https:\/\/doi.org\/10.1016\/j.jaut.2016.03.013S0896-8411(16)30026-9","DOI":"10.1016\/j.jaut.2016.03.013S0896-8411(16)30026-9"},{"key":"8892_CR150","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1089\/ten.TEB.2013.0664","volume":"20","author":"R El Omar","year":"2014","unstructured":"El Omar R, Beroud J, Stoltz JF, Menu P, Velot E, Decot V (2014) Umbilical cord mesenchymal stem cells: the new gold standard for mesenchymal stem cell-based therapies? Tissue Eng Part B Rev 20:523\u2013544. https:\/\/doi.org\/10.1089\/ten.TEB.2013.0664","journal-title":"Tissue Eng Part B Rev"},{"key":"8892_CR151","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1089\/scd.2010.0140","volume":"19","author":"F Mosna","year":"2010","unstructured":"Mosna F, Sensebe L, Krampera M (2010) Human bone marrow and adipose tissue mesenchymal stem cells: a user\u2019s guide. Stem Cells Dev 19:1449\u20131470. https:\/\/doi.org\/10.1089\/scd.2010.0140","journal-title":"Stem Cells Dev"},{"key":"8892_CR152","doi-asserted-by":"publisher","unstructured":"Zhang\u00a0Q, Xiang\u00a0W, Yi\u00a0DY, Xue\u00a0BZ, Wen\u00a0WW, Abdelmaksoud\u00a0A, Xiong\u00a0NX, Jiang\u00a0XB, Zhao\u00a0HY, Fu\u00a0P (2018) Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas. Stem Cell Res Ther 9\u2013228.\u00a0[pii] https:\/\/doi.org\/10.1186\/s13287-018-0977-z10.1186\/s13287-018-0977-z","DOI":"10.1186\/s13287-018-0977-z10.1186\/s13287-018-0977-z"},{"key":"8892_CR153","doi-asserted-by":"publisher","unstructured":"Nunes\u00a0HC, Scarano\u00a0WR, Deffune\u00a0E, Felisbino\u00a0SL, Porreca\u00a0I, Delella\u00a0FK (2018) Bisphenol a and mesenchymal stem cells: recent insights. Life Sci 206:22\u201328.\u00a0[pii] S0024-3205(18)30281-9 https:\/\/doi.org\/10.1016\/j.lfs.2018.05.023","DOI":"10.1016\/j.lfs.2018.05.023"},{"key":"8892_CR154","doi-asserted-by":"publisher","unstructured":"Maxson\u00a0S, Lopez\u00a0EA, Yoo\u00a0D, Danilkovitch-Miagkova\u00a0A, Leroux\u00a0MA (2012) Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Transl Med 1:142\u2013149.\u00a0[pii] https:\/\/doi.org\/10.5966\/sctm.2011-00181\/2\/142","DOI":"10.5966\/sctm.2011-00181\/2\/142"},{"key":"8892_CR155","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/art.39477","volume":"68","author":"AT Maria","year":"2016","unstructured":"Maria AT, Toupet K, Bony C, Pirot N, Vozenin MC, Petit B, Roger P, Batteux F, Le Quellec A, Jorgensen C, Noel D, Guilpain P (2016) Antifibrotic, antioxidant, and immunomodulatory effects of mesenchymal stem cells in HOCl-induced systemic sclerosis. Arthritis Rheumatol 68:1013\u20131025. https:\/\/doi.org\/10.1002\/art.39477","journal-title":"Arthritis Rheumatol"},{"key":"8892_CR156","doi-asserted-by":"publisher","unstructured":"Wang\u00a0YH, Wu\u00a0DB, Chen\u00a0B, Chen\u00a0EQ, Tang\u00a0H (2018) Progress in mesenchymal stem cell-based therapy for acute liver failure. Stem Cell Res Ther 9\u2013227. [pii] https:\/\/doi.org\/10.1186\/s13287-018-0972-410.1186\/s13287-018-0972-4","DOI":"10.1186\/s13287-018-0972-410.1186\/s13287-018-0972-4"},{"key":"8892_CR157","doi-asserted-by":"publisher","unstructured":"Bernardo\u00a0ME, Fibbe\u00a0WE (2013) Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell 13:392\u2013402.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.stem.2013.09.006S1934-5909(13)00406-2","DOI":"10.1016\/j.stem.2013.09.006S1934-5909(13)00406-2"},{"key":"8892_CR158","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1517\/14728222.2013.746954","volume":"17","author":"RJ MacFarlane","year":"2013","unstructured":"MacFarlane RJ, Graham SM, Davies PS, Korres N, Tsouchnica H, Heliotis M, Mantalaris A, Tsiridis E (2013) Anti-inflammatory role and immunomodulation of mesenchymal stem cells in systemic joint diseases: potential for treatment. Expert Opin Ther Targets 17:243\u2013254. https:\/\/doi.org\/10.1517\/14728222.2013.746954","journal-title":"Expert Opin Ther Targets"},{"key":"8892_CR159","doi-asserted-by":"publisher","unstructured":"van Rhijn-Brouwer FC, Gremmels\u00a0H, Fledderus\u00a0JO, Radstake\u00a0TR, Verhaar\u00a0MC,\u00a0van Laar JM (2016) Cellular therapies in systemic sclerosis: recent progress. Curr Rheumatol Rep 18:12.\u00a0[pii] https:\/\/doi.org\/10.1007\/s11926-015-0555-710.1007\/s11926-015-0555-7","DOI":"10.1007\/s11926-015-0555-710.1007\/s11926-015-0555-7"},{"key":"8892_CR160","doi-asserted-by":"publisher","unstructured":"Nauta\u00a0AJ, Westerhuis\u00a0G, Kruisselbrink\u00a0AB, Lurvink\u00a0EG, Willemze\u00a0R, Fibbe\u00a0WE (2006) Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood 108:2114\u20132120.\u00a0[pii] blood-2005-11-011650 https:\/\/doi.org\/10.1182\/blood-2005-11-011650","DOI":"10.1182\/blood-2005-11-011650"},{"key":"8892_CR161","doi-asserted-by":"publisher","unstructured":"Nauta\u00a0AJ, Fibbe\u00a0WE (2007) Immunomodulatory properties of mesenchymal stromal cells Blood 110:3499\u20133506. [pii] blood-2007-02-069716 https:\/\/doi.org\/10.1182\/blood-2007-02-069716","DOI":"10.1182\/blood-2007-02-069716"},{"key":"8892_CR162","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4252\/wjsc.v8.i9.268","volume":"8","author":"OK Ma","year":"2016","unstructured":"Ma OK, Chan KH (2016) Immunomodulation by mesenchymal stem cells: interplay between mesenchymal stem cells and regulatory lymphocytes. World J Stem Cells 8:268\u2013278. https:\/\/doi.org\/10.4252\/wjsc.v8.i9.268","journal-title":"World J Stem Cells"},{"key":"8892_CR163","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/01.TP.0000045055.63901.A9","volume":"75","author":"WT Tse","year":"2003","unstructured":"Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC (2003) Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75:389\u2013397. https:\/\/doi.org\/10.1097\/01.TP.0000045055.63901.A9","journal-title":"Transplantation"},{"key":"8892_CR164","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11373-004-8183-7","volume":"12","author":"E Klyushnenkova","year":"2005","unstructured":"Klyushnenkova E, Mosca JD, Zernetkina V, Majumdar MK, Beggs KJ, Simonetti DW, Deans RJ, McIntosh KR (2005) T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci 12:47\u201357. https:\/\/doi.org\/10.1007\/s11373-004-8183-7","journal-title":"J Biomed Sci"},{"key":"8892_CR165","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/art.37894","volume":"65","author":"M Chen","year":"2013","unstructured":"Chen M, Su W, Lin X, Guo Z, Wang J, Zhang Q, Brand D, Ryffel B, Huang J, Liu Z, He X, Le AD, Zheng SG (2013) Adoptive transfer of human gingiva-derived mesenchymal stem cells ameliorates collagen-induced arthritis via suppression of Th1 and Th17 cells and enhancement of regulatory T cell differentiation. Arthritis Rheum 65:1181\u20131193. https:\/\/doi.org\/10.1002\/art.37894","journal-title":"Arthritis Rheum"},{"key":"8892_CR166","doi-asserted-by":"publisher","unstructured":"Luz-Crawford\u00a0P, Kurte\u00a0M, Bravo-Alegria\u00a0J, Contreras\u00a0R, Nova-Lamperti\u00a0E, Tejedor\u00a0G, Noel\u00a0D, Jorgensen\u00a0C, Figueroa\u00a0F, Djouad\u00a0F, Carrion\u00a0F (2013) Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells. Stem Cell Res Ther 4:65.\u00a0[pii] https:\/\/doi.org\/10.1186\/scrt216scrt216","DOI":"10.1186\/scrt216scrt216"},{"key":"8892_CR167","doi-asserted-by":"publisher","unstructured":"Gonzalez-Rey\u00a0E, Gonzalez\u00a0MA, Varela\u00a0N, O\u2019Valle\u00a0F, Hernandez-Cortes\u00a0P, Rico\u00a0L, Buscher\u00a0D, Delgado\u00a0M (2010) Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann Rheum Dis 69:241\u2013248.\u00a0[pii] https:\/\/doi.org\/10.1136\/ard.2008.101881ard.2008.101881","DOI":"10.1136\/ard.2008.101881ard.2008.101881"},{"key":"8892_CR168","doi-asserted-by":"publisher","unstructured":"Corcione\u00a0A, Benvenuto\u00a0F, Ferretti\u00a0E, Giunti\u00a0D, Cappiello\u00a0V, Cazzanti\u00a0F, Risso\u00a0M, Gualandi\u00a0F, Mancardi\u00a0GL, Pistoia\u00a0V, Uccelli\u00a0A (2006) Human mesenchymal stem cells modulate B-cell functions. Blood 107:367\u2013372.\u00a0[pii] 2005-07-2657 https:\/\/doi.org\/10.1182\/blood-2005-07-2657","DOI":"10.1182\/blood-2005-07-2657"},{"key":"8892_CR169","doi-asserted-by":"publisher","unstructured":"Fan\u00a0L, Hu\u00a0C, Chen\u00a0J, Cen\u00a0P, Wang\u00a0J, Li\u00a0L (2016) Interaction between mesenchymal stem cells and B-cells. Int J Mol Sci 17.\u00a0[pii] https:\/\/doi.org\/10.3390\/ijms17050650E650","DOI":"10.3390\/ijms17050650E650"},{"key":"8892_CR170","doi-asserted-by":"publisher","unstructured":"Abdolmohammadi\u00a0K, Pakdel\u00a0FD, Aghaei\u00a0H, Assadiasl\u00a0S, Fatahi\u00a0Y, Rouzbahani\u00a0NH, Rezaiemanesh\u00a0A, Soleimani\u00a0M, Tayebi\u00a0L, Nicknam\u00a0MH (2019) Ankylosing spondylitis and mesenchymal stromal\/stem cell therapy: a new therapeutic approach. Biomed Pharmacother 109:1196\u20131205.\u00a0[pii] S0753-3322(18)35676-2 https:\/\/doi.org\/10.1016\/j.biopha.2018.10.137","DOI":"10.1016\/j.biopha.2018.10.137"},{"key":"8892_CR171","doi-asserted-by":"publisher","unstructured":"Sotiropoulou\u00a0PA, Perez\u00a0SA, Gritzapis\u00a0AD, Baxevanis\u00a0CN, Papamichail\u00a0M (2006) Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24:74\u201385.\u00a0[pii] 2004-0359 https:\/\/doi.org\/10.1634\/stemcells.2004-0359","DOI":"10.1634\/stemcells.2004-0359"},{"key":"8892_CR172","doi-asserted-by":"publisher","unstructured":"Spaggiari\u00a0GM, Capobianco\u00a0A, Abdelrazik\u00a0H, Becchetti\u00a0F, Mingari\u00a0MC, Moretta\u00a0L (2008) Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111:1327\u20131333.\u00a0[pii] blood-2007-02-074997 https:\/\/doi.org\/10.1182\/blood-2007-02-074997","DOI":"10.1182\/blood-2007-02-074997"},{"key":"8892_CR173","doi-asserted-by":"publisher","first-page":"e1173","DOI":"10.1002\/term.2452","volume":"12","author":"M Gazdic","year":"2018","unstructured":"Gazdic M, Simovic Markovic B, Vucicevic L, Nikolic T, Djonov V, Arsenijevic N, Trajkovic V, Lukic ML, Volarevic V (2018) Mesenchymal stem cells protect from acute liver injury by attenuating hepatotoxicity of liver natural killer T cells in an inducible nitric oxide synthase- and indoleamine 2,3-dioxygenase-dependent manner. J Tissue Eng Regen Med 12:e1173\u2013e1185. https:\/\/doi.org\/10.1002\/term.2452","journal-title":"J Tissue Eng Regen Med"},{"key":"8892_CR174","doi-asserted-by":"publisher","unstructured":"Jiang\u00a0XX, Zhang\u00a0Y, Liu\u00a0B, Zhang\u00a0SX, Wu\u00a0Y, Yu\u00a0XD, Mao\u00a0N (2005) Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105:4120\u20134126.\u00a0[pii] 2004-02-0586 https:\/\/doi.org\/10.1182\/blood-2004-02-0586","DOI":"10.1182\/blood-2004-02-0586"},{"key":"8892_CR175","doi-asserted-by":"publisher","unstructured":"Ramasamy\u00a0R, Fazekasova\u00a0H, Lam\u00a0EW, Soeiro\u00a0I, Lombardi\u00a0G, Dazzi\u00a0F (2007) Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation 83:71\u201376.\u00a0[pii] https:\/\/doi.org\/10.1097\/01.tp.0000244572.24780.5400007890-200701150-00014","DOI":"10.1097\/01.tp.0000244572.24780.5400007890-200701150-00014"},{"key":"8892_CR176","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009252","volume":"5","author":"J Maggini","year":"2010","unstructured":"Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzon IM, Nepomnaschy I, Costa H, Canones C, Raiden S, Vermeulen M, Geffner JR (2010) Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One 5:e9252. https:\/\/doi.org\/10.1371\/journal.pone.0009252","journal-title":"PLoS ONE"},{"key":"8892_CR177","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1002\/stem.503","volume":"28","author":"QZ Zhang","year":"2010","unstructured":"Zhang QZ, Su WR, Shi SH, Wilder-Smith P, Xiang AP, Wong A, Nguyen AL, Kwon CW, Le AD (2010) Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells 28:1856\u20131868. https:\/\/doi.org\/10.1002\/stem.503","journal-title":"Stem Cells"},{"key":"8892_CR178","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1089\/154732804323099190","volume":"13","author":"W Zhang","year":"2004","unstructured":"Zhang W, Ge W, Li C, You S, Liao L, Han Q, Deng W, Zhao RC (2004) Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte-derived dendritic cells. Stem Cells Dev 13:263\u2013271. https:\/\/doi.org\/10.1089\/154732804323099190","journal-title":"Stem Cells Dev"},{"key":"8892_CR179","doi-asserted-by":"publisher","unstructured":"English\u00a0K, Barry\u00a0FP, Mahon\u00a0BP (2008) Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol Lett 115:50\u201358.\u00a0[pii] S0165-2478(07)00257-X https:\/\/doi.org\/10.1016\/j.imlet.2007.10.002","DOI":"10.1016\/j.imlet.2007.10.002"},{"key":"8892_CR180","doi-asserted-by":"publisher","unstructured":"Bartholomew\u00a0A, Sturgeon\u00a0C, Siatskas\u00a0M, Ferrer\u00a0K, McIntosh\u00a0K, Patil\u00a0S, Hardy\u00a0W, Devine\u00a0S, Ucker\u00a0D, Deans\u00a0R, Moseley\u00a0A, Hoffman\u00a0R (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42\u201348.\u00a0[pii] S0301472X0100769X https:\/\/doi.org\/10.1016\/s0301-472x(01)00769-x","DOI":"10.1016\/s0301-472x(01)00769-x"},{"key":"8892_CR181","doi-asserted-by":"publisher","unstructured":"Le Blanc K, Rasmusson\u00a0I, Sundberg\u00a0B, Gotherstrom\u00a0C, Hassan\u00a0M, Uzunel\u00a0M, Ringden O (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439\u20131441.\u00a0[pii] https:\/\/doi.org\/10.1016\/S0140-6736(04)16104-7S0140-6736(04)16104-7","DOI":"10.1016\/S0140-6736(04)16104-7S0140-6736(04)16104-7"},{"key":"8892_CR182","doi-asserted-by":"publisher","unstructured":"Le Blanc K, Tammik\u00a0C, Rosendahl\u00a0K, Zetterberg\u00a0E, Ringden\u00a0O (2003) HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31:890\u2013896.\u00a0[pii] S0301472X03001103 https:\/\/doi.org\/10.1016\/s0301-472x(03)00110-3","DOI":"10.1016\/s0301-472x(03)00110-3"},{"key":"8892_CR183","doi-asserted-by":"publisher","unstructured":"van Laar\u00a0JM, Tyndall\u00a0A (2006) Adult stem cells in the treatment of autoimmune diseases. Rheumatology (Oxford) 45:1187\u20131193.\u00a0[pii] kel158 https:\/\/doi.org\/10.1093\/rheumatology\/kel158","DOI":"10.1093\/rheumatology\/kel158"},{"key":"8892_CR184","doi-asserted-by":"publisher","unstructured":"Detry\u00a0O, Vandermeulen\u00a0M, Delbouille\u00a0MH, Somja\u00a0J, Bletard\u00a0N, Briquet\u00a0A, Lechanteur\u00a0C, Giet\u00a0O, Baudoux\u00a0E, Hannon\u00a0M, Baron\u00a0F, Beguin\u00a0Y (2017) Infusion of mesenchymal stromal cells after deceased liver transplantation: a phase I-II, open-label, clinical study. J Hepatol 67:47\u201355.\u00a0\u00a0[pii] S0168-8278(17)30131-9 https:\/\/doi.org\/10.1016\/j.jhep.2017.03.001","DOI":"10.1016\/j.jhep.2017.03.001"},{"key":"8892_CR185","doi-asserted-by":"publisher","unstructured":"Puissant\u00a0B, Barreau\u00a0C, Bourin\u00a0P, Clavel\u00a0C, Corre\u00a0J, Bousquet\u00a0C, Taureau\u00a0C, Cousin\u00a0B, Abbal\u00a0M, Laharrague\u00a0P, Penicaud\u00a0L, Casteilla L, Blancher\u00a0A (2005) Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol 129:118\u2013129.\u00a0[pii] BJH5409 https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05409.x","DOI":"10.1111\/j.1365-2141.2005.05409.x"},{"key":"8892_CR186","doi-asserted-by":"publisher","unstructured":"Beyth\u00a0S, Borovsky\u00a0Z, Mevorach\u00a0D, Liebergall\u00a0M, Gazit\u00a0Z, Aslan\u00a0H, Galun\u00a0E, Rachmilewitz\u00a0J (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105:2214\u20132219.\u00a0[pii] 2004-07-2921 https:\/\/doi.org\/10.1182\/blood-2004-07-2921","DOI":"10.1182\/blood-2004-07-2921"},{"key":"8892_CR187","doi-asserted-by":"publisher","unstructured":"Guiducci S, Manetti\u00a0M, Romano\u00a0E, Mazzanti\u00a0B, Ceccarelli\u00a0C,\u00a0Dal Pozzo S, Milia\u00a0AF,\u00a0 Bellando-Randone\u00a0S, Fiori\u00a0G, Conforti\u00a0ML, Saccardi\u00a0R, Ibba-Manneschi\u00a0L, Matucci-Cerinic\u00a0M (2011) Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro. Ann Rheum Dis 70:2011\u20132021.\u00a0[pii] https:\/\/doi.org\/10.1136\/ard.2011.150607ard.2011.150607","DOI":"10.1136\/ard.2011.150607ard.2011.150607"},{"key":"8892_CR188","doi-asserted-by":"publisher","unstructured":"Meirelles da\u00a0S, Fontes\u00a0AM, Covas\u00a0DT, Caplan\u00a0AI (2009) Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 20:419\u2013427.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.cytogfr.2009.10.002S1359-6101(09)00077-X","DOI":"10.1016\/j.cytogfr.2009.10.002S1359-6101(09)00077-X"},{"key":"8892_CR189","doi-asserted-by":"publisher","unstructured":"Pers\u00a0YM, Maumus\u00a0M, Bony\u00a0C, Jorgensen\u00a0C, Noel\u00a0D (2018) Contribution of microRNAs to the immunosuppressive function of mesenchymal stem cells. Biochimie 155:109\u2013118.\u00a0[pii] S0300-9084(18)30196-2 https:\/\/doi.org\/10.1016\/j.biochi.2018.07.001","DOI":"10.1016\/j.biochi.2018.07.001"},{"key":"8892_CR190","doi-asserted-by":"publisher","unstructured":"Linero\u00a0I, Chaparro\u00a0O (2014) Paracrine effect of mesenchymal stem cells derived from human adipose tissue in bone regeneration. PLoS One 9:e107001.\u00a0[pii] https:\/\/doi.org\/10.1371\/journal.pone.0107001PONE-D-14-28553","DOI":"10.1371\/journal.pone.0107001PONE-D-14-28553"},{"key":"8892_CR191","doi-asserted-by":"publisher","unstructured":"Mukhamedshina\u00a0YO, Gracheva\u00a0OA, Mukhutdinova\u00a0DM, Chelyshev\u00a0YA, Rizvanov\u00a0AA (2019) Mesenchymal stem cells and the neuronal microenvironment in the area of spinal cord injury. Neural Regen Res 14:227\u2013237.\u00a0[pii] https:\/\/doi.org\/10.4103\/1673-5374.244778NeuralRegenRes_2019_14_2_227_244778","DOI":"10.4103\/1673-5374.244778NeuralRegenRes_2019_14_2_227_244778"},{"key":"8892_CR192","doi-asserted-by":"publisher","unstructured":"Djouad\u00a0F, Charbonnier\u00a0LM, Bouffi\u00a0C, Louis-Plence\u00a0P, Bony\u00a0C, Apparailly\u00a0F, Cantos\u00a0C, Jorgensen\u00a0C, Noel\u00a0D (2007) Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 25:2025\u20132032.\u00a0[pii] 2006-0548 https:\/\/doi.org\/10.1634\/stemcells.2006-0548","DOI":"10.1634\/stemcells.2006-0548"},{"key":"8892_CR193","doi-asserted-by":"publisher","unstructured":"Zhang\u00a0Q, Shi\u00a0S, Liu\u00a0Y, Uyanne J, Shi\u00a0Y, Le\u00a0AD (2009) Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol 183:7787\u20137798.\u00a0[pii] https:\/\/doi.org\/10.4049\/jimmunol.0902318jimmunol.0902318","DOI":"10.4049\/jimmunol.0902318jimmunol.0902318"},{"key":"8892_CR194","doi-asserted-by":"publisher","unstructured":"Sato\u00a0K, Ozaki\u00a0K, Oh\u00a0I, Meguro\u00a0A, Hatanaka\u00a0K, Nagai\u00a0T, Muroi\u00a0K, Ozawa\u00a0K (2007) Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 109:228\u2013234. [pii] blood-2006-02-002246\u00a0 https:\/\/doi.org\/10.1182\/blood-2006-02-002246","DOI":"10.1182\/blood-2006-02-002246"},{"key":"8892_CR195","doi-asserted-by":"publisher","unstructured":"Selmani\u00a0Z, Naji\u00a0A, Zidi\u00a0I, Favier\u00a0B, Gaiffe\u00a0E, Obert\u00a0L, Borg\u00a0C, Saas\u00a0P, Tiberghien\u00a0P, Rouas-Freiss\u00a0N, Carosella\u00a0ED, Deschaseaux\u00a0F (2008) Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells 26:212\u2013222.\u00a0[pii] 2007-0554 https:\/\/doi.org\/10.1634\/stemcells.2007-0554","DOI":"10.1634\/stemcells.2007-0554"},{"key":"8892_CR196","doi-asserted-by":"publisher","unstructured":"de Oliveira Bravo M, Carvalho\u00a0JL, Saldanha-Araujo F (2016) Adenosine production: A common path for mesenchymal stem-cell and regulatory T-cell-mediated immunosuppression. Purinergic Signal 12:595\u2013609.\u00a0[pii] https:\/\/doi.org\/10.1007\/s11302-016-9529-010.1007\/s11302-016-9529-0","DOI":"10.1007\/s11302-016-9529-010.1007\/s11302-016-9529-0"},{"key":"8892_CR197","doi-asserted-by":"publisher","unstructured":"Choi H, Lee\u00a0RH, Bazhanov\u00a0N, Oh\u00a0JY, Prockop\u00a0DJ (2011) Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2\/NF-kappaB signaling in resident macrophages. Blood 118:330\u2013338.\u00a0[pii] https:\/\/doi.org\/10.1182\/blood-2010-12-327353blood-2010-12-327353","DOI":"10.1182\/blood-2010-12-327353blood-2010-12-327353"},{"key":"8892_CR198","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/stem.2509","volume":"35","author":"LC Davies","year":"2017","unstructured":"Davies LC, Heldring N, Kadri N, Le Blanc K (2017) Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression. Stem Cells 35:766\u2013776. https:\/\/doi.org\/10.1002\/stem.2509","journal-title":"Stem Cells"},{"key":"8892_CR199","doi-asserted-by":"publisher","unstructured":"Djouad\u00a0F, Bouffi\u00a0C, Ghannam\u00a0S, Noel\u00a0D,\u00a0Jorgensen C (2009) Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Nat Rev Rheumatol 5:392\u2013399. [pii] https:\/\/doi.org\/10.1038\/nrrheum.2009.104nrrheum.2009.104","DOI":"10.1038\/nrrheum.2009.104nrrheum.2009.104"},{"key":"8892_CR200","doi-asserted-by":"publisher","unstructured":"Aggarwal\u00a0S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815\u20131822.\u00a0[pii] 2004-04-1559 https:\/\/doi.org\/10.1182\/blood-2004-04-1559","DOI":"10.1182\/blood-2004-04-1559"},{"key":"8892_CR201","doi-asserted-by":"publisher","unstructured":"Madrigal\u00a0M, Rao\u00a0KS, Riordan\u00a0NH (2014) A review of therapeutic effects of mesenchymal stem cell secretions and induction of secretory modification by different culture methods. J Transl Med 12:260.\u00a0[pii] https:\/\/doi.org\/10.1186\/s12967-014-0260-8s12967-014-0260-8","DOI":"10.1186\/s12967-014-0260-8s12967-014-0260-8"},{"key":"8892_CR202","doi-asserted-by":"publisher","unstructured":"Gieseke\u00a0F, Bohringer\u00a0J, Bussolari\u00a0R, Dominici\u00a0M, Handgretinger\u00a0R, Muller\u00a0I (2010) Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood 116:3770\u20133779.\u00a0[pii] https:\/\/doi.org\/10.1182\/blood-2010-02-270777blood-2010-02-270777","DOI":"10.1182\/blood-2010-02-270777blood-2010-02-270777"},{"key":"8892_CR203","doi-asserted-by":"publisher","unstructured":"Gao\u00a0F, Chiu\u00a0SM, Motan\u00a0DA, Zhang\u00a0Z, Chen\u00a0L, Ji\u00a0HL, Tse\u00a0HF, Fu\u00a0QL, Lian\u00a0Q (2016) Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis 7 e2062.\u00a0[pii] https:\/\/doi.org\/10.1038\/cddis.2015.327cddis2015327","DOI":"10.1038\/cddis.2015.327cddis2015327"},{"key":"8892_CR204","doi-asserted-by":"publisher","unstructured":"Meisel\u00a0R, Zibert\u00a0A, Laryea\u00a0M, Gobel\u00a0U, Daubener\u00a0W, Dilloo\u00a0D (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103:4619\u20134621.\u00a0[pii] https:\/\/doi.org\/10.1182\/blood-2003-11-39092003-11-3909","DOI":"10.1182\/blood-2003-11-39092003-11-3909"},{"key":"8892_CR205","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1146\/annurev-physiol-021014-071641","volume":"77","author":"S Kourembanas","year":"2015","unstructured":"Kourembanas S (2015) Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy. Annu Rev Physiol 77:13\u201327. https:\/\/doi.org\/10.1146\/annurev-physiol-021014-071641","journal-title":"Annu Rev Physiol"},{"key":"8892_CR206","doi-asserted-by":"publisher","unstructured":"Zhu\u00a0Y, Feng\u00a0X (2018) Genetic contribution to mesenchymal stem cell dysfunction in systemic lupus erythematosus. Stem Cell Res Ther 9:149.\u00a0[pii] https:\/\/doi.org\/10.1186\/s13287-018-0898-x10.1186\/s13287-018-0898-x","DOI":"10.1186\/s13287-018-0898-x10.1186\/s13287-018-0898-x"},{"key":"8892_CR207","doi-asserted-by":"publisher","unstructured":"Zhao\u00a0L, Hu\u00a0C, Zhang\u00a0P, Jiang H, Chen\u00a0J (2018) Novel preconditioning strategies for enhancing the migratory ability of mesenchymal stem cells in acute kidney injury. Stem Cell Res Ther 9:225.\u00a0[pii] https:\/\/doi.org\/10.1186\/s13287-018-0973-310.1186\/s13287-018-0973-3","DOI":"10.1186\/s13287-018-0973-310.1186\/s13287-018-0973-3"},{"key":"8892_CR208","doi-asserted-by":"publisher","unstructured":"De Luca L, Trino\u00a0S, Laurenzana\u00a0I, Lamorte\u00a0D, Caivano\u00a0A,\u00a0Del Vecchio L, Musto\u00a0P (2017) Mesenchymal stem cell derived extracellular vesicles: a role in hematopoietic transplantation?. Int J Mol Sci 18:E1022.\u00a0[pii] https:\/\/doi.org\/10.3390\/ijms18051022ijms18051022","DOI":"10.3390\/ijms18051022ijms18051022"},{"key":"8892_CR209","doi-asserted-by":"publisher","unstructured":"Kaundal\u00a0U, Bagai\u00a0U, Rakha\u00a0A (2018) Immunomodulatory plasticity of mesenchymal stem cells: a potential key to successful solid organ transplantation. J Transl Med 16:31.\u00a0[pii] https:\/\/doi.org\/10.1186\/s12967-018-1403-010.1186\/s12967-018-1403-0","DOI":"10.1186\/s12967-018-1403-010.1186\/s12967-018-1403-0"},{"key":"8892_CR210","doi-asserted-by":"publisher","first-page":"3057624","DOI":"10.1155\/2018\/3057624","volume":"2018","author":"M Wang","year":"2018","unstructured":"Wang M, Yuan Q, Xie L (2018) Mesenchymal stem cell-based immunomodulation: properties and clinical application. Stem Cells Int 2018:3057624. https:\/\/doi.org\/10.1155\/2018\/3057624","journal-title":"Stem Cells Int"},{"key":"8892_CR211","doi-asserted-by":"publisher","unstructured":"Ren\u00a0G, Zhang\u00a0L, Zhao\u00a0X, Xu\u00a0G, Zhang\u00a0Y, Roberts\u00a0AI, Zhao\u00a0RC, Shi\u00a0Y (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide Cell. Stem Cell 2:141\u2013150.\u00a0[pii] S1934-5909(07)00314-1 https:\/\/doi.org\/10.1016\/j.stem.2007.11.014","DOI":"10.1016\/j.stem.2007.11.014"},{"key":"8892_CR212","doi-asserted-by":"publisher","unstructured":"Krampera\u00a0M, Cosmi\u00a0L, Angeli\u00a0R, Pasini\u00a0A, Liotta\u00a0F, Andreini\u00a0A, Santarlasci\u00a0V, Mazzinghi\u00a0B, Pizzolo\u00a0G, Vinante\u00a0F, Romagnani\u00a0P, Maggi\u00a0E, Romagnani\u00a0S, Annunziato\u00a0F (2006) Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24:386\u2013398.\u00a0[pii] 2005-0008 https:\/\/doi.org\/10.1634\/stemcells.2005-0008","DOI":"10.1634\/stemcells.2005-0008"},{"key":"8892_CR213","doi-asserted-by":"publisher","unstructured":"Fan\u00a0H, Zhao\u00a0G, Liu\u00a0L, Liu\u00a0F, Gong\u00a0W, Liu\u00a0X, Yang\u00a0L, Wang\u00a0J, Hou\u00a0Y (2012) Pre-treatment with IL-1beta enhances the efficacy of MSC transplantation in DSS-induced colitis. Cell Mol Immunol 9:473\u2013481.\u00a0[pii] https:\/\/doi.org\/10.1038\/cmi.2012.40cmi201240","DOI":"10.1038\/cmi.2012.40cmi201240"},{"key":"8892_CR214","doi-asserted-by":"publisher","unstructured":"Liotta\u00a0F, Angeli\u00a0R, Cosmi\u00a0L, Fili\u00a0L, Manuelli\u00a0C, Frosali\u00a0F, Mazzinghi\u00a0B, Maggi\u00a0L, Pasini\u00a0A, Lisi\u00a0V, Santarlasci\u00a0V, Consoloni\u00a0L, Angelotti\u00a0ML, Romagnani\u00a0P, Parronchi\u00a0P, Krampera\u00a0M, Maggi\u00a0E, Romagnani\u00a0S, Annunziato\u00a0F (2008) Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells 26:279\u2013289.\u00a0[pii] 2007-0454 https:\/\/doi.org\/10.1634\/stemcells.2007-0454","DOI":"10.1634\/stemcells.2007-0454"},{"key":"8892_CR215","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1002\/art.21012","volume":"52","author":"F Djouad","year":"2005","unstructured":"Djouad F, Fritz V, Apparailly F, Louis-Plence P, Bony C, Sany J, Jorgensen C, Noel D (2005) Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum 52:1595\u20131603. https:\/\/doi.org\/10.1002\/art.21012","journal-title":"Arthritis Rheum"},{"key":"8892_CR216","doi-asserted-by":"publisher","unstructured":"Kwon\u00a0SG, Kwon\u00a0YW, Lee\u00a0TW, Park\u00a0GT, Kim\u00a0JH (2018) Recent advances in stem cell therapeutics and tissue engineering strategies. Biomater Res 22:36.\u00a0[pii] https:\/\/doi.org\/10.1186\/s40824-018-0148-4148","DOI":"10.1186\/s40824-018-0148-4148"},{"key":"8892_CR217","doi-asserted-by":"publisher","unstructured":"Chen\u00a0T, Wu\u00a0Y, Gu\u00a0W, Xu\u00a0Q (2018) Response of vascular mesenchymal stem\/progenitor cells to hyperlipidemia. Cell Mol Life Sci 75:4079\u20134091.\u00a0[pii] https:\/\/doi.org\/10.1007\/s00018-018-2859-z10.1007\/s00018-018-2859-z","DOI":"10.1007\/s00018-018-2859-z10.1007\/s00018-018-2859-z"},{"key":"8892_CR218","doi-asserted-by":"publisher","first-page":"9099","DOI":"10.1002\/jcp.26860","volume":"233","author":"M Soundararajan","year":"2018","unstructured":"Soundararajan M, Kannan S (2018) Fibroblasts and mesenchymal stem cells: two sides of the same coin? J Cell Physiol 233:9099\u20139109. https:\/\/doi.org\/10.1002\/jcp.26860","journal-title":"J Cell Physiol"},{"key":"8892_CR219","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1517\/14712591003610606","volume":"10","author":"WM Jackson","year":"2010","unstructured":"Jackson WM, Nesti LJ, Tuan RS (2010) Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells. Expert Opin Biol Ther 10:505\u2013517. https:\/\/doi.org\/10.1517\/14712591003610606","journal-title":"Expert Opin Biol Ther"},{"key":"8892_CR220","doi-asserted-by":"publisher","first-page":"5450768","DOI":"10.1155\/2018\/5450768","volume":"2018","author":"A Tomokiyo","year":"2018","unstructured":"Tomokiyo A, Yoshida S, Hamano S, Hasegawa D, Sugii H, Maeda H (2018) Detection, characterization, and clinical application of mesenchymal stem cells in periodontal ligament tissue. Stem Cells Int 2018:5450768. https:\/\/doi.org\/10.1155\/2018\/5450768","journal-title":"Stem Cells Int"},{"key":"8892_CR221","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1111\/trf.12421","volume":"54","author":"RR Sharma","year":"2014","unstructured":"Sharma RR, Pollock K, Hubel A, McKenna D (2014) Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion 54:1418\u20131437. https:\/\/doi.org\/10.1111\/trf.12421","journal-title":"Transfusion"},{"key":"8892_CR222","doi-asserted-by":"publisher","unstructured":"Ichim\u00a0TE, O\u2019Heeron\u00a0P, Kesari\u00a0S (2018) Fibroblasts as a practical alternative to mesenchymal stem cells. J Transl Med 16:212.\u00a0[pii] https:\/\/doi.org\/10.1186\/s12967-018-1536-110.1186\/s12967-018-1536-1","DOI":"10.1186\/s12967-018-1536-110.1186\/s12967-018-1536-1"},{"key":"8892_CR223","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1002\/jcp.27152","volume":"234","author":"F Marofi","year":"2019","unstructured":"Marofi F, Vahedi G, Hasanzadeh A, Salarinasab S, Arzhanga P, Khademi B, Farshdousti Hagh M (2019) Mesenchymal stem cells as the game-changing tools in the treatment of various organs disorders: mirage or reality? J Cell Physiol 234:1268\u20131288. https:\/\/doi.org\/10.1002\/jcp.27152","journal-title":"J Cell Physiol"},{"key":"8892_CR224","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3727\/000000006783981503","volume":"15","author":"KJ Beggs","year":"2006","unstructured":"Beggs KJ, Lyubimov A, Borneman JN, Bartholomew A, Moseley A, Dodds R, Archambault MP, Smith AK, McIntosh KR (2006) Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons. Cell Transplant 15:711\u2013721. https:\/\/doi.org\/10.3727\/000000006783981503","journal-title":"Cell Transplant"},{"key":"8892_CR225","doi-asserted-by":"publisher","unstructured":"Harrell\u00a0CR, Markovic\u00a0BS, Fellabaum\u00a0C, Arsenijevic\u00a0A, Volarevic\u00a0V (2019) Mesenchymal stem cell-based therapy of osteoarthritis: current knowledge and future perspectives. Biomed Pharmacother 109:2318\u20132326.\u00a0[pii] S0753-3322(18)34307-5 https:\/\/doi.org\/10.1016\/j.biopha.2018.11.099","DOI":"10.1016\/j.biopha.2018.11.099"},{"key":"8892_CR226","doi-asserted-by":"publisher","unstructured":"Bagno\u00a0L, Hatzistergos\u00a0KE, Balkan\u00a0W, Hare\u00a0JM (2018) Mesenchymal stem cell-based therapy for cardiovascular disease: progress and challenges. Mol Ther 26:1610\u20131623.\u00a0[pii] S1525-0016(18)30212-0 https:\/\/doi.org\/10.1016\/j.ymthe.2018.05.009","DOI":"10.1016\/j.ymthe.2018.05.009"},{"key":"8892_CR227","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/MOH.0b013e32832aacb3","volume":"16","author":"A Tyndall","year":"2009","unstructured":"Tyndall A, Gratwohl A (2009) Adult stem cell transplantation in autoimmune disease. Curr Opin Hematol 16:285\u2013291. https:\/\/doi.org\/10.1097\/MOH.0b013e32832aacb3","journal-title":"Curr Opin Hematol"},{"key":"8892_CR228","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/sctm.18-0024","volume":"7","author":"TEG Krueger","year":"2018","unstructured":"Krueger TEG, Thorek DLJ, Denmeade SR, Isaacs JT, Brennen WN (2018) Concise review: mesenchymal stem cell-based drug delivery: the good, the bad, the ugly, and the promise. Stem Cells Transl Med 7:651\u2013663. https:\/\/doi.org\/10.1002\/sctm.18-0024","journal-title":"Stem Cells Transl Med"},{"key":"8892_CR229","doi-asserted-by":"publisher","unstructured":"Scuteri\u00a0A, Monfrini\u00a0M (2018) Mesenchymal stem cells as new therapeutic approach for diabetes and pancreatic disorders. Int J Mol Sci 19:E2783.\u00a0[pii] https:\/\/doi.org\/10.3390\/ijms19092783ijms19092783","DOI":"10.3390\/ijms19092783ijms19092783"},{"key":"8892_CR230","doi-asserted-by":"publisher","unstructured":"Passweg\u00a0J, Tyndall\u00a0A (2007) Autologous stem cell transplantation in autoimmune diseases. Semin Hematol 44:278\u2013285.\u00a0[pii] S0037-1963(07)00117-5 https:\/\/doi.org\/10.1053\/j.seminhematol.2007.08.001","DOI":"10.1053\/j.seminhematol.2007.08.001"},{"key":"8892_CR231","doi-asserted-by":"publisher","unstructured":"Tyndall\u00a0A, Furst\u00a0DE (2007) Adult stem cell treatment of scleroderma. Curr Opin Rheumatol 19:604\u2013610. [pii] https:\/\/doi.org\/10.1097\/BOR.0b013e3282e6f53400002281-200711000-00014","DOI":"10.1097\/BOR.0b013e3282e6f53400002281-200711000-00014"},{"key":"8892_CR232","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1002\/jcb.24193","volume":"113","author":"MK Mamidi","year":"2012","unstructured":"Mamidi MK, Nathan KG, Singh G, Thrichelvam ST, Mohd Yusof NA, Fakharuzi NA, Zakaria Z, Bhonde R, Das AK, Majumdar AS (2012) Comparative cellular and molecular analyses of pooled bone marrow multipotent mesenchymal stromal cells during continuous passaging and after successive cryopreservation. J Cell Biochem 113:3153\u20133164. https:\/\/doi.org\/10.1002\/jcb.24193","journal-title":"J Cell Biochem"},{"key":"8892_CR233","doi-asserted-by":"publisher","unstructured":"Martinello\u00a0T, Bronzini\u00a0I, Maccatrozzo\u00a0L, Mollo\u00a0A, Sampaolesi\u00a0M, Mascarello\u00a0F, Decaminada\u00a0M, Patruno\u00a0M (2011) Canine adipose-derived-mesenchymal stem cells do not lose stem features after a long-term cryopreservation. Res Vet Sci 91:18\u201324.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.rvsc.2010.07.024S0034-5288(10)00260-2","DOI":"10.1016\/j.rvsc.2010.07.024S0034-5288(10)00260-2"},{"key":"8892_CR234","doi-asserted-by":"publisher","unstructured":"Tyndall\u00a0A (2014) Mesenchymal stem cell treatments in rheumatology: a glass half full? Nat Rev Rheumatol 10:117\u2013124.\u00a0[pii] https:\/\/doi.org\/10.1038\/nrrheum.2013.166nrrheum.2013.166","DOI":"10.1038\/nrrheum.2013.166nrrheum.2013.166"},{"key":"8892_CR235","doi-asserted-by":"publisher","unstructured":"Hare\u00a0JM, Traverse\u00a0JH, Henry\u00a0TD, Dib\u00a0N, Strumpf RK, Schulman\u00a0SP, Gerstenblith\u00a0G, DeMaria\u00a0AN, Denktas\u00a0AE, Gammon\u00a0RS,\u00a0Jr Hermiller JB, Reisman\u00a0MA, Schaer\u00a0GL, Sherman\u00a0W (2009) A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 54:2277\u20132286.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.jacc.2009.06.055S0735-1097(09)03092-7","DOI":"10.1016\/j.jacc.2009.06.055S0735-1097(09)03092-7"},{"key":"8892_CR236","doi-asserted-by":"publisher","unstructured":"Park\u00a0JS, Suryaprakash\u00a0S, Lao\u00a0YH, Leong\u00a0KW (2015) Engineering mesenchymal stem cells for regenerative medicine and drug delivery. Methods 84:3\u201316.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.ymeth.2015.03.002S1046-2023(15)00096-1","DOI":"10.1016\/j.ymeth.2015.03.002S1046-2023(15)00096-1"},{"key":"8892_CR237","doi-asserted-by":"publisher","unstructured":"Macrin\u00a0D, Joseph\u00a0JP, Pillai\u00a0AA, Devi\u00a0A (2017) Eminent sources of adult mesenchymal stem cells and their therapeutic imminence. Stem Cell Rev Rep 13:741\u2013756.\u00a0[pii] https:\/\/doi.org\/10.1007\/s12015-017-9759-810.1007\/s12015-017-9759-8","DOI":"10.1007\/s12015-017-9759-810.1007\/s12015-017-9759-8"},{"key":"8892_CR238","doi-asserted-by":"publisher","unstructured":"Luo\u00a0R, Lu\u00a0Y, Liu\u00a0J, Cheng\u00a0J, Chen\u00a0Y (2019) Enhancement of the efficacy of mesenchymal stem cells in the treatment of ischemic diseases. Biomed Pharmacother 109:2022\u20132034.\u00a0[pii] S0753-3322(18)37084-7 https:\/\/doi.org\/10.1016\/j.biopha.2018.11.068","DOI":"10.1016\/j.biopha.2018.11.068"},{"key":"8892_CR239","doi-asserted-by":"publisher","unstructured":"Sage\u00a0EK, Thakrar\u00a0RM, Janes\u00a0SM (2016) Genetically modified mesenchymal stromal cells in cancer therapy. Cytotherapy 18:1435\u20131445.\u00a0[pii] S1465-3249(16)30512-6 https:\/\/doi.org\/10.1016\/j.jcyt.2016.09.003","DOI":"10.1016\/j.jcyt.2016.09.003"},{"key":"8892_CR240","doi-asserted-by":"publisher","unstructured":"Belmar-Lopez\u00a0C, Mendoza\u00a0G, Oberg\u00a0D, Burnet\u00a0J, Simon\u00a0C, Cervello\u00a0I, Iglesias\u00a0M, Ramirez\u00a0JC, Lopez-Larrubia\u00a0P, Quintanilla\u00a0M, Martin-Duque\u00a0P (2013) Tissue-derived mesenchymal stromal cells used as vehicles for anti-tumor therapy exert different in vivo effects on migration capacity and tumor growth. BMC Med 11:139.\u00a0[pii] https:\/\/doi.org\/10.1186\/1741-7015-11-1391741-7015-11-139","DOI":"10.1186\/1741-7015-11-1391741-7015-11-139"},{"key":"8892_CR241","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.3389\/fimmu.2017.01770","volume":"8","author":"F Marofi","year":"2017","unstructured":"Marofi F, Vahedi G, Biglari A, Esmaeilzadeh A, Athari SS (2017) Mesenchymal stromal\/stem cells: a new era in the cell-based targeted gene therapy of cancer. Front Immunol 8:1770. https:\/\/doi.org\/10.3389\/fimmu.2017.01770","journal-title":"Front Immunol"},{"key":"8892_CR242","doi-asserted-by":"publisher","unstructured":"Connick\u00a0P, Kolappan\u00a0M, Crawley\u00a0C, Webber\u00a0DJ, Patani\u00a0R, Michell\u00a0AW, Du\u00a0MQ, Luan\u00a0SL, Altmann\u00a0DR, Thompson\u00a0AJ, Compston\u00a0A, Scott\u00a0MA, Miller\u00a0DH, Chandran\u00a0S (2012) Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol 11:150\u2013156.\u00a0[pii] https:\/\/doi.org\/10.1016\/S1474-4422(11)70305-2S1474-4422(11)70305-2","DOI":"10.1016\/S1474-4422(11)70305-2S1474-4422(11)70305-2"},{"key":"8892_CR243","doi-asserted-by":"publisher","unstructured":"Lalu\u00a0MM, McIntyre\u00a0L, Pugliese\u00a0C, Fergusson\u00a0D, Winston\u00a0BW, Marshall\u00a0JC, Granton\u00a0J, Stewart\u00a0DJ (2012) Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One 7:e47559.\u00a0[pii] https:\/\/doi.org\/10.1371\/journal.pone.0047559PONE-D-12-19799","DOI":"10.1371\/journal.pone.0047559PONE-D-12-19799"},{"key":"8892_CR244","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/stem.430","volume":"28","author":"JS Lee","year":"2010","unstructured":"Lee JS, Hong JM, Moon GJ, Lee PH, Ahn YH, Bang OY (2010) A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28:1099\u20131106. https:\/\/doi.org\/10.1002\/stem.430","journal-title":"Stem Cells"},{"key":"8892_CR245","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/stem.1118","volume":"30","author":"L von Bahr","year":"2012","unstructured":"von Bahr L, Batsis I, Moll G, Hagg M, Szakos A, Sundberg B, Uzunel M, Ringden O, Le Blanc K (2012) Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. Stem Cells 30:1575\u20131578. https:\/\/doi.org\/10.1002\/stem.1118","journal-title":"Stem Cells"},{"key":"8892_CR246","doi-asserted-by":"publisher","unstructured":"Lamo-Espinosa\u00a0JM, Mora\u00a0G, Blanco\u00a0JF, Granero-Molto\u00a0F, Nunez-Cordoba\u00a0JM, Lopez-Elio S, Andreu\u00a0E, Sanchez-Guijo\u00a0F, Aquerreta\u00a0JD, Bondia\u00a0JM, Valenti-Azcarate\u00a0A, DCD Canizo M, Villaron EM, Valenti-Nin JR, Prosper F (2018) Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a multicenter randomized controlled clinical trial (phase I\/II). J Transl Med 16:213.\u00a0[pii] https:\/\/doi.org\/10.1186\/s12967-018-1591-710.1186\/s12967-018-1591-7","DOI":"10.1186\/s12967-018-1591-710.1186\/s12967-018-1591-7"},{"key":"8892_CR247","doi-asserted-by":"publisher","unstructured":"Akiyama\u00a0K, Chen\u00a0C, Wang\u00a0D, Xu\u00a0X, Qu\u00a0C, Yamaza\u00a0T, Cai\u00a0T, Chen\u00a0W, Sun\u00a0L, Shi\u00a0S (2012) Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-\/FAS-mediated T cell apoptosis. Cell Stem Cell 10:544\u2013555.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.stem.2012.03.007S1934-5909(12)00124-5","DOI":"10.1016\/j.stem.2012.03.007S1934-5909(12)00124-5"},{"key":"8892_CR248","doi-asserted-by":"publisher","unstructured":"Skyler\u00a0JS, Fonseca\u00a0VA, Segal\u00a0KR, Rosenstock\u00a0J (2015) Allogeneic mesenchymal precursor cells in type 2 diabetes: a randomized, placebo-controlled, dose-escalation safety and tolerability pilot study. Diabetes Care 38:1742\u20131749.\u00a0[pii] https:\/\/doi.org\/10.2337\/dc14-2830dc14-2830","DOI":"10.2337\/dc14-2830dc14-2830"},{"key":"8892_CR249","doi-asserted-by":"publisher","unstructured":"Si\u00a0YL, Zhao\u00a0YL, Hao\u00a0HJ, Fu\u00a0XB, Han\u00a0WD (2011) MSCs: Biological characteristics, clinical applications and their outstanding concerns. Ageing Res Rev 10:93\u2013103.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.arr.2010.08.005S1568-1637(10)00062-0","DOI":"10.1016\/j.arr.2010.08.005S1568-1637(10)00062-0"},{"key":"8892_CR250","doi-asserted-by":"publisher","unstructured":"Ben-David\u00a0U, Benvenisty\u00a0N (2011) The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer 11:268\u2013277.\u00a0[pii] https:\/\/doi.org\/10.1038\/nrc3034nrc3034","DOI":"10.1038\/nrc3034nrc3034"},{"key":"8892_CR251","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/stem.37","volume":"27","author":"PS Knoepfler","year":"2009","unstructured":"Knoepfler PS (2009) Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 27:1050\u20131056. https:\/\/doi.org\/10.1002\/stem.37","journal-title":"Stem Cells"},{"key":"8892_CR252","doi-asserted-by":"publisher","first-page":"8618","DOI":"10.1002\/jcp.27846","volume":"234","author":"MB Gugjoo","year":"2019","unstructured":"Gugjoo MB, Amarpal F, MR, Shah, RA, Sharma, GT, (2019) Mesenchymal stem cell: Basic research and potential applications in cattle and buffalo. J Cell Physiol 234:8618\u20138635. https:\/\/doi.org\/10.1002\/jcp.27846","journal-title":"J Cell Physiol"},{"key":"8892_CR253","first-page":"920","volume":"42","author":"XQ Guan","year":"2004","unstructured":"Guan XQ, Yu JL, Li LQ, Liu GX (2004) Study on mesenchymal stem cells entering the brain through the blood-brain barrier. Zhonghua Er Ke Za Zhi 42:920\u2013923","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"8892_CR254","doi-asserted-by":"publisher","unstructured":"Ortiz\u00a0LA, Gambelli\u00a0F, McBride\u00a0C, Gaupp\u00a0D, Baddoo\u00a0M, Kaminski\u00a0N, Phinney\u00a0DG (2003) Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 100:8407\u20138411.\u00a0[pii] https:\/\/doi.org\/10.1073\/pnas.14329291001432929100","DOI":"10.1073\/pnas.14329291001432929100"},{"key":"8892_CR255","doi-asserted-by":"publisher","unstructured":"Zhao\u00a0F, Zhang\u00a0YF, Liu\u00a0YG, Zhou\u00a0JJ, Li\u00a0ZK, Wu\u00a0CG, Qi\u00a0HW (2008) Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats. Transplant Proc 40:1700\u20131705.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.transproceed.2008.01.080S0041-1345(08)00471-5","DOI":"10.1016\/j.transproceed.2008.01.080S0041-1345(08)00471-5"},{"key":"8892_CR256","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/iwj.12034","volume":"11","author":"Y Wu","year":"2014","unstructured":"Wu Y, Huang S, Enhe J, Ma K, Yang S, Sun T, Fu X (2014) Bone marrow-derived mesenchymal stem cell attenuates skin fibrosis development in mice. Int Wound J 11:701\u2013710. https:\/\/doi.org\/10.1111\/iwj.12034","journal-title":"Int Wound J"},{"key":"8892_CR257","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3727\/096368909788809857","volume":"18","author":"A Cargnoni","year":"2009","unstructured":"Cargnoni A, Gibelli L, Tosini A, Signoroni PB, Nassuato C, Arienti D, Lombardi G, Albertini A, Wengler GS, Parolini O (2009) Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant 18:405\u2013422. https:\/\/doi.org\/10.3727\/096368909788809857","journal-title":"Cell Transplant"},{"key":"8892_CR258","doi-asserted-by":"publisher","unstructured":"Moodley\u00a0Y, Atienza\u00a0D, Manuelpillai\u00a0U, Samuel\u00a0CS, Tchongue\u00a0J, Ilancheran\u00a0S, Boyd\u00a0R, Trounson\u00a0A (2009) Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol 175:303\u2013313.\u00a0[pii] https:\/\/doi.org\/10.2353\/ajpath.2009.080629S0002-9440(10)60545-7","DOI":"10.2353\/ajpath.2009.080629S0002-9440(10)60545-7"},{"key":"8892_CR259","doi-asserted-by":"publisher","unstructured":"Scuderi\u00a0N, Ceccarelli\u00a0S, Onesti\u00a0MG, Fioramonti\u00a0P, Guidi\u00a0C, Romano\u00a0F, Frati\u00a0L, Angeloni\u00a0A, Marchese\u00a0C (2013) Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis. Cell Transplant 22:779\u2013795.\u00a0[pii] ct0441scuderi https:\/\/doi.org\/10.3727\/096368912X639017","DOI":"10.3727\/096368912X639017"},{"key":"8892_CR260","doi-asserted-by":"publisher","unstructured":"Zhang\u00a0H, Liang\u00a0J, Tang\u00a0X, Wang\u00a0D, Feng\u00a0X, Wang\u00a0F, Hua\u00a0B, Wang\u00a0H, Sun\u00a0L (2017) Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis. Arthritis Res Ther 19:165.\u00a0[pii] https:\/\/doi.org\/10.1186\/s13075-017-1373-210.1186\/s13075-017-1373-2","DOI":"10.1186\/s13075-017-1373-210.1186\/s13075-017-1373-2"},{"key":"8892_CR261","doi-asserted-by":"publisher","unstructured":"Borges\u00a0FT, Convento\u00a0MB, Schor\u00a0N (2018) Bone marrow-derived mesenchymal stromal cell: what next? Stem Cells Cloning 11:77\u201383.\u00a0[pii] https:\/\/doi.org\/10.2147\/SCCAA.S147804sccaa-11-077","DOI":"10.2147\/SCCAA.S147804sccaa-11-077"},{"key":"8892_CR262","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0005846","volume":"4","author":"W Wagner","year":"2009","unstructured":"Wagner W, Bork S, Horn P, Krunic D, Walenda T, Diehlmann A, Benes V, Blake J, Huber FX, Eckstein V, Boukamp P, Ho AD (2009) Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One 4:e5846. https:\/\/doi.org\/10.1371\/journal.pone.0005846","journal-title":"PLoS ONE"},{"key":"8892_CR263","doi-asserted-by":"publisher","unstructured":"Eltoukhy\u00a0HS, Sinha\u00a0G, Moore\u00a0CA, Gergues\u00a0M, Rameshwar\u00a0P (2018) Secretome within the bone marrow microenvironment: a basis for mesenchymal stem cell treatment and role in cancer dormancy. Biochimie 155:92\u2013103.\u00a0[pii] S0300-9084(18)30152-4 https:\/\/doi.org\/10.1016\/j.biochi.2018.05.018","DOI":"10.1016\/j.biochi.2018.05.018"},{"key":"8892_CR264","doi-asserted-by":"publisher","unstructured":"Gomes\u00a0ED, de Castro JV, Costa\u00a0BM, Salgado\u00a0AJ (2018) The impact of mesenchymal stem cells and their secretome as a treatment for gliomas. Biochimie 155:59\u201366.\u00a0[pii] S0300-9084(18)30203-7 https:\/\/doi.org\/10.1016\/j.biochi.2018.07.008","DOI":"10.1016\/j.biochi.2018.07.008"},{"key":"8892_CR265","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/cyto.a.23242","volume":"93","author":"D Mushahary","year":"2018","unstructured":"Mushahary D, Spittler A, Kasper C, Weber V, Charwat V (2018) Isolation, cultivation, and characterization of human mesenchymal stem cells. Cytometry A 93:19\u201331. https:\/\/doi.org\/10.1002\/cyto.a.23242","journal-title":"Cytometry A"},{"key":"8892_CR266","doi-asserted-by":"publisher","unstructured":"Florea\u00a0V, Rieger\u00a0AC, DiFede\u00a0DL, El-Khorazaty\u00a0J, Natsumeda\u00a0M, Banerjee\u00a0MN, Tompkins\u00a0BA, Khan\u00a0A, Schulman\u00a0IH, Landin\u00a0AM, Mushtaq\u00a0M, Golpanian\u00a0S, Lowery\u00a0MH, Byrnes\u00a0JJ, Hendel\u00a0RC, Cohen\u00a0MG, Valasaki\u00a0K, Pujol\u00a0MV, Ghersin\u00a0E, Miki\u00a0R, Delgado\u00a0C,\u00a0 Abuzeid\u00a0F, Vidro-Casiano\u00a0M, Saltzman\u00a0RG, DaFonseca\u00a0D, Caceres\u00a0LV, Ramdas\u00a0KN, Mendizabal\u00a0A, Heldman\u00a0AW, Mitrani\u00a0RD, Hare\u00a0JM (2017) Dose comparison study of allogeneic mesenchymal stem cells in patients with ischemic cardiomyopathy (the TRIDENT Study). Circ Res 121:1279\u20131290.\u00a0[pii] https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311827CIRCRESAHA.117.311827","DOI":"10.1161\/CIRCRESAHA.117.311827CIRCRESAHA.117.311827"},{"key":"8892_CR267","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s12015-007-9001-1","volume":"3","author":"W Wagner","year":"2007","unstructured":"Wagner W, Ho AD (2007) Mesenchymal stem cell preparations\u2013comparing apples and oranges. Stem Cell Rev 3:239\u2013248. https:\/\/doi.org\/10.1007\/s12015-007-9001-1","journal-title":"Stem Cell Rev"},{"key":"8892_CR268","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1089\/scd.2012.0594","volume":"22","author":"C Menard","year":"2013","unstructured":"Menard C, Pacelli L, Bassi G, Dulong J, Bifari F, Bezier I, Zanoncello J, Ricciardi M, Latour M, Bourin P, Schrezenmeier H, Sensebe L, Tarte K, Krampera M (2013) Clinical-grade mesenchymal stromal cells produced under various good manufacturing practice processes differ in their immunomodulatory properties: standardization of immune quality controls. Stem Cells Dev 22:1789\u20131801. https:\/\/doi.org\/10.1089\/scd.2012.0594","journal-title":"Stem Cells Dev"},{"key":"8892_CR269","doi-asserted-by":"publisher","unstructured":"Kumamoto\u00a0M, Nishiwaki\u00a0T, Matsuo\u00a0N, Kimura\u00a0H, Matsushima\u00a0K (2009) Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury. Eur Respir J 34:740\u2013748.\u00a0[pii] https:\/\/doi.org\/10.1183\/09031936.0012850809031936.00128508","DOI":"10.1183\/09031936.0012850809031936.00128508"},{"key":"8892_CR270","doi-asserted-by":"publisher","unstructured":"Kim\u00a0D, Cho\u00a0GS, Han\u00a0C, Park\u00a0DH, Park\u00a0HK, Woo\u00a0DH, Kim\u00a0JH (2017) Current understanding of stem cell and secretome therapies in liver diseases. Tissue Eng Regen Med 14:653\u2013665.\u00a0[pii] https:\/\/doi.org\/10.1007\/s13770-017-0093-793","DOI":"10.1007\/s13770-017-0093-793"},{"key":"8892_CR271","doi-asserted-by":"publisher","unstructured":"Jakovljevic\u00a0J, Harrell\u00a0CR, Fellabaum C, Arsenijevic\u00a0A, Jovicic\u00a0N, Volarevic\u00a0V (2018) Modulation of autophagy as new approach in mesenchymal stem cell-based therapy. Biomed Pharmacother 104:404\u2013410.\u00a0[pii] S0753-3322(18)31186-7 https:\/\/doi.org\/10.1016\/j.biopha.2018.05.061","DOI":"10.1016\/j.biopha.2018.05.061"},{"key":"8892_CR272","doi-asserted-by":"publisher","unstructured":"Bernardo\u00a0ME, Cometa\u00a0AM, Pagliara\u00a0D, Vinti\u00a0L, Rossi\u00a0F, Cristantielli\u00a0R, Palumbo\u00a0G, Locatelli\u00a0F (2011) Ex vivo expansion of mesenchymal stromal cells. Best Pract Res Clin Haematol 24:73\u201381.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.beha.2010.11.002S1521-6926(10)00131-3","DOI":"10.1016\/j.beha.2010.11.002S1521-6926(10)00131-3"},{"key":"8892_CR273","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-1-60761-999-4_15","volume":"698","author":"F dos Santos","year":"2011","unstructured":"dos Santos F, Andrade PZ, Eibes G, da Silva CL, Cabral JM (2011) Ex vivo expansion of human mesenchymal stem cells on microcarriers. Methods Mol Biol 698:189\u2013198. https:\/\/doi.org\/10.1007\/978-1-60761-999-4_15","journal-title":"Methods Mol Biol"},{"key":"8892_CR274","doi-asserted-by":"publisher","unstructured":"Jossen\u00a0V,\u00a0van den Bos C, Eibl\u00a0R, Eibl\u00a0D (2018) Manufacturing human mesenchymal stem cells at clinical scale: process and regulatory challenges. Appl Microbiol Biotechnol 102:3981\u20133994.\u00a0[pii] https:\/\/doi.org\/10.1007\/s00253-018-8912-x10.1007\/s00253-018-8912-x","DOI":"10.1007\/s00253-018-8912-x10.1007\/s00253-018-8912-x"},{"key":"8892_CR275","doi-asserted-by":"publisher","unstructured":"Burst\u00a0VR, Gillis\u00a0M, Putsch\u00a0F, Herzog\u00a0R, Fischer\u00a0JH, Heid\u00a0P, Muller-Ehmsen\u00a0J, Schenk\u00a0K, Fries\u00a0JW, Baldamus\u00a0CA, Benzing\u00a0T (2010) Poor cell survival limits the beneficial impact of mesenchymal stem cell transplantation on acute kidney injury. Nephron Exp Nephrol 114:e107\u2013116.\u00a0[pii] https:\/\/doi.org\/10.1159\/000262318000262318","DOI":"10.1159\/000262318000262318"},{"key":"8892_CR276","doi-asserted-by":"publisher","unstructured":"Shi\u00a0RZ, Li\u00a0QP (2008) Improving outcome of transplanted mesenchymal stem cells for ischemic heart disease. Biochem Biophys Res Commun 376:247\u2013250.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.bbrc.2008.09.004S0006-291X(08)01744-0","DOI":"10.1016\/j.bbrc.2008.09.004S0006-291X(08)01744-0"},{"key":"8892_CR277","doi-asserted-by":"publisher","unstructured":"Copland\u00a0IB (2011) Mesenchymal stromal cells for cardiovascular disease. J Cardiovasc Dis Res 2:3\u201313.\u00a0[pii] https:\/\/doi.org\/10.4103\/0975-3583.78581JCDR-2-3","DOI":"10.4103\/0975-3583.78581JCDR-2-3"},{"key":"8892_CR278","doi-asserted-by":"publisher","unstructured":"Mias\u00a0C, Trouche\u00a0E, Seguelas\u00a0MH, Calcagno\u00a0F, Dignat-George\u00a0F, Sabatier\u00a0F, Piercecchi-Marti\u00a0MD, Daniel\u00a0L, Bianchi\u00a0P, Calise\u00a0D, Bourin\u00a0P, Parini\u00a0A, Cussac\u00a0D (2008) Ex vivo pretreatment with melatonin improves survival, proangiogenic\/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells 26:1749\u20131757.\u00a0[pii] https:\/\/doi.org\/10.1634\/stemcells.2007-10002007-1000","DOI":"10.1634\/stemcells.2007-10002007-1000"},{"key":"8892_CR279","doi-asserted-by":"publisher","unstructured":"Chang\u00a0W, Song\u00a0BW, Moon\u00a0JY, Cha\u00a0MJ, Ham\u00a0O, Lee\u00a0SY, Choi\u00a0E, Hwang\u00a0KC (2013) Anti-death strategies against oxidative stress in grafted mesenchymal stem cells. Histol Histopathol 28:1529\u20131536.\u00a0[pii] https:\/\/doi.org\/10.14670\/HH-28.1529HH-11-360","DOI":"10.14670\/HH-28.1529HH-11-360"},{"key":"8892_CR280","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/stem.302","volume":"28","author":"H Song","year":"2010","unstructured":"Song H, Cha MJ, Song BW, Kim IK, Chang W, Lim S, Choi EJ, Ham O, Lee SY, Chung N, Jang Y, Hwang KC (2010) Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex. Stem Cells 28:555\u2013563. https:\/\/doi.org\/10.1002\/stem.302","journal-title":"Stem Cells"},{"key":"8892_CR281","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4252\/wjsc.v8.i3.73","volume":"8","author":"A De Becker","year":"2016","unstructured":"De Becker A, Riet IV (2016) Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy? World J Stem Cells 8:73\u201387. https:\/\/doi.org\/10.4252\/wjsc.v8.i3.73","journal-title":"World J Stem Cells"},{"key":"8892_CR282","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.3389\/fimmu.2018.02571","volume":"9","author":"ATJ Maria","year":"2018","unstructured":"Maria ATJ, Toupet K, Maumus M, Rozier P, Vozenin MC, Le Quellec A, Jorgensen C, Noel D, Guilpain P (2018) Fibrosis development in HOCl-induced systemic sclerosis: a multistage process hampered by mesenchymal stem cells. Front Immunol 9:2571. https:\/\/doi.org\/10.3389\/fimmu.2018.02571","journal-title":"Front Immunol"},{"key":"8892_CR283","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/jcp.21940","volume":"222","author":"NZ Kuhn","year":"2010","unstructured":"Kuhn NZ, Tuan RS (2010) Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. J Cell Physiol 222:268\u2013277. https:\/\/doi.org\/10.1002\/jcp.21940","journal-title":"J Cell Physiol"},{"key":"8892_CR284","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2013.94emm201394[pii]","volume":"45","author":"MB Murphy","year":"2013","unstructured":"Murphy MB, Moncivais K, Caplan AI (2013) Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med 45:e54. https:\/\/doi.org\/10.1038\/emm.2013.94emm201394[pii]","journal-title":"Exp Mol Med"},{"key":"8892_CR285","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/biof.1374","volume":"43","author":"V Volarevic","year":"2017","unstructured":"Volarevic V, Gazdic M, Markovic BS, Jovicic N, Djonov V, Arsenijevic N (2017) Mesenchymal stem cell-derived factors: immuno-modulatory effects and therapeutic potential. BioFactors 43:633\u2013644. https:\/\/doi.org\/10.1002\/biof.1374","journal-title":"BioFactors"},{"key":"8892_CR286","doi-asserted-by":"publisher","unstructured":"Wang\u00a0Y, Chen\u00a0X, Cao\u00a0W, Shi\u00a0Y (2014) Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat Immunol 15:1009\u20131016.\u00a0[pii] https:\/\/doi.org\/10.1038\/ni.3002ni.3002","DOI":"10.1038\/ni.3002ni.3002"},{"key":"8892_CR287","doi-asserted-by":"publisher","unstructured":"Papadopoulou\u00a0A, Yiangou\u00a0M, Athanasiou\u00a0E, Zogas\u00a0N, Kaloyannidis\u00a0P, Batsis\u00a0I, Fassas\u00a0A, Anagnostopoulos\u00a0A, Yannaki\u00a0E (2012) Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis. Ann Rheum Dis 71:1733\u20131740.\u00a0[pii] https:\/\/doi.org\/10.1136\/annrheumdis-2011-200985annrheumdis-2011-200985","DOI":"10.1136\/annrheumdis-2011-200985annrheumdis-2011-200985"},{"key":"8892_CR288","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009016","volume":"5","author":"SJ Prasanna","year":"2010","unstructured":"Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB (2010) Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One 5:e9016. https:\/\/doi.org\/10.1371\/journal.pone.0009016","journal-title":"PLoS ONE"},{"key":"8892_CR289","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1089\/scd.2016.0349","volume":"26","author":"GD Kusuma","year":"2017","unstructured":"Kusuma GD, Carthew J, Lim R, Frith JE (2017) Effect of the microenvironment on mesenchymal stem cell paracrine signaling: opportunities to engineer the therapeutic effect. Stem Cells Dev 26:617\u2013631. https:\/\/doi.org\/10.1089\/scd.2016.0349","journal-title":"Stem Cells Dev"},{"key":"8892_CR290","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010088","volume":"5","author":"RS Waterman","year":"2010","unstructured":"Waterman RS, Tomchuck SL, Henkle SL, Betancourt AM (2010) A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One 5:e10088. https:\/\/doi.org\/10.1371\/journal.pone.0010088","journal-title":"PLoS ONE"},{"key":"8892_CR291","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/iub.1469","volume":"68","author":"SM Shalaby","year":"2016","unstructured":"Shalaby SM, Sabbah NA, Saber T, Abdel Hamid RA (2016) Adipose-derived mesenchymal stem cells modulate the immune response in chronic experimental autoimmune encephalomyelitis model. IUBMB Life 68:106\u2013115. https:\/\/doi.org\/10.1002\/iub.1469","journal-title":"IUBMB Life"},{"key":"8892_CR292","doi-asserted-by":"publisher","unstructured":"Gonzalez-Rey\u00a0E, Anderson\u00a0P, Gonzalez\u00a0MA, Rico\u00a0L, Buscher\u00a0D, Delgado\u00a0M (2009) Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58:929\u2013939.\u00a0[pii] https:\/\/doi.org\/10.1136\/gut.2008.168534gut.2008.168534","DOI":"10.1136\/gut.2008.168534gut.2008.168534"},{"key":"8892_CR293","doi-asserted-by":"publisher","unstructured":"Sudres\u00a0M, Norol\u00a0F, Trenado\u00a0A, Gregoire\u00a0S, Charlotte\u00a0F, Levacher\u00a0B, Lataillade\u00a0JJ, Bourin P, Holy\u00a0X, Vernant\u00a0JP, Klatzmann\u00a0D, Cohen\u00a0JL (2006) Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J Immunol 176:7761\u20137767.\u00a0[pii] 176\/12\/7761 https:\/\/doi.org\/10.4049\/jimmunol.176.12.7761","DOI":"10.4049\/jimmunol.176.12.7761"},{"key":"8892_CR294","doi-asserted-by":"publisher","unstructured":"Alvarez\u00a0D, Levine\u00a0M, Rojas\u00a0M (2015) Regenerative medicine in the treatment of idiopathic pulmonary fibrosis: Current position. Stem Cells Cloning 8:61\u201365.\u00a0[pii] https:\/\/doi.org\/10.2147\/SCCAA.S49801sccaa-8-061","DOI":"10.2147\/SCCAA.S49801sccaa-8-061"},{"key":"8892_CR295","doi-asserted-by":"publisher","unstructured":"Srour\u00a0N, Thebaud\u00a0B (2015) Mesenchymal stromal cells in animal bleomycin pulmonary fibrosis models: A systematic review. Stem Cells Transl Med 4:1500\u20131510.\u00a0[pii] https:\/\/doi.org\/10.5966\/sctm.2015-0121sctm.2015-0121","DOI":"10.5966\/sctm.2015-0121sctm.2015-0121"},{"key":"8892_CR296","doi-asserted-by":"publisher","unstructured":"Perez-Estenaga\u00a0I, Prosper\u00a0F, Pelacho\u00a0B (2018) Allogeneic mesenchymal stem cells and biomaterials: the perfect match for cardiac repair? Int J Mol Sci 19:E3236.\u00a0[pii] https:\/\/doi.org\/10.3390\/ijms19103236ijms19103236","DOI":"10.3390\/ijms19103236ijms19103236"},{"key":"8892_CR297","doi-asserted-by":"publisher","unstructured":"Rengasamy\u00a0M, Gupta\u00a0PK, Kolkundkar\u00a0U, Singh\u00a0G, Balasubramanian\u00a0S, SundarRaj\u00a0S,\u00a0 Chullikana\u00a0A, Majumdar\u00a0AS (2016) Preclinical safety & toxicity evaluation of pooled, allogeneic human bone marrow-derived mesenchymal stromal cells. Indian J Med Res 144:852\u2013864.\u00a0[pii] https:\/\/doi.org\/10.4103\/ijmr.IJMR_1842_15IndianJMedRes_2016_144_6_852_205349","DOI":"10.4103\/ijmr.IJMR_1842_15IndianJMedRes_2016_144_6_852_205349"},{"key":"8892_CR298","doi-asserted-by":"publisher","unstructured":"Bernardo\u00a0ME, Zaffaroni\u00a0N, Novara\u00a0F, Cometa\u00a0AM, Avanzini\u00a0MA, Moretta\u00a0A, Montagna\u00a0D, Maccario\u00a0R, Villa\u00a0R, Daidone\u00a0MG, Zuffardi\u00a0O, Locatelli\u00a0F (2007) Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res 67:9142\u20139149.\u00a0[pii] 67\/19\/9142 https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-4690","DOI":"10.1158\/0008-5472.CAN-06-4690"},{"key":"8892_CR299","doi-asserted-by":"publisher","unstructured":"Volarevic\u00a0V, Markovic\u00a0BS, Gazdic\u00a0M, Volarevic\u00a0A, Jovicic\u00a0N, Arsenijevic\u00a0N, Armstrong\u00a0L, Djonov\u00a0V, Lako\u00a0M, Stojkovic\u00a0M (2018) Ethical and safety issues of stem cell-based therapy. Int J Med Sci 15:36\u201345.\u00a0[pii] https:\/\/doi.org\/10.7150\/ijms.21666ijmsv15p0036","DOI":"10.7150\/ijms.21666ijmsv15p0036"},{"key":"8892_CR300","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2217\/rme-2017-0078","volume":"13","author":"KW Yong","year":"2018","unstructured":"Yong KW, Choi JR, Dolbashid AS, Wan Safwani WKZ (2018) Biosafety and bioefficacy assessment of human mesenchymal stem cells: what do we know so far? Regen Med 13:219\u2013232. https:\/\/doi.org\/10.2217\/rme-2017-0078","journal-title":"Regen Med"},{"key":"8892_CR301","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002213","volume":"3","author":"W Wagner","year":"2008","unstructured":"Wagner W, Horn P, Castoldi M, Diehlmann A, Bork S, Saffrich R, Benes V, Blake J, Pfister S, Eckstein V, Ho AD (2008) Replicative senescence of mesenchymal stem cells: A continuous and organized process. PLoS One 3:e2213. https:\/\/doi.org\/10.1371\/journal.pone.0002213","journal-title":"PLoS ONE"},{"key":"8892_CR302","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1089\/ars.2012.4692","volume":"18","author":"PJ Ho","year":"2013","unstructured":"Ho PJ, Yen ML, Tang BC, Chen CT, Yen BL (2013) H2O2 accumulation mediates differentiation capacity alteration, but not proliferative decline, in senescent human fetal mesenchymal stem cells. Antioxid Redox Signal 18:1895\u20131905. https:\/\/doi.org\/10.1089\/ars.2012.4692","journal-title":"Antioxid Redox Signal"},{"key":"8892_CR303","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10561-014-9451-z","volume":"16","author":"X Wang","year":"2015","unstructured":"Wang X, Liu C, Li S, Xu Y, Chen P, Liu Y, Ding Q, Wahapu W, Hong B, Yang M (2015) Effects of continuous passage on immunomodulatory properties of human adipose-derived stem cells. Cell Tissue Bank 16:143\u2013150. https:\/\/doi.org\/10.1007\/s10561-014-9451-z","journal-title":"Cell Tissue Bank"},{"key":"8892_CR304","doi-asserted-by":"publisher","unstructured":"Ben-David\u00a0U, Mayshar\u00a0Y, Benvenisty\u00a0N (2011) Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell 9:97\u2013102.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.stem.2011.06.013S1934-5909(11)00328-6","DOI":"10.1016\/j.stem.2011.06.013S1934-5909(11)00328-6"},{"key":"8892_CR305","doi-asserted-by":"publisher","unstructured":"Roemeling-van Rhijn\u00a0M,\u00a0de Klein A, Douben\u00a0H, Pan\u00a0Q,\u00a0van der \u00a0Laan LJ, Ijzermans\u00a0JN, Betjes\u00a0MG, Baan\u00a0CC, Weimar\u00a0W, Hoogduijn\u00a0MJ (2013) Culture expansion induces non-tumorigenic aneuploidy in adipose tissue-derived mesenchymal stromal cells. Cytotherapy 15:1352\u20131361.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.jcyt.2013.07.004S1465-3249(13)00632-4","DOI":"10.1016\/j.jcyt.2013.07.004S1465-3249(13)00632-4"},{"key":"8892_CR306","doi-asserted-by":"publisher","unstructured":"Phan\u00a0J, Kumar\u00a0P, Hao\u00a0D, Gao\u00a0K, Farmer\u00a0D, Wang\u00a0A (2018) Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy. J Extracell Vesicles 7:1522236.\u00a0[pii] https:\/\/doi.org\/10.1080\/20013078.2018.15222361522236","DOI":"10.1080\/20013078.2018.15222361522236"},{"key":"8892_CR307","doi-asserted-by":"publisher","unstructured":"Rosland\u00a0GV, Svendsen\u00a0A, Torsvik\u00a0A, Sobala\u00a0E, McCormack\u00a0E, Immervoll\u00a0H, Mysliwietz\u00a0J, Tonn\u00a0JC, Goldbrunner\u00a0R, Lonning\u00a0PE, Bjerkvig\u00a0R, Schichor\u00a0C (2009) Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res 69:5331\u20135339.\u00a0[pii] https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-46300008-5472.CAN-08-4630","DOI":"10.1158\/0008-5472.CAN-08-46300008-5472.CAN-08-4630"},{"key":"8892_CR308","doi-asserted-by":"publisher","unstructured":"Miura\u00a0M, Miura\u00a0Y, Padilla-Nash\u00a0HM, Molinolo\u00a0AA, Fu\u00a0B, Patel\u00a0V, Seo\u00a0BM, Sonoyama W, Zheng\u00a0JJ, Baker\u00a0CC, Chen\u00a0W, Ried\u00a0T, Shi\u00a0S (2006) Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells 24:1095\u20131103.\u00a0[pii] 2005-0403 https:\/\/doi.org\/10.1634\/stemcells.2005-0403","DOI":"10.1634\/stemcells.2005-0403"},{"key":"8892_CR309","doi-asserted-by":"publisher","unstructured":"Tan\u00a0B, Shen\u00a0L, Yang\u00a0K, Huang\u00a0D, Li\u00a0X, Li\u00a0Y, Zhao\u00a0L, Chen\u00a0J, Yi\u00a0Q, Xu\u00a0H, Tian\u00a0J, Zhu\u00a0J (2018) C6 glioma-conditioned medium induces malignant transformation of mesenchymal stem cells: possible role of S100B\/RAGE pathway. Biochem Biophys Res Commun 495:78\u201385.\u00a0[pii] S0006-291X(17)32050-8 https:\/\/doi.org\/10.1016\/j.bbrc.2017.10.071","DOI":"10.1016\/j.bbrc.2017.10.071"},{"key":"8892_CR310","doi-asserted-by":"publisher","unstructured":"Jeong JO, Han\u00a0JW, Kim\u00a0JM, Cho\u00a0HJ, Park\u00a0C, Lee\u00a0N, Kim\u00a0DW, Yoon\u00a0YS (2011) Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circ Res 108:1340\u20131347.\u00a0[pii] https:\/\/doi.org\/10.1161\/CIRCRESAHA.110.239848CIRCRESAHA.110.239848","DOI":"10.1161\/CIRCRESAHA.110.239848CIRCRESAHA.110.239848"},{"key":"8892_CR311","doi-asserted-by":"publisher","unstructured":"Shi\u00a0Y, Du\u00a0L, Lin\u00a0L, Wang\u00a0Y (2017) Tumour-associated mesenchymal stem\/stromal cells: emerging therapeutic targets. Nat Rev Drug Discov 16:35\u201352.\u00a0[pii] https:\/\/doi.org\/10.1038\/nrd.2016.193nrd.2016.193","DOI":"10.1038\/nrd.2016.193nrd.2016.193"},{"key":"8892_CR312","doi-asserted-by":"publisher","unstructured":"Moniri\u00a0MR, Dai\u00a0LJ, Warnock\u00a0GL (2014) The challenge of pancreatic cancer therapy and novel treatment strategy using engineered mesenchymal stem cells. Cancer Gene Ther 21:12\u201323.\u00a0[pii] https:\/\/doi.org\/10.1038\/cgt.2013.83cgt201383","DOI":"10.1038\/cgt.2013.83cgt201383"},{"key":"8892_CR313","doi-asserted-by":"publisher","unstructured":"Tsai\u00a0KS, Yang\u00a0SH, Lei\u00a0YP, Tsai\u00a0CC, Chen\u00a0HW, Hsu\u00a0CY, Chen\u00a0LL, Wang\u00a0HW, Miller\u00a0SA, Chiou\u00a0SH, Hung\u00a0MC, Hung\u00a0SC (2011) Mesenchymal stem cells promote formation of colorectal tumors in mice. Gastroenterology 141:1046\u20131056.\u00a0[pii] https:\/\/doi.org\/10.1053\/j.gastro.2011.05.045S0016-5085(11)00748-7","DOI":"10.1053\/j.gastro.2011.05.045S0016-5085(11)00748-7"},{"key":"8892_CR314","doi-asserted-by":"publisher","unstructured":"Stagg\u00a0J (2007) Immune regulation by mesenchymal stem cells: two sides to the coin. Tissue Antigens 69:1\u20139.\u00a0[pii] TAN739 https:\/\/doi.org\/10.1111\/j.1399-0039.2006.00739.x","DOI":"10.1111\/j.1399-0039.2006.00739.x"},{"key":"8892_CR315","doi-asserted-by":"publisher","unstructured":"Djouad\u00a0F, Plence\u00a0P, Bony\u00a0C, Tropel\u00a0P, Apparailly\u00a0F, Sany\u00a0J, Noel\u00a0D, Jorgensen\u00a0C (2003) Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102:3837\u20133844.\u00a0[pii] https:\/\/doi.org\/10.1182\/blood-2003-04-11932003-04-1193","DOI":"10.1182\/blood-2003-04-11932003-04-1193"},{"key":"8892_CR316","doi-asserted-by":"publisher","unstructured":"Ball\u00a0SG, Shuttleworth\u00a0CA, Kielty\u00a0CM (2007) Mesenchymal stem cells and neovascularization: role of platelet-derived growth factor receptors. J Cell Mol Med 11:1012\u20131030.\u00a0[pii] JCMM120\u00a0https:\/\/doi.org\/10.1111\/j.1582-4934.2007.00120.x","DOI":"10.1111\/j.1582-4934.2007.00120.x"},{"key":"8892_CR317","doi-asserted-by":"publisher","unstructured":"Liu\u00a0Y, Han\u00a0ZP, Zhang\u00a0SS, Jing\u00a0YY, Bu\u00a0XX, Wang\u00a0CY, Sun K, Jiang\u00a0GC, Zhao\u00a0X, Li\u00a0R, Gao\u00a0L, Zhao\u00a0QD, Wu\u00a0MC, Wei\u00a0LX (2011) Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. J Biol Chem 286:25007\u201325015.\u00a0[pii] https:\/\/doi.org\/10.1074\/jbc.M110.213108M110.213108","DOI":"10.1074\/jbc.M110.213108M110.213108"},{"key":"8892_CR318","doi-asserted-by":"publisher","unstructured":"Loebinger\u00a0MR, Janes\u00a0SM (2010) Stem cells as vectors for antitumour therapy. Thorax 65:362\u2013369.\u00a0[pii] https:\/\/doi.org\/10.1136\/thx.2009.12802565\/4\/362","DOI":"10.1136\/thx.2009.12802565\/4\/362"},{"key":"8892_CR319","doi-asserted-by":"publisher","unstructured":"Bouffi\u00a0C, Djouad\u00a0F, Mathieu\u00a0M, Noel\u00a0D, Jorgensen\u00a0C (2009) Multipotent mesenchymal stromal cells and rheumatoid arthritis: risk or benefit? Rheumatology (Oxford) 48:1185\u20131189.\u00a0[pii] https:\/\/doi.org\/10.1093\/rheumatology\/kep162kep162","DOI":"10.1093\/rheumatology\/kep162kep162"},{"key":"8892_CR320","doi-asserted-by":"publisher","unstructured":"Le Blanc K, Frassoni\u00a0F, Ball\u00a0L, Locatelli\u00a0F, Roelofs\u00a0H, Lewis\u00a0I, Lanino E, Sundberg\u00a0B, Bernardo\u00a0ME, Remberger\u00a0M, Dini\u00a0G, Egeler\u00a0RM, Bacigalupo\u00a0A, Fibbe\u00a0W, Ringden\u00a0O (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: A phase II study. Lancet 371:1579\u20131586.\u00a0[pii] https:\/\/doi.org\/10.1016\/S0140-6736(08)60690-XS0140-6736(08)60690-X","DOI":"10.1016\/S0140-6736(08)60690-XS0140-6736(08)60690-X"},{"key":"8892_CR321","doi-asserted-by":"publisher","unstructured":"Torsvik\u00a0A, Rosland\u00a0GV, Svendsen\u00a0A, Molven\u00a0A, Immervoll\u00a0H, McCormack\u00a0E, Lonning\u00a0PE, Primon\u00a0M, Sobala\u00a0E, Tonn\u00a0JC, Goldbrunner\u00a0R, Schichor\u00a0C, Mysliwietz\u00a0J, Lah\u00a0TT, Motaln\u00a0H, Knappskog\u00a0S, Bjerkvig\u00a0R (2010) Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter. Cancer Res 70:6393\u20136396.\u00a0[pii] https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-13050008-5472.CAN-10-1305","DOI":"10.1158\/0008-5472.CAN-10-13050008-5472.CAN-10-1305"},{"key":"8892_CR322","doi-asserted-by":"publisher","unstructured":"Tarte\u00a0K, Gaillard\u00a0J, Lataillade\u00a0JJ, Fouillard\u00a0L, Becker\u00a0M, Mossafa\u00a0H, Tchirkov\u00a0A, Rouard\u00a0H, Henry\u00a0C, Splingard\u00a0M, Dulong\u00a0J, Monnier\u00a0D, Gourmelon\u00a0P, Gorin\u00a0NC, Sensebe\u00a0L (2010) Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood 115:1549\u20131553.\u00a0[pii] https:\/\/doi.org\/10.1182\/blood-2009-05-219907blood-2009-05-219907","DOI":"10.1182\/blood-2009-05-219907blood-2009-05-219907"},{"key":"8892_CR323","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1089\/scd.2010.0466","volume":"20","author":"JC Ra","year":"2011","unstructured":"Ra JC, Shin IS, Kim SH, Kang SK, Kang BC, Lee HY, Kim YJ, Jo JY, Yoon EJ, Choi HJ, Kwon E (2011) Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. Stem Cells Dev 20:1297\u20131308. https:\/\/doi.org\/10.1089\/scd.2010.0466","journal-title":"Stem Cells Dev"},{"key":"8892_CR324","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fmed.2018.00142","volume":"5","author":"A Tzouvelekis","year":"2018","unstructured":"Tzouvelekis A, Toonkel R, Karampitsakos T, Medapalli K, Ninou I, Aidinis V, Bouros D, Glassberg MK (2018) Mesenchymal stem cells for the treatment of idiopathic pulmonary fibrosis. Front Med (Lausanne) 5:142. https:\/\/doi.org\/10.3389\/fmed.2018.00142","journal-title":"Front Med (Lausanne)"},{"key":"8892_CR325","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/scd.2008.0092","volume":"18","author":"F Togel","year":"2009","unstructured":"Togel F, Cohen A, Zhang P, Yang Y, Hu Z, Westenfelder C (2009) Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury. Stem Cells Dev 18:475\u2013485. https:\/\/doi.org\/10.1089\/scd.2008.0092","journal-title":"Stem Cells Dev"},{"key":"8892_CR326","doi-asserted-by":"publisher","unstructured":"Glassberg\u00a0MK, Minkiewicz\u00a0J, Toonkel\u00a0RL, Simonet\u00a0ES, Rubio\u00a0GA, DiFede\u00a0D, Shafazand\u00a0S, Khan\u00a0A, Pujol\u00a0MV, LaRussa\u00a0VF, Lancaster\u00a0LH, Rosen\u00a0GD, Fishman\u00a0J, Mageto\u00a0YN, Mendizabal\u00a0A, Hare\u00a0JM (2017) Allogeneic human mesenchymal stem cells in patients with idiopathic pulmonary fibrosis via intravenous delivery (AETHER): A phase I safety clinical trial. Chest 151:971\u2013981.\u00a0[pii] S0012-3692(16)62462-5 https:\/\/doi.org\/10.1016\/j.chest.2016.10.061","DOI":"10.1016\/j.chest.2016.10.061"},{"key":"8892_CR327","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/stem.2847","volume":"36","author":"ME Bateman","year":"2018","unstructured":"Bateman ME, Strong AL, Gimble JM, Bunnell BA (2018) Concise review: using fat to fight disease: a systematic review of nonhomologous adipose-derived stromal\/stem cell therapies. Stem Cells 36:1311\u20131328. https:\/\/doi.org\/10.1002\/stem.2847","journal-title":"Stem Cells"},{"key":"8892_CR328","doi-asserted-by":"publisher","unstructured":"Rani\u00a0S, Ryan\u00a0AE, Griffin\u00a0MD, Ritter\u00a0T (2015) Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications. Mol Ther 23:812\u2013823.\u00a0[pii] S1525-0016(16)30106-X https:\/\/doi.org\/10.1038\/mt.2015.44","DOI":"10.1038\/mt.2015.44"},{"key":"8892_CR329","doi-asserted-by":"publisher","unstructured":"Kim\u00a0N, Cho\u00a0SG (2015) New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation. Int J Stem Cells 8:54\u201368.\u00a0[pii] https:\/\/doi.org\/10.15283\/ijsc.2015.8.1.54ijsc-08-54","DOI":"10.15283\/ijsc.2015.8.1.54ijsc-08-54"},{"key":"8892_CR330","doi-asserted-by":"publisher","first-page":"4379","DOI":"10.3748\/wjg.v21.i14.4379","volume":"21","author":"A Taddio","year":"2015","unstructured":"Taddio A, Tommasini A, Valencic E, Biagi E, Decorti G, De Iudicibus S, Cuzzoni E, Gaipa G, Badolato R, Prandini A, Biondi A, Ventura A (2015) Failure of interferon-gamma pre-treated mesenchymal stem cell treatment in a patient with Crohn\u2019s disease. World J Gastroenterol 21:4379\u20134384. https:\/\/doi.org\/10.3748\/wjg.v21.i14.4379","journal-title":"World J Gastroenterol"},{"key":"8892_CR331","doi-asserted-by":"publisher","unstructured":"Li\u00a0H, Rong\u00a0P, Ma\u00a0X, Nie\u00a0W, Chen\u00a0C, Yang\u00a0C, Zhang\u00a0J, Dong\u00a0Q, Wang\u00a0W (2018) Paracrine effect of mesenchymal stem cell as a novel therapeutic strategy for diabetic nephropathy. Life Sci 215:113\u2013118.\u00a0[pii] S0024-3205(18)30706-9 https:\/\/doi.org\/10.1016\/j.lfs.2018.11.001","DOI":"10.1016\/j.lfs.2018.11.001"},{"key":"8892_CR332","doi-asserted-by":"publisher","unstructured":"Meseguer-Olmo\u00a0L, Montellano\u00a0AJ, Martinez\u00a0T, Martinez\u00a0CM, Revilla-Nuin\u00a0B, Roldan\u00a0M, Mora\u00a0CF, Lopez-Lucas\u00a0MD, Fuente\u00a0T (2017) Intraarticular and intravenous administration of (99M)Tc-HMPAO-labeled human mesenchymal stem cells ((99M)TC-AH-MSCS): In vivo imaging and biodistribution. Nucl Med Biol 46:36\u201342.\u00a0[pii] S0969-8051(16)30382-1 https:\/\/doi.org\/10.1016\/j.nucmedbio.2016.12.003","DOI":"10.1016\/j.nucmedbio.2016.12.003"},{"key":"8892_CR333","doi-asserted-by":"publisher","unstructured":"Leibacher\u00a0J, Dauber\u00a0K, Ehser\u00a0S, Brixner\u00a0V, Kollar\u00a0K, Vogel\u00a0A, Spohn\u00a0G, Schafer\u00a0R, Seifried\u00a0E, Henschler\u00a0R (2017) Human mesenchymal stromal cells undergo apoptosis and fragmentation after intravenous application in immune-competent mice. Cytotherapy 19:61\u201374.\u00a0[pii] S1465-3249(16)30524-2 https:\/\/doi.org\/10.1016\/j.jcyt.2016.09.010","DOI":"10.1016\/j.jcyt.2016.09.010"},{"key":"8892_CR334","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fncel.2018.00317","volume":"12","author":"EE Reza-Zaldivar","year":"2018","unstructured":"Reza-Zaldivar EE, Hernandez-Sapiens MA, Minjarez B, Gutierrez-Mercado YK, Marquez-Aguirre AL, Canales-Aguirre AA (2018) Potential effects of MSC-derived exosomes in neuroplasticity in Alzheimer\u2019s disease. Front Cell Neurosci 12:317. https:\/\/doi.org\/10.3389\/fncel.2018.00317","journal-title":"Front Cell Neurosci"},{"key":"8892_CR335","doi-asserted-by":"publisher","unstructured":"Furlani\u00a0D, Ugurlucan\u00a0M, Ong\u00a0L, Bieback\u00a0K, Pittermann\u00a0E, Westien\u00a0I, Wang\u00a0W, Yerebakan\u00a0C, Li\u00a0W, Gaebel\u00a0R, Li\u00a0RK, Vollmar\u00a0B, Steinhoff\u00a0G, Ma\u00a0N (2009) Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy. Microvasc Res 77:370\u2013376.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.mvr.2009.02.001S0026-2862(09)00069-7","DOI":"10.1016\/j.mvr.2009.02.001S0026-2862(09)00069-7"},{"key":"8892_CR336","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/stem.1111","volume":"30","author":"G Moll","year":"2012","unstructured":"Moll G, Rasmusson-Duprez I, von Bahr L, Connolly-Andersen AM, Elgue G, Funke L, Hamad OA, Lonnies H, Magnusson PU, Sanchez J, Teramura Y, Nilsson-Ekdahl K, Ringden O, Korsgren O, Nilsson B, Le Blanc K (2012) Are therapeutic human mesenchymal stromal cells compatible with human blood? Stem Cells 30:1565\u20131574. https:\/\/doi.org\/10.1002\/stem.1111","journal-title":"Stem Cells"},{"key":"8892_CR337","doi-asserted-by":"publisher","unstructured":"Packham\u00a0DK, Fraser\u00a0IR, Kerr\u00a0PG, Segal\u00a0KR (2016) Allogeneic mesenchymal precursor cells (MPC) in diabetic nephropathy: A randomized, placebo-controlled, dose escalation study. EBioMedicine 12:263\u2013269.\u00a0[pii] S2352-3964(16)30418-2 https:\/\/doi.org\/10.1016\/j.ebiom.2016.09.011","DOI":"10.1016\/j.ebiom.2016.09.011"},{"key":"8892_CR338","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12015-013-9492-x","volume":"10","author":"J Ge","year":"2014","unstructured":"Ge J, Guo L, Wang S, Zhang Y, Cai T, Zhao RC, Wu Y (2014) The size of mesenchymal stem cells is a significant cause of vascular obstructions and stroke. Stem Cell Rev Rep 10:295\u2013303. https:\/\/doi.org\/10.1007\/s12015-013-9492-x","journal-title":"Stem Cell Rev Rep"},{"key":"8892_CR339","doi-asserted-by":"publisher","unstructured":"Janowski\u00a0M, Lyczek\u00a0A, Engels\u00a0C, Xu\u00a0J, Lukomska\u00a0B, Bulte\u00a0JW, Walczak\u00a0P (2013) Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation. J Cereb Blood Flow Metab 33:921\u2013927.\u00a0[pii] https:\/\/doi.org\/10.1038\/jcbfm.2013.32jcbfm201332","DOI":"10.1038\/jcbfm.2013.32jcbfm201332"},{"key":"8892_CR340","doi-asserted-by":"publisher","unstructured":"Cipriani\u00a0P, Carubbi\u00a0F, Liakouli\u00a0V, Marrelli\u00a0A, Perricone C, Perricone\u00a0R, Alesse\u00a0E, Giacomelli\u00a0R (2013) Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy. Autoimmun Rev 12:709\u2013716.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.autrev.2012.10.004S1568-9972(12)00262-5","DOI":"10.1016\/j.autrev.2012.10.004S1568-9972(12)00262-5"},{"key":"8892_CR341","doi-asserted-by":"publisher","unstructured":"De Miguel MP, Fuentes-Julian\u00a0S, Blazquez-Martinez\u00a0A, Pascual\u00a0CY, Aller\u00a0MA, Arias\u00a0J, Arnalich-Montiel\u00a0F (2012) Immunosuppressive properties of mesenchymal stem cells: advances and applications. Curr Mol Med 12:574\u2013591.\u00a0[pii] CMM-EPUB-20120418-003 https:\/\/doi.org\/10.2174\/156652412800619950","DOI":"10.2174\/156652412800619950"},{"key":"8892_CR342","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1111\/j.1582-4934.2011.01509.x","volume":"16","author":"S Schu","year":"2012","unstructured":"Schu S, Nosov M, O\u2019Flynn L, Shaw G, Treacy O, Barry F, Murphy M, O\u2019Brien T, Ritter T (2012) Immunogenicity of allogeneic mesenchymal stem cells. J Cell Mol Med 16:2094\u20132103. https:\/\/doi.org\/10.1111\/j.1582-4934.2011.01509.x","journal-title":"J Cell Mol Med"},{"key":"8892_CR343","doi-asserted-by":"publisher","unstructured":"Ankrum\u00a0JA, Ong\u00a0JF, Karp\u00a0JM (2014) Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol 32:252\u2013260.\u00a0[pii] https:\/\/doi.org\/10.1038\/nbt.2816nbt.2816","DOI":"10.1038\/nbt.2816nbt.2816"},{"key":"8892_CR344","doi-asserted-by":"publisher","unstructured":"Zhang\u00a0J, Huang\u00a0X, Wang\u00a0H, Liu\u00a0X, Zhang\u00a0T, Wang\u00a0Y, Hu\u00a0D (2015) The challenges and promises of allogeneic mesenchymal stem cells for use as a cell-based therapy. Stem Cell Res Ther 6:234.\u00a0[pii] https:\/\/doi.org\/10.1186\/s13287-015-0240-910.1186\/s13287-015-0240-9","DOI":"10.1186\/s13287-015-0240-910.1186\/s13287-015-0240-9"},{"key":"8892_CR345","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/path.2469","volume":"217","author":"AI Caplan","year":"2009","unstructured":"Caplan AI (2009) Why are MSCs therapeutic? New data: new insight. J Pathol 217:318\u2013324. https:\/\/doi.org\/10.1002\/path.2469","journal-title":"J Pathol"},{"key":"8892_CR346","doi-asserted-by":"publisher","unstructured":"Eliopoulos\u00a0N, Stagg\u00a0J, Lejeune\u00a0L, Pommey\u00a0S, Galipeau\u00a0J (2005) Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice. Blood 106:4057\u20134065.\u00a0[pii] 2005-03-1004 https:\/\/doi.org\/10.1182\/blood-2005-03-1004","DOI":"10.1182\/blood-2005-03-1004"},{"key":"8892_CR347","doi-asserted-by":"publisher","first-page":"5830103","DOI":"10.1155\/2016\/5830103","volume":"2016","author":"SD Owens","year":"2016","unstructured":"Owens SD, Kol A, Walker NJ, Borjesson DL (2016) Allogeneic mesenchymal stem cell treatment induces specific alloantibodies in horses. Stem Cells Int 2016:5830103. https:\/\/doi.org\/10.1155\/2016\/5830103","journal-title":"Stem Cells Int"},{"key":"8892_CR348","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1002\/stem.217","volume":"27","author":"L Zangi","year":"2009","unstructured":"Zangi L, Margalit R, Reich-Zeliger S, Bachar-Lustig E, Beilhack A, Negrin R, Reisner Y (2009) Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells. Stem Cells 27:2865\u20132874. https:\/\/doi.org\/10.1002\/stem.217","journal-title":"Stem Cells"},{"key":"8892_CR349","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.3389\/fimmu.2017.01626","volume":"8","author":"P Lohan","year":"2017","unstructured":"Lohan P, Treacy O, Griffin MD, Ritter T, Ryan AE (2017) Anti-donor immune responses elicited by allogeneic mesenchymal stem cells and their extracellular vesicles: are we still learning? Front Immunol 8:1626. https:\/\/doi.org\/10.3389\/fimmu.2017.01626","journal-title":"Front Immunol"},{"key":"8892_CR350","doi-asserted-by":"publisher","unstructured":"Reinders\u00a0ME, Dreyer\u00a0GJ, Bank\u00a0JR, Roelofs\u00a0H, Heidt\u00a0S, Roelen\u00a0DL, Zandvliet\u00a0ML, Huurman\u00a0VA, Fibbe\u00a0WE,\u00a0van Kooten C, Claas\u00a0FH, Rabelink\u00a0TJ,\u00a0de Fijter JW (2015) Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study. J Transl Med 13:344.\u00a0[pii] https:\/\/doi.org\/10.1186\/s12967-015-0700-010.1186\/s12967-015-0700-0","DOI":"10.1186\/s12967-015-0700-010.1186\/s12967-015-0700-0"},{"key":"8892_CR351","doi-asserted-by":"publisher","unstructured":"Spaggiari\u00a0GM, Capobianco\u00a0A, Becchetti\u00a0S, Mingari\u00a0MC, Moretta\u00a0L (2006) Mesenchymal stem cell-natural killer cell interactions: Evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107:1484\u20131490.\u00a0[pii] 2005-07-2775 https:\/\/doi.org\/10.1182\/blood-2005-07-2775","DOI":"10.1182\/blood-2005-07-2775"},{"key":"8892_CR352","doi-asserted-by":"publisher","unstructured":"Crop\u00a0MJ, Korevaar\u00a0SS,\u00a0de Kuiper R,\u00a0Ijzermans JN, van Besouw NM, Baan CC, Weimar W, Hoogduijn MJ (2011)\u00a0Human mesenchymal stem cells are susceptible to lysis by CD8(+) T cells and NK cells. Cell Transplant 20:1547\u20131559.\u00a0[pii] https:\/\/doi.org\/10.3727\/096368910X564076ct0231cropetalpdf","DOI":"10.3727\/096368910X564076ct0231cropetalpdf"},{"key":"8892_CR353","doi-asserted-by":"publisher","unstructured":"Larghero\u00a0J, Farge\u00a0D, Braccini\u00a0A, Lecourt\u00a0S, Scherberich\u00a0A, Fois E, Verrecchia\u00a0F, Daikeler\u00a0T, Gluckman\u00a0E, Tyndall\u00a0A, Bocelli-Tyndall\u00a0C (2008) Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis. Ann Rheum Dis 67:443\u2013449.\u00a0[pii] ard.2007.071233 https:\/\/doi.org\/10.1136\/ard.2007.071233","DOI":"10.1136\/ard.2007.071233"},{"key":"8892_CR354","doi-asserted-by":"publisher","unstructured":"Marinaro\u00a0F, Sanchez-Margallo\u00a0FM, Alvarez\u00a0V, Lopez\u00a0E, Tarazona\u00a0R, Brun\u00a0MV, Blazquez\u00a0R, Casado\u00a0JG (2019) Meshes in a mess: Mesenchymal stem cell-based therapies for soft tissue reinforcement. Acta Biomater 85:60\u201374.\u00a0[pii] S1742-7061(18)30705-0 https:\/\/doi.org\/10.1016\/j.actbio.2018.11.042","DOI":"10.1016\/j.actbio.2018.11.042"},{"key":"8892_CR355","doi-asserted-by":"publisher","unstructured":"Melick\u00a0G, Hayman\u00a0N, Landsman\u00a0AS (2018) Mesenchymal stem cell applications for joints in the foot and ankle. Clin Podiatr Med Surg 35:323\u2013330.\u00a0[pii] S0891-8422(18)30022-3 https:\/\/doi.org\/10.1016\/j.cpm.2018.02.007","DOI":"10.1016\/j.cpm.2018.02.007"},{"key":"8892_CR356","doi-asserted-by":"publisher","unstructured":"Hare\u00a0JM, DiFede\u00a0DL, Rieger\u00a0AC, Florea\u00a0V, Landin AM, El-Khorazaty\u00a0J, Khan\u00a0A, Mushtaq\u00a0M, Lowery\u00a0MH, Byrnes\u00a0JJ, Hendel\u00a0RC, Cohen\u00a0MG, Alfonso\u00a0CE, Valasaki\u00a0K, Pujol\u00a0MV, Golpanian\u00a0S, Ghersin\u00a0E, Fishman\u00a0JE, Pattany\u00a0P, Gomes\u00a0SA, Delgado\u00a0C, Miki\u00a0R, Abuzeid\u00a0F, Vidro-Casiano\u00a0M, Premer\u00a0C, Medina\u00a0A, Porras\u00a0V, Hatzistergos\u00a0KE, Anderson\u00a0E, Mendizabal\u00a0A, Mitrani\u00a0R, Heldman\u00a0AW (2017) Randomized comparison of allogeneic versus autologous mesenchymal stem cells for nonischemic dilated cardiomyopathy: POSEIDON-DCM trial. J Am Coll Cardiol 69:526\u2013537.\u00a0[pii] S0735-1097(16)36906-6 https:\/\/doi.org\/10.1016\/j.jacc.2016.11.009","DOI":"10.1016\/j.jacc.2016.11.009"},{"key":"8892_CR357","doi-asserted-by":"publisher","unstructured":"Hegner\u00a0B, Schaub\u00a0T, Catar\u00a0R, Kusch\u00a0A, Wagner\u00a0P, Essin\u00a0K, Lange\u00a0C, Riemekasten\u00a0G, Dragun\u00a0D (2016) Intrinsic deregulation of vascular smooth muscle and myofibroblast differentiation in mesenchymal stromal cells from patients with systemic sclerosis. PLoS One 11:e0153101.\u00a0[pii] https:\/\/doi.org\/10.1371\/journal.pone.0153101PONE-D-16-04561","DOI":"10.1371\/journal.pone.0153101PONE-D-16-04561"},{"key":"8892_CR358","doi-asserted-by":"publisher","unstructured":"Stolzing\u00a0A, Jones\u00a0E, McGonagle\u00a0D, Scutt\u00a0A (2008) Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies. Mech Ageing Dev 129:163\u2013173.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.mad.2007.12.002S0047-6374(07)00179-0","DOI":"10.1016\/j.mad.2007.12.002S0047-6374(07)00179-0"},{"key":"8892_CR359","doi-asserted-by":"publisher","unstructured":"Beane\u00a0OS, Fonseca\u00a0VC, Cooper\u00a0LL, Koren\u00a0G, Darling\u00a0EM (2014) Impact of aging on the regenerative properties of bone marrow-, muscle-, and adipose-derived mesenchymal stem\/stromal cells. PLoS One 9:e115963.\u00a0[pii] https:\/\/doi.org\/10.1371\/journal.pone.0115963PONE-D-14-41711","DOI":"10.1371\/journal.pone.0115963PONE-D-14-41711"},{"key":"8892_CR360","doi-asserted-by":"publisher","unstructured":"Wang\u00a0J, Liao\u00a0L, Wang\u00a0S, Tan\u00a0J (2013) Cell therapy with autologous mesenchymal stem cells-how the disease process impacts clinical considerations. Cytotherapy 15:893\u2013904.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.jcyt.2013.01.218S1465-3249(13)00489-1","DOI":"10.1016\/j.jcyt.2013.01.218S1465-3249(13)00489-1"},{"key":"8892_CR361","doi-asserted-by":"publisher","unstructured":"Kornicka\u00a0K, Houston\u00a0J, Marycz\u00a0K (2018) Dysfunction of mesenchymal stem cells isolated from metabolic syndrome and type 2 diabetic patients as result of oxidative stress and autophagy may limit their potential therapeutic use. Stem Cell Rev Rep 14:337\u2013345. [pii] https:\/\/doi.org\/10.1007\/s12015-018-9809-x10.1007\/s12015-018-9809-x","DOI":"10.1007\/s12015-018-9809-x10.1007\/s12015-018-9809-x"},{"key":"8892_CR362","doi-asserted-by":"publisher","unstructured":"Griffin\u00a0M, Ryan\u00a0CM, Pathan\u00a0O, Abraham D, Denton\u00a0CP, Butler\u00a0PE (2017) Characteristics of human adipose derived stem cells in scleroderma in comparison to sex and age matched normal controls: implications for regenerative medicine. Stem Cell Res Ther 8:23. [pii] https:\/\/doi.org\/10.1186\/s13287-016-0444-710.1186\/s13287-016-0444-7","DOI":"10.1186\/s13287-016-0444-710.1186\/s13287-016-0444-7"},{"key":"8892_CR363","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/cei.12111","volume":"173","author":"P Cipriani","year":"2013","unstructured":"Cipriani P, Di Benedetto P, Liakouli V, Del Papa B, Di Padova M, Di Ianni M, Marrelli A, Alesse E, Giacomelli R (2013) Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: Implications for cellular-based therapy. Clin Exp Immunol 173:195\u2013206. https:\/\/doi.org\/10.1111\/cei.12111","journal-title":"Clin Exp Immunol"},{"key":"8892_CR364","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3727\/096368917X694822","volume":"26","author":"C Capelli","year":"2017","unstructured":"Capelli C, Zaccara E, Cipriani P, Di Benedetto P, Maglione W, Andracco R, Di Luca G, Pignataro F, Giacomelli R, Introna M, Vitali C, Del Papa N (2017) Phenotypical and functional characteristics of in vitro-expanded adipose-derived mesenchymal stromal cells from patients with systematic sclerosis. Cell Transplant 26:841\u2013854. https:\/\/doi.org\/10.3727\/096368917X694822","journal-title":"Cell Transplant"},{"key":"8892_CR365","doi-asserted-by":"publisher","unstructured":"Virzi\u00a0F, Bianca\u00a0P, Giammona\u00a0A, Apuzzo\u00a0T,\u00a0Di Franco S, Mangiapane\u00a0LR, Colorito\u00a0ML, Catalano\u00a0D, Scavo\u00a0E, Nicotra\u00a0A, Benfante\u00a0A, Pistone\u00a0G, Caputo\u00a0V, Dieli\u00a0F, Pirrello\u00a0R, Stassi\u00a0G (2017) Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients. Stem Cell Res Ther 8:236.\u00a0[pii] https:\/\/doi.org\/10.1186\/s13287-017-0690-310.1186\/s13287-017-0690-3","DOI":"10.1186\/s13287-017-0690-310.1186\/s13287-017-0690-3"},{"key":"8892_CR366","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1002\/art.22035","volume":"54","author":"N Del Papa","year":"2006","unstructured":"Del Papa N, Quirici N, Soligo D, Scavullo C, Cortiana M, Borsotti C, Maglione W, Comina DP, Vitali C, Fraticelli P, Gabrielli A, Cortelezzi A, Lambertenghi-Deliliers G (2006) Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum 54:2605\u20132615. https:\/\/doi.org\/10.1002\/art.22035","journal-title":"Arthritis Rheum"},{"key":"8892_CR367","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10456-013-9338-9","volume":"16","author":"P Cipriani","year":"2013","unstructured":"Cipriani P, Marrelli A, Benedetto PD, Liakouli V, Carubbi F, Ruscitti P, Alvaro S, Pantano I, Campese AF, Grazioli P, Screpanti I, Giacomelli R (2013) Scleroderma mesenchymal stem cells display a different phenotype from healthy controls; implications for regenerative medicine. Angiogenesis 16:595\u2013607. https:\/\/doi.org\/10.1007\/s10456-013-9338-9","journal-title":"Angiogenesis"},{"key":"8892_CR368","doi-asserted-by":"publisher","unstructured":"Cipriani\u00a0P,\u00a0Di Benedetto\u00a0P,\u00a0 Ruscitti\u00a0P, Campese\u00a0AF, Liakouli\u00a0V, Carubbi\u00a0F, Pantano I, Berardicurt\u00a0O, Screpanti\u00a0I, Giacomelli\u00a0R (2014) Impaired endothelium-mesenchymal stem cells cross-talk in systemic sclerosis: a link between vascular and fibrotic features. Arthritis Res Ther 16:442.\u00a0[pii] https:\/\/doi.org\/10.1186\/s13075-014-0442-zs13075-014-0442-z","DOI":"10.1186\/s13075-014-0442-zs13075-014-0442-z"},{"key":"8892_CR369","doi-asserted-by":"publisher","unstructured":"Scruggs\u00a0BA, Semon\u00a0JA, Zhang\u00a0X, Zhang\u00a0S, Bowles\u00a0AC, Pandey\u00a0AC, Imhof\u00a0KM, Kalueff\u00a0AV, Gimble\u00a0JM, Bunnell\u00a0BA (2013) Age of the donor reduces the ability of human adipose-derived stem cells to alleviate symptoms in the experimental autoimmune encephalomyelitis mouse model. Stem Cells Transl Med 2:797\u2013807.\u00a0[pii] https:\/\/doi.org\/10.5966\/sctm.2013-0026sctm.2013-0026","DOI":"10.5966\/sctm.2013-0026sctm.2013-0026"},{"key":"8892_CR370","doi-asserted-by":"publisher","unstructured":"Berglund\u00a0AK, Fortier\u00a0LA, Antczak\u00a0DF, Schnabel\u00a0LV (2017) Immunoprivileged no more: Measuring the immunogenicity of allogeneic adult mesenchymal stem cells. Stem Cell Res Ther 8:288.\u00a0[pii] https:\/\/doi.org\/10.1186\/s13287-017-0742-810.1186\/s13287-017-0742-8","DOI":"10.1186\/s13287-017-0742-810.1186\/s13287-017-0742-8"},{"key":"8892_CR371","doi-asserted-by":"publisher","unstructured":"Barrachina\u00a0L, Romero\u00a0A, Zaragoza\u00a0P, Rodellar\u00a0C, Vazquez\u00a0FJ (2018) Practical considerations for clinical use of mesenchymal stem cells: from the laboratory to the horse. Vet J 238:49\u201357.\u00a0[pii] S1090-0233(18)30379-4 https:\/\/doi.org\/10.1016\/j.tvjl.2018.07.004","DOI":"10.1016\/j.tvjl.2018.07.004"},{"key":"8892_CR372","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2217\/rme.15.14","volume":"10","author":"C Consentius","year":"2015","unstructured":"Consentius C, Reinke P, Volk HD (2015) Immunogenicity of allogeneic mesenchymal stromal cells: what has been seen in vitro and in vivo? Regen Med 10:305\u2013315. https:\/\/doi.org\/10.2217\/rme.15.14","journal-title":"Regen Med"},{"key":"8892_CR373","doi-asserted-by":"publisher","unstructured":"He\u00a0Y, Chen\u00a0D, Yang\u00a0L, Hou\u00a0Q, Ma\u00a0H, Xu\u00a0X (2018) The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure. Stem Cell Res Ther 9:263.\u00a0[pii] https:\/\/doi.org\/10.1186\/s13287-018-1008-910.1186\/s13287-018-1008-9","DOI":"10.1186\/s13287-018-1008-910.1186\/s13287-018-1008-9"},{"key":"8892_CR374","doi-asserted-by":"publisher","unstructured":"Ogawa\u00a0Y, Morikawa\u00a0S, Okano\u00a0H, Mabuchi\u00a0Y, Suzuki\u00a0S, Yaguchi T, Sato\u00a0Y, Mukai\u00a0S, Yaguchi\u00a0S, Inaba\u00a0T, Okamoto\u00a0S, Kawakami\u00a0Y, Tsubota\u00a0K, Matsuzaki Y, Shimmura\u00a0S (2016) MHC-compatible bone marrow stromal\/stem cells trigger fibrosis by activating host T cells in a scleroderma mouse model. Elife 5:e09394.\u00a0[pii] https:\/\/doi.org\/10.7554\/eLife.09394e09394","DOI":"10.7554\/eLife.09394e09394"},{"key":"8892_CR375","doi-asserted-by":"publisher","unstructured":"Lai\u00a0RC, Yeo\u00a0RW, Lim\u00a0SK (2015) Mesenchymal stem cell exosomes. Semin Cell Dev Biol 40:82\u201388.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.semcdb.2015.03.001S1084-9521(15)00044-0","DOI":"10.1016\/j.semcdb.2015.03.001S1084-9521(15)00044-0"},{"key":"8892_CR376","doi-asserted-by":"publisher","unstructured":"Konala\u00a0VB, Mamidi\u00a0MK, Bhonde\u00a0R, Das\u00a0AK, Pochampally\u00a0R, Pal\u00a0R (2016) The current landscape of the mesenchymal stromal cell secretome: a new paradigm for cell-free regeneration. Cytotherapy 18:13\u201324.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.jcyt.2015.10.008S1465-3249(15)01101-9","DOI":"10.1016\/j.jcyt.2015.10.008S1465-3249(15)01101-9"},{"key":"8892_CR377","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/sctm.16-0363","volume":"6","author":"C Lo Sicco","year":"2017","unstructured":"Lo Sicco C, Reverberi D, Balbi C, Ulivi V, Principi E, Pascucci L, Becherini P, Bosco MC, Varesio L, Franzin C, Pozzobon M, Cancedda R, Tasso R (2017) Mesenchymal stem cell-derived extracellular vesicles as mediators of anti-inflammatory effects: endorsement of macrophage polarization. Stem Cells Transl Med 6:1018\u20131028. https:\/\/doi.org\/10.1002\/sctm.16-0363","journal-title":"Stem Cells Transl Med"},{"key":"8892_CR378","doi-asserted-by":"publisher","unstructured":"Biancone\u00a0L, Bruno\u00a0S, Deregibus\u00a0MC, Tetta\u00a0C, Camussi\u00a0G (2012) Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant 27:3037\u20133042.\u00a0[pii] https:\/\/doi.org\/10.1093\/ndt\/gfs168gfs168","DOI":"10.1093\/ndt\/gfs168gfs168"},{"key":"8892_CR379","doi-asserted-by":"publisher","unstructured":"Ramos TL, Sanchez-Abarca LI, Muntion S, Preciado S, Puig N, Lopez-Ruano G, Hernandez-Hernandez A, Redondo A, Ortega R, Rodriguez C, Sanchez-Guijo F, del Canizo C (2016) MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry. Cell Commun Signal 14:2. [pii] https:\/\/doi.org\/10.1186\/s12964-015-0124-810.1186\/s12964-015-0124-8","DOI":"10.1186\/s12964-015-0124-810.1186\/s12964-015-0124-8"},{"key":"8892_CR380","doi-asserted-by":"publisher","unstructured":"Lai\u00a0RC, Tan\u00a0SS, Yeo\u00a0RW, Choo\u00a0AB, Reiner\u00a0AT, Su\u00a0Y, Shen\u00a0Y, Fu\u00a0Z, Alexander\u00a0L, Sze\u00a0SK, Lim\u00a0SK (2016) MSC secretes at least 3 EV types each with a unique permutation of membrane lipid, protein and RNA. J Extracell Vesicles 5:29828.\u00a0[pii] https:\/\/doi.org\/10.3402\/jev.v5.2982829828","DOI":"10.3402\/jev.v5.2982829828"},{"key":"8892_CR381","doi-asserted-by":"publisher","unstructured":"Raposo\u00a0G, Stoorvogel\u00a0W (2013) Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol 200:373\u2013383.\u00a0[pii] https:\/\/doi.org\/10.1083\/jcb.201211138jcb.201211138","DOI":"10.1083\/jcb.201211138jcb.201211138"},{"key":"8892_CR382","doi-asserted-by":"publisher","unstructured":"Ela S, Mager I, Breakefield XO, Wood MJ (2013) Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 12:347\u2013357.\u00a0[pii] https:\/\/doi.org\/10.1038\/nrd3978nrd3978","DOI":"10.1038\/nrd3978nrd3978"},{"key":"8892_CR383","doi-asserted-by":"publisher","unstructured":"Yanez-Mo\u00a0M, Siljander\u00a0PR, Andreu\u00a0Z, Zavec\u00a0AB, Borras\u00a0FE, Buzas\u00a0EI, Buzas\u00a0K, Casal\u00a0E, Cappello\u00a0F, Carvalho\u00a0J, Colas\u00a0E, Cordeiro-da Silva\u00a0A, Fais\u00a0S, Falcon-Perez\u00a0JM, Ghobrial\u00a0IM, Giebel\u00a0B, Gimona\u00a0M, Graner\u00a0M, Gursel\u00a0I, Gursel\u00a0M, Heegaard\u00a0NH, Hendrix\u00a0A, Kierulf\u00a0P, Kokubun\u00a0K, Kosanovic\u00a0M, Kralj-Iglic\u00a0V, Kramer-Albers\u00a0EM, Laitinen\u00a0S, Lasser\u00a0C, Lener\u00a0T, Ligeti\u00a0E, Line\u00a0A, Lipps\u00a0G, Llorente\u00a0A, Lotvall\u00a0J, Mancek-Keber\u00a0M, Marcilla\u00a0A, Mittelbrunn\u00a0M, Nazarenko\u00a0I, Nolte-\u2018t Hoen EN, Nyman TA, O\u2019Driscoll L, Olivan M, Oliveira C, Pallinger E, Del Portillo HA, Reventos J, Rigau M, Rohde E, Sammar M, Sanchez-Madrid F, Santarem N, Schallmoser K, Ostenfeld MS, Stoorvogel W, Stukelj R, Van der Grein SG, Vasconcelos MH, Wauben MH, De Wever O (2015) Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 4:27066.\u00a0[pii] https:\/\/doi.org\/10.3402\/jev.v4.2706627066","DOI":"10.3402\/jev.v4.2706627066"},{"key":"8892_CR384","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo M, Raposo G, Thery C (2014) Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255\u2013289. https:\/\/doi.org\/10.1146\/annurev-cellbio-101512-122326","journal-title":"Annu Rev Cell Dev Biol"},{"key":"8892_CR385","doi-asserted-by":"publisher","unstructured":"Lee\u00a0Y,\u00a0El Andaloussi S, Wood\u00a0MJ (2012) Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet 21:R125\u2013134.\u00a0[pii] dds31 https:\/\/doi.org\/10.1093\/hmg\/dds317","DOI":"10.1093\/hmg\/dds317"},{"key":"8892_CR386","doi-asserted-by":"publisher","unstructured":"Thery C (2011) Exosomes: secreted vesicles and intercellular communications. F1000. Biol Rep 3:15.\u00a0[pii] https:\/\/doi.org\/10.3410\/B3-1515","DOI":"10.3410\/B3-1515"},{"key":"8892_CR387","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1080\/07853890.2019.1592215","volume":"51","author":"T Zhu","year":"2019","unstructured":"Zhu T, Wang Y, Jin H, Li L (2019) The role of exosome in autoimmune connective tissue disease. Ann Med 51:101\u2013108. https:\/\/doi.org\/10.1080\/07853890.2019.1592215","journal-title":"Ann Med"},{"key":"8892_CR388","doi-asserted-by":"publisher","unstructured":"Mohammadipoor\u00a0A, Antebi\u00a0B, Batchinsky\u00a0AI, Cancio\u00a0LC (2018) Therapeutic potential of products derived from mesenchymal stem\/stromal cells in pulmonary disease. Respir Res 19:218.\u00a0[pii] https:\/\/doi.org\/10.1186\/s12931-018-0921-x10.1186\/s12931-018-0921-x","DOI":"10.1186\/s12931-018-0921-x10.1186\/s12931-018-0921-x"},{"key":"8892_CR389","doi-asserted-by":"publisher","unstructured":"Mokarizadeh\u00a0A, Delirezh\u00a0N, Morshedi\u00a0A, Mosayebi\u00a0G, Farshid\u00a0AA, Mardani (2012) Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling. Immunol Lett 147:47\u201354.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.imlet.2012.06.001S0165-2478(12)00158-7","DOI":"10.1016\/j.imlet.2012.06.001S0165-2478(12)00158-7"},{"key":"8892_CR390","doi-asserted-by":"publisher","unstructured":"Jeyaram\u00a0A, Jay\u00a0SM (2017) Preservation and storage stability of extracellular vesicles for therapeutic applications. AAPS J 20:1.\u00a0[pii] https:\/\/doi.org\/10.1208\/s12248-017-0160-y10.1208\/s12248-017-0160-y","DOI":"10.1208\/s12248-017-0160-y10.1208\/s12248-017-0160-y"},{"key":"8892_CR391","doi-asserted-by":"publisher","unstructured":"Qiu\u00a0G, Zheng\u00a0G, Ge\u00a0M, Wang\u00a0J, Huang\u00a0R, Shu\u00a0Q, Xu J (2018) Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs. Stem Cell Res Ther 9:320.\u00a0[pii] https:\/\/doi.org\/10.1186\/s13287-018-1069-910.1186\/s13287-018-1069-9","DOI":"10.1186\/s13287-018-1069-910.1186\/s13287-018-1069-9"},{"key":"8892_CR392","doi-asserted-by":"publisher","unstructured":"Lotvall\u00a0J, Hill\u00a0AF, Hochberg\u00a0F, Buzas\u00a0EI,\u00a0Di Vizio D, Gardiner\u00a0C, Gho\u00a0YS, Kurochkin\u00a0IV, Mathivanan S, Quesenberry\u00a0P, Sahoo\u00a0S, Tahara\u00a0H, Wauben\u00a0MH, Witwer\u00a0KW, Thery\u00a0C (2014) Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles 3:26913.\u00a0[pii] https:\/\/doi.org\/10.3402\/jev.v3.2691326913","DOI":"10.3402\/jev.v3.2691326913"},{"key":"8892_CR393","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1002\/pmic.201200373","volume":"13","author":"T Katsuda","year":"2013","unstructured":"Katsuda T, Kosaka N, Takeshita F, Ochiya T (2013) The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles. Proteomics 13:1637\u20131653. https:\/\/doi.org\/10.1002\/pmic.201200373","journal-title":"Proteomics"},{"key":"8892_CR394","doi-asserted-by":"publisher","first-page":"9415367","DOI":"10.1155\/2018\/9415367","volume":"2018","author":"J Phelps","year":"2018","unstructured":"Phelps J, Sanati-Nezhad A, Ungrin M, Duncan NA, Sen A (2018) Bioprocessing of mesenchymal stem cells and their derivatives: toward cell-free therapeutics. Stem Cells Int 2018:9415367. https:\/\/doi.org\/10.1155\/2018\/9415367","journal-title":"Stem Cells Int"},{"key":"8892_CR395","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fphar.2016.00231","volume":"7","author":"A Marote","year":"2016","unstructured":"Marote A, Teixeira FG, Mendes-Pinheiro B, Salgado AJ (2016) MSCs-derived exosomes: cell-secreted nanovesicles with regenerative potential. Front Pharmacol 7:231. https:\/\/doi.org\/10.3389\/fphar.2016.00231","journal-title":"Front Pharmacol"},{"key":"8892_CR396","doi-asserted-by":"publisher","unstructured":"Willis\u00a0GR, Fernandez-Gonzalez\u00a0A, Reis\u00a0M, Mitsialis\u00a0SA, Kourembanas\u00a0S (2018) Macrophage immunomodulation: the gatekeeper for mesenchymal stem cell derived-exosomes in pulmonary arterial hypertension? Int J Mol Sci 19:E2534 [pii] https:\/\/doi.org\/10.3390\/ijms19092534ijms19092534","DOI":"10.3390\/ijms19092534ijms19092534"},{"key":"8892_CR397","doi-asserted-by":"publisher","unstructured":"Yu\u00a0B, Zhang\u00a0X, Li\u00a0X (2014) Exosomes derived from mesenchymal stem cells. Int J Mol Sci 15:4142\u20134157.\u00a0[pii] https:\/\/doi.org\/10.3390\/ijms15034142ijms15034142","DOI":"10.3390\/ijms15034142ijms15034142"},{"key":"8892_CR398","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1164\/rccm.201410-1765OC","volume":"192","author":"A Monsel","year":"2015","unstructured":"Monsel A, Zhu YG, Gennai S, Hao Q, Hu S, Rouby JJ, Rosenzwajg M, Matthay MA, Lee JW (2015) Therapeutic effects of human mesenchymal stem cell-derived microvesicles in severe pneumonia in mice. Am J Respir Crit Care Med 192:324\u2013336. https:\/\/doi.org\/10.1164\/rccm.201410-1765OC","journal-title":"Am J Respir Crit Care Med"},{"key":"8892_CR399","doi-asserted-by":"publisher","unstructured":"Chen\u00a0JY, An\u00a0R, Liu\u00a0ZJ, Wang\u00a0JJ, Chen\u00a0SZ, Hong\u00a0MM, Liu\u00a0JH, Xiao\u00a0MY, Chen\u00a0YF (2014) Therapeutic effects of mesenchymal stem cell-derived microvesicles on pulmonary arterial hypertension in rats. Acta Pharmacol Sin 35:1121\u20131128.\u00a0[pii] https:\/\/doi.org\/10.1038\/aps.2014.61aps201461","DOI":"10.1038\/aps.2014.61aps201461"},{"key":"8892_CR400","doi-asserted-by":"publisher","unstructured":"Egger\u00a0D, Tripisciano\u00a0C, Weber\u00a0V, Dominici\u00a0M, Kasper\u00a0C (2018) Dynamic cultivation of mesenchymal stem cell aggregates. Bioengineering (Basel) 5:E48. [pii] https:\/\/doi.org\/10.3390\/bioengineering5020048bioengineering5020048","DOI":"10.3390\/bioengineering5020048bioengineering5020048"},{"key":"8892_CR401","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/stem.2575","volume":"35","author":"DG Phinney","year":"2017","unstructured":"Phinney DG, Pittenger MF (2017) Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells 35:851\u2013858. https:\/\/doi.org\/10.1002\/stem.2575","journal-title":"Stem Cells"},{"key":"8892_CR402","doi-asserted-by":"publisher","unstructured":"Robbins\u00a0PD, Morelli\u00a0AE (2014) Regulation of immune responses by extracellular vesicles. Nat Rev Immunol 14:195\u2013208.\u00a0[pii] nri3622 https:\/\/doi.org\/10.1038\/nri3622","DOI":"10.1038\/nri3622"},{"key":"8892_CR403","doi-asserted-by":"publisher","unstructured":"Mentkowski\u00a0KI, Snitzer\u00a0JD, Rusnak\u00a0S, Lang\u00a0JK (2018) Therapeutic potential of engineered extracellular vesicles. AAPS J 20:50.\u00a0[pii] https:\/\/doi.org\/10.1208\/s12248-018-0211-z10.1208\/s12248-018-0211-z","DOI":"10.1208\/s12248-018-0211-z10.1208\/s12248-018-0211-z"},{"key":"8892_CR404","doi-asserted-by":"publisher","unstructured":"Ranganath SH, Levy O, Inamdar\u00a0MS, Karp JM (2012) Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease Cell. Stem Cell 10:244\u2013258.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.stem.2012.02.005S1934-5909(12)00063-X","DOI":"10.1016\/j.stem.2012.02.005S1934-5909(12)00063-X"},{"key":"8892_CR405","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1517\/14712598.2016.1170804","volume":"16","author":"A Monsel","year":"2016","unstructured":"Monsel A, Zhu YG, Gudapati V, Lim H, Lee JW (2016) Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases. Expert Opin Biol Ther 16:859\u2013871. https:\/\/doi.org\/10.1517\/14712598.2016.1170804","journal-title":"Expert Opin Biol Ther"},{"key":"8892_CR406","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/scd.2008.0253","volume":"18","author":"UM Fischer","year":"2009","unstructured":"Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, Laine GA, Cox CS Jr (2009) Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev 18:683\u2013692. https:\/\/doi.org\/10.1089\/scd.2008.0253","journal-title":"Stem Cells Dev"},{"key":"8892_CR407","doi-asserted-by":"publisher","unstructured":"Qiu G, Zheng G, Ge M, Wang J, Huang R, Shu Q, Xu J (2018) Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs. Stem Cell Res Ther 9:320. [pii] https:\/\/doi.org\/10.1186\/s13287-018-1069-910.1186\/s13287-018-1069-9","DOI":"10.1186\/s13287-018-1069-910.1186\/s13287-018-1069-9"},{"key":"8892_CR408","doi-asserted-by":"publisher","unstructured":"Mulcahy LA, Pink RC, Carter DR (2014) Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles 3.\u00a0[pii] https:\/\/doi.org\/10.3402\/jev.v3.2464124641","DOI":"10.3402\/jev.v3.2464124641"},{"key":"8892_CR409","doi-asserted-by":"publisher","unstructured":"Merino-Gonzalez C, Zuniga FA, Escudero C, Ormazabal V, Reyes C, Nova-Lamperti E, Salomon C, Aguayo C (2016) Mesenchymal stem cell-derived extracellular vesicles promote angiogenesis: potencial clinical application. Front Physiol 7:240. https:\/\/doi.org\/10.3389\/fphys.2016.00024","DOI":"10.3389\/fphys.2016.00024"},{"key":"8892_CR410","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00109-013-1110-5","volume":"92","author":"S Bian","year":"2014","unstructured":"Bian S, Zhang L, Duan L, Wang X, Min Y, Yu H (2014) Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model. J Mol Med (Berl) 92:387\u2013397. https:\/\/doi.org\/10.1007\/s00109-013-1110-5","journal-title":"J Mol Med (Berl)"},{"key":"8892_CR411","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1089\/neu.2017.5063","volume":"34","author":"JH Huang","year":"2017","unstructured":"Huang JH, Yin XM, Xu Y, Xu CC, Lin X, Ye FB, Cao Y, Lin FY (2017) Systemic administration of exosomes released from mesenchymal stromal cells attenuates apoptosis, inflammation, and promotes angiogenesis after spinal cord injury in rats. J Neurotrauma 34:3388\u20133396. https:\/\/doi.org\/10.1089\/neu.2017.5063","journal-title":"J Neurotrauma"},{"key":"8892_CR412","doi-asserted-by":"publisher","unstructured":"Abreu SC, Weiss DJ, Rocco PR (2016) Extracellular vesicles derived from mesenchymal stromal cells: a therapeutic option in respiratory diseases? Stem Cell Res Ther 7:53.\u00a0[pii] https:\/\/doi.org\/10.1186\/s13287-016-0317-010.1186\/s13287-016-0317-0","DOI":"10.1186\/s13287-016-0317-010.1186\/s13287-016-0317-0"},{"key":"8892_CR413","doi-asserted-by":"publisher","unstructured":"Holm MM, Kaiser J, Schwab ME (2018) Extracellular vesicles: multimodal envoys in neural maintenance and repair. Trends Neurosci 41:360\u2013372.\u00a0[pii] S0166-2236(18)30067-5 https:\/\/doi.org\/10.1016\/j.tins.2018.03.006","DOI":"10.1016\/j.tins.2018.03.006"},{"key":"8892_CR414","doi-asserted-by":"publisher","unstructured":"Ophelders DR, Wolfs TG, Jellema RK, Zwanenburg A, Andriessen P, Delhaas T, Ludwig AK, Radtke S, Peters V, Janssen L, Giebel B, Kramer BW (2016) Mesenchymal stromal cell-derived extracellular vesicles protect the fetal brain after hypoxia-ischemia. Stem Cells Transl Med 5:754\u2013763.\u00a0[pii] https:\/\/doi.org\/10.5966\/sctm.2015-0197sctm.2015-0197","DOI":"10.5966\/sctm.2015-0197sctm.2015-0197"},{"key":"8892_CR415","doi-asserted-by":"publisher","unstructured":"Kim SM, Kim HS (2017) Engineering of extracellular vesicles as drug delivery vehicles Stem Cell Investig 4:74.\u00a0[pii] https:\/\/doi.org\/10.21037\/sci.2017.08.07sci-04-2017.08.07","DOI":"10.21037\/sci.2017.08.07sci-04-2017.08.07"},{"key":"8892_CR416","doi-asserted-by":"publisher","unstructured":"Buzas EI, Gyorgy B, Nagy G, Falus A, Gay S (2014) Emerging role of extracellular vesicles in inflammatory diseases. Nat Rev Rheumatol 10:356\u2013364.\u00a0[pii] https:\/\/doi.org\/10.1038\/nrrheum.2014.19nrrheum.2014.19","DOI":"10.1038\/nrrheum.2014.19nrrheum.2014.19"},{"key":"8892_CR417","doi-asserted-by":"publisher","unstructured":"Witwer KW, Buzas EI, Bemis LT, Bora A, L\u00e4sser C, L\u00f6tvall J, Nolte-\u2019t Hoen EN, Piper MG, Sivaraman S, Skog J, Th\u00e9ry C, Wauben MH, Hochberg F (2013) Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles 2.\u00a0[pii] https:\/\/doi.org\/10.3402\/jev.v2i0.2036020360","DOI":"10.3402\/jev.v2i0.2036020360"},{"key":"8892_CR418","doi-asserted-by":"publisher","unstructured":"Lener\u00a0T, Gimona\u00a0M, Aigner\u00a0L, Borger\u00a0V, Buzas\u00a0E, Camussi\u00a0G, Chaput\u00a0N, Chatterjee\u00a0D, Court\u00a0FA,\u00a0Del Portillo HA, O\u2019Driscoll\u00a0L, Fais\u00a0S, Falcon-Perez\u00a0JM, Felderhoff-Mueser U, Fraile\u00a0L, Gho\u00a0YS, Gorgens\u00a0A, Gupta\u00a0RC, Hendrix\u00a0A, Hermann\u00a0DM, Hill\u00a0AF, Hochberg\u00a0F, Horn\u00a0PA,\u00a0de Kleijn D, Kordelas\u00a0L, Kramer\u00a0BW, Kramer-Albers\u00a0EM, Laner-Plamberger\u00a0S, Laitinen\u00a0S, Leonardi\u00a0T, Lorenowicz\u00a0MJ, Lim\u00a0SK, Lotvall\u00a0J, Maguire\u00a0CA, Marcilla\u00a0A, Nazarenko\u00a0I, Ochiya\u00a0T, Patel\u00a0T, Pedersen\u00a0S, Pocsfalvi\u00a0G, Pluchino\u00a0S, Quesenberry\u00a0P, Reischl\u00a0IG, Rivera\u00a0FJ, Sanzenbacher\u00a0R, Schallmoser\u00a0K, Slaper-Cortenbach\u00a0I, Strunk\u00a0D, Tonn\u00a0T, Vader\u00a0P,\u00a0van Balkom BW, Wauben\u00a0M, Andaloussi\u00a0SE, Thery\u00a0C, Rohde\u00a0E, Giebel\u00a0B (2015) Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles 4:30087.\u00a0[pii] https:\/\/doi.org\/10.3402\/jev.v4.3008730087","DOI":"10.3402\/jev.v4.3008730087"},{"key":"8892_CR419","doi-asserted-by":"publisher","unstructured":"Otsuru\u00a0S, Desbourdes\u00a0L, Guess\u00a0AJ, Hofmann\u00a0TJ, Relation\u00a0T, Kaito\u00a0T, Dominici\u00a0M, Iwamoto\u00a0M, Horwitz\u00a0EM (2018) Extracellular vesicles released from mesenchymal stromal cells stimulate bone growth in osteogenesis imperfecta. Cytotherapy 20:62\u201373.\u00a0[pii] S1465-3249(17)30711-9 https:\/\/doi.org\/10.1016\/j.jcyt.2017.09.012","DOI":"10.1016\/j.jcyt.2017.09.012"},{"key":"8892_CR420","doi-asserted-by":"publisher","unstructured":"Teixeira\u00a0FG, Panchalingam\u00a0KM, Assuncao-Silva\u00a0R, Serra\u00a0SC, Mendes-Pinheiro\u00a0B, Patricio\u00a0P, Jung\u00a0S, Anjo\u00a0SI, Manadas\u00a0B, Pinto\u00a0L, Sousa\u00a0N, Behie\u00a0LA, Salgado\u00a0AJ (2016) Modulation of the mesenchymal stem cell secretome using computer-controlled bioreactors: impact on neuronal cell proliferation, survival and differentiation. Sci Rep 6:27791.\u00a0[pii] https:\/\/doi.org\/10.1038\/srep27791srep27791","DOI":"10.1038\/srep27791srep27791"},{"key":"8892_CR421","doi-asserted-by":"publisher","unstructured":"Gao\u00a0J, Dennis\u00a0JE, Muzic\u00a0RF, Lundberg\u00a0M, Caplan\u00a0AI (2001) The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169:12\u201320.\u00a0[pii] 47856 https:\/\/doi.org\/10.1159\/000047856","DOI":"10.1159\/000047856"},{"key":"8892_CR422","doi-asserted-by":"publisher","unstructured":"Breitbach\u00a0M, Bostani\u00a0T, Roell\u00a0W, Xia\u00a0Y, Dewald\u00a0O, Nygren\u00a0JM, Fries\u00a0JW, Tiemann\u00a0K, Bohlen\u00a0H, Hescheler\u00a0J, Welz\u00a0A, Bloch\u00a0W, Jacobsen\u00a0SE, Fleischmann\u00a0BK (2007) Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110:1362\u20131369.\u00a0[pii] blood-2006-12-063412 https:\/\/doi.org\/10.1182\/blood-2006-12-063412","DOI":"10.1182\/blood-2006-12-063412"},{"key":"8892_CR423","doi-asserted-by":"publisher","unstructured":"Wang\u00a0W, Itaka\u00a0K, Ohba\u00a0S, Nishiyama\u00a0N, Chung\u00a0UI, Yamasaki\u00a0Y, Kataoka\u00a0K (2009) 3D spheroid culture system on micropatterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells. Biomaterials 30:2705\u20132715.\u00a0[pii] S0142-9612(09)00051-9 https:\/\/doi.org\/10.1016\/j.biomaterials.2009.01.030","DOI":"10.1016\/j.biomaterials.2009.01.030"},{"key":"8892_CR424","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1089\/ten.TEC.2009.0432","volume":"16","author":"JE Frith","year":"2010","unstructured":"Frith JE, Thomson B, Genever PG (2010) Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods 16:735\u2013749. https:\/\/doi.org\/10.1089\/ten.TEC.2009.0432","journal-title":"Tissue Eng Part C Methods"},{"key":"8892_CR425","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fcvm.2017.00063","volume":"4","author":"GR Willis","year":"2017","unstructured":"Willis GR, Kourembanas S, Mitsialis SA (2017) Toward exosome-based therapeutics: isolation, heterogeneity, and fit-for-purpose potency. Front Cardiovasc Med 4:63. https:\/\/doi.org\/10.3389\/fcvm.2017.00063","journal-title":"Front Cardiovasc Med"},{"key":"8892_CR426","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1089\/scd.2014.0563","volume":"24","author":"AV Gouveia de Andrade","year":"2015","unstructured":"Gouveia de Andrade AV, Bertolino G, Riewaldt J, Bieback K, Karbanova J, Odendahl M, Bornhauser M, Schmitz M, Corbeil D, Tonn T (2015) Extracellular vesicles secreted by bone marrow- and adipose tissue-derived mesenchymal stromal cells fail to suppress lymphocyte proliferation. Stem Cells Dev 24:1374\u20131376. https:\/\/doi.org\/10.1089\/scd.2014.0563","journal-title":"Stem Cells Dev"},{"key":"8892_CR427","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3389\/fimmu.2014.00525","volume":"5","author":"M Franquesa","year":"2014","unstructured":"Franquesa M, Hoogduijn MJ, Ripoll E, Luk F, Salih M, Betjes MG, Torras J, Baan CC, Grinyo JM, Merino AM (2014) Update on controls for isolation and quantification methodology of extracellular vesicles derived from adipose tissue mesenchymal stem cells. Front Immunol 5:525. https:\/\/doi.org\/10.3389\/fimmu.2014.00525","journal-title":"Front Immunol"},{"key":"8892_CR428","doi-asserted-by":"publisher","unstructured":"Chen\u00a0TS, Arslan\u00a0F, Yin\u00a0Y, Tan\u00a0SS, Lai\u00a0RC, Choo\u00a0AB, Padmanabhan\u00a0J, Lee\u00a0CN,\u00a0de Kleijn DP, Lim\u00a0SK (2011) Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs. J Transl Med 9:47.\u00a0[pii] https:\/\/doi.org\/10.1186\/1479-5876-9-471479-5876-9-47","DOI":"10.1186\/1479-5876-9-471479-5876-9-47"},{"key":"8892_CR429","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1089\/scd.2014.0091","volume":"23","author":"A Conforti","year":"2014","unstructured":"Conforti A, Scarsella M, Starc N, Giorda E, Biagini S, Proia A, Carsetti R, Locatelli F, Bernardo ME (2014) Microvescicles derived from mesenchymal stromal cells are not as effective as their cellular counterpart in the ability to modulate immune responses in vitro. Stem Cells Dev 23:2591\u20132599. https:\/\/doi.org\/10.1089\/scd.2014.0091","journal-title":"Stem Cells Dev"},{"key":"8892_CR430","doi-asserted-by":"publisher","unstructured":"Haney\u00a0MJ, Klyachko\u00a0NL, Zhao\u00a0Y, Gupta\u00a0R, Plotnikova\u00a0EG, He\u00a0Z, Patel\u00a0T, Piroyan\u00a0A, Sokolsky\u00a0M, Kabanov\u00a0AV, Batrakova\u00a0EV (2015) Exosomes as drug delivery vehicles for Parkinson\u2019s disease therapy. J Control Release 207:18\u201330.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.jconrel.2015.03.033S0168-3659(15)00213-8","DOI":"10.1016\/j.jconrel.2015.03.033S0168-3659(15)00213-8"},{"key":"8892_CR431","doi-asserted-by":"publisher","unstructured":"Xin\u00a0H, Li\u00a0Y, Cui\u00a0Y, Yang\u00a0JJ, Zhang\u00a0ZG, Chopp\u00a0M (2013) Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. J Cereb Blood Flow Metab 33:1711\u20131715.\u00a0[pii] https:\/\/doi.org\/10.1038\/jcbfm.2013.152jcbfm2013152","DOI":"10.1038\/jcbfm.2013.152jcbfm2013152"},{"key":"8892_CR432","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1089\/scd.2016.0107","volume":"25","author":"L Wang","year":"2016","unstructured":"Wang L, Gu Z, Zhao X, Yang N, Wang F, Deng A, Zhao S, Luo L, Wei H, Guan L, Gao Z, Li Y, Liu D, Gao C (2016) Extracellular vesicles released from human umbilical cord-derived mesenchymal stromal cells prevent life-threatening acute graft-versus-host disease in a mouse model of allogeneic hematopoietic stem cell transplantation. Stem Cells Dev 25:1874\u20131883. https:\/\/doi.org\/10.1089\/scd.2016.0107","journal-title":"Stem Cells Dev"},{"key":"8892_CR433","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/scd.2012.0395","volume":"22","author":"T Li","year":"2013","unstructured":"Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, Wang M, Zhou Y, Zhu W, Li W, Xu W (2013) Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev 22:845\u2013854. https:\/\/doi.org\/10.1089\/scd.2012.0395","journal-title":"Stem Cells Dev"},{"key":"8892_CR434","doi-asserted-by":"publisher","unstructured":"Nargesi\u00a0AA, Lerman\u00a0LO, Eirin\u00a0A (2017) Mesenchymal stem cell-derived extracellular vesicles for renal repair. Curr Gene Ther 17:29\u201342.\u00a0[pii] https:\/\/doi.org\/10.2174\/1566523217666170412110724CGT-EPUB-82756","DOI":"10.2174\/1566523217666170412110724CGT-EPUB-82756"},{"key":"8892_CR435","doi-asserted-by":"publisher","unstructured":"Na\u00a0YK, Ban\u00a0JJ, Lee\u00a0M, Im\u00a0W, Kim\u00a0M (2017) Wound healing potential of adipose tissue stem cell extract. Biochem Biophys Res Commun 485:30\u201334.\u00a0[pii] S0006-291X(17)30161-4 https:\/\/doi.org\/10.1016\/j.bbrc.2017.01.103","DOI":"10.1016\/j.bbrc.2017.01.103"},{"key":"8892_CR436","doi-asserted-by":"publisher","unstructured":"Xu\u00a0J, Wang\u00a0B, Sun\u00a0Y, Wu\u00a0T, Liu\u00a0Y, Zhang\u00a0J, Lee\u00a0WY, Pan\u00a0X, Chai\u00a0Y, Li\u00a0G (2016) Human fetal mesenchymal stem cell secretome enhances bone consolidation in distraction osteogenesis. Stem Cell Res Ther 7:134.\u00a0[pii] https:\/\/doi.org\/10.1186\/s13287-016-0392-210.1186\/s13287-016-0392-2","DOI":"10.1186\/s13287-016-0392-210.1186\/s13287-016-0392-2"},{"key":"8892_CR437","doi-asserted-by":"publisher","unstructured":"Bai\u00a0L, Lennon\u00a0DP, Caplan\u00a0AI, DeChant\u00a0A, Hecker\u00a0J, Kranso\u00a0J, Zaremba\u00a0A, Miller\u00a0RH (2012) Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci 15:862\u2013870.\u00a0[pii] https:\/\/doi.org\/10.1038\/nn.3109nn.3109","DOI":"10.1038\/nn.3109nn.3109"},{"key":"8892_CR438","doi-asserted-by":"publisher","unstructured":"Kordelas\u00a0L, Rebmann\u00a0V, Ludwig\u00a0AK, Radtke\u00a0S, Ruesing\u00a0J, Doeppner\u00a0TR, Epple\u00a0M, Horn\u00a0PA, Beelen\u00a0DW, Giebel\u00a0B (2014) MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Leukemia 28 :970\u2013973.\u00a0[pii] https:\/\/doi.org\/10.1038\/leu.2014.41leu201441","DOI":"10.1038\/leu.2014.41leu201441"},{"key":"8892_CR439","doi-asserted-by":"publisher","unstructured":"Nassar\u00a0W, El-Ansary\u00a0M, Sabry\u00a0D, Mostafa\u00a0MA, Fayad\u00a0T, Kotb\u00a0E, Temraz\u00a0M, Saad\u00a0AN, Essa\u00a0W, Adel\u00a0H (2016) Umbilical cord mesenchymal stem cells derived extracellular vesicles can safely ameliorate the progression of chronic kidney diseases. Biomater Res 20:21.\u00a0[pii] https:\/\/doi.org\/10.1186\/s40824-016-0068-068","DOI":"10.1186\/s40824-016-0068-068"},{"key":"8892_CR440","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.3389\/fimmu.2018.01985","volume":"9","author":"DTB Thuan","year":"2018","unstructured":"Thuan DTB, Zayed H, Eid AH, Abou-Saleh H, Nasrallah GK, Mangoni AA, Pintus G (2018) A Potential link between oxidative stress and endothelial-to-mesenchymal transition in systemic sclerosis. Front Immunol 9:1985. https:\/\/doi.org\/10.3389\/fimmu.2018.01985","journal-title":"Front Immunol"},{"key":"8892_CR441","doi-asserted-by":"publisher","unstructured":"Wang\u00a0S, Qu\u00a0X, Zhao\u00a0RC (2012) Clinical applications of mesenchymal stem cells. J Hematol Oncol 5:19.\u00a0[pii] https:\/\/doi.org\/10.1186\/1756-8722-5-191756-8722-5-19","DOI":"10.1186\/1756-8722-5-191756-8722-5-19"},{"key":"8892_CR442","doi-asserted-by":"publisher","unstructured":"Karnoub\u00a0AE, Dash\u00a0AB, Vo\u00a0AP, Sullivan\u00a0A, Brooks\u00a0MW, Bell\u00a0GW, Richardson\u00a0AL, Polyak\u00a0K, Tubo\u00a0R, Weinberg\u00a0RA (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449:557\u2013563.\u00a0[pii] nature06188 https:\/\/doi.org\/10.1038\/nature06188","DOI":"10.1038\/nature06188"},{"key":"8892_CR443","doi-asserted-by":"publisher","unstructured":"Ankrum\u00a0J, Karp\u00a0JM (2010) Mesenchymal stem cell therapy: two steps forward, one step back. Trends Mol Med 16:203\u2013209.\u00a0[pii] https:\/\/doi.org\/10.1016\/j.molmed.2010.02.005S1471-4914(10)00024-9","DOI":"10.1016\/j.molmed.2010.02.005S1471-4914(10)00024-9"},{"key":"8892_CR444","doi-asserted-by":"publisher","first-page":"9521629","DOI":"10.1155\/2016\/9521629","volume":"2016","author":"J Paulini","year":"2016","unstructured":"Paulini J, Higuti E, Bastos RM, Gomes SA, Rangel EB (2016) Mesenchymal stem cells as therapeutic candidates for halting the progression of diabetic nephropathy. Stem Cells Int 2016:9521629. https:\/\/doi.org\/10.1155\/2016\/9521629","journal-title":"Stem Cells Int"},{"key":"8892_CR445","doi-asserted-by":"publisher","first-page":"1314709","DOI":"10.1155\/2016\/1314709","volume":"2016","author":"H Tao","year":"2016","unstructured":"Tao H, Han Z, Han ZC, Li Z (2016) Proangiogenic features of mesenchymal stem cells and their therapeutic applications. Stem Cells Int 2016:1314709. https:\/\/doi.org\/10.1155\/2016\/1314709","journal-title":"Stem Cells Int"},{"key":"8892_CR446","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s12015-011-9312-0","volume":"8","author":"M Abumaree","year":"2012","unstructured":"Abumaree M, Al Jumah M, Pace RA, Kalionis B (2012) Immunosuppressive properties of mesenchymal stem cells. Stem Cell Rev Rep 8:375\u2013392. https:\/\/doi.org\/10.1007\/s12015-011-9312-0","journal-title":"Stem Cell Rev Rep"},{"key":"8892_CR447","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1089\/ten.TEB.2016.0365","volume":"23","author":"Y Fu","year":"2017","unstructured":"Fu Y, Karbaat L, Wu L, Leijten J, Both SK, Karperien M (2017) Trophic effects of mesenchymal stem cells in tissue regeneration. Tissue Eng Part B Rev 23:515\u2013528. https:\/\/doi.org\/10.1089\/ten.TEB.2016.0365","journal-title":"Tissue Eng Part B Rev"},{"key":"8892_CR448","doi-asserted-by":"publisher","unstructured":"Chen\u00a0C, Akiyama\u00a0K, Yamaza\u00a0T, You YO ,\u00a0Xu X,\u00a0Li B, Zhao\u00a0Y, Shi\u00a0S (2014)\u00a0Telomerase governs immunomodulatory properties of mesenchymal stem cells by regulating FAS ligand expression EMBO. Mol Med 6:322\u2013334. [pii] https:\/\/doi.org\/10.1002\/emmm.201303000emmm.201303000","DOI":"10.1002\/emmm.201303000emmm.201303000"},{"key":"8892_CR449","doi-asserted-by":"publisher","unstructured":"Guillaume-Jugnot P, Daumas\u00a0A, Magalon\u00a0J, Sautereau\u00a0N, Veran\u00a0J, Magalon\u00a0G, Sabatier\u00a0F,\u00a0 Granel\u00a0B (2016) State of the art. Autologous fat graft and adipose tissue-derived stromal vascular fraction injection for hand therapy in systemic sclerosis patients. Curr Res Transl Med 64:35\u201342.\u00a0[pii]\u00a0https:\/\/doi.org\/10.1016\/j.retram.2016.01.006S2452-3186(16)00007-6","DOI":"10.1016\/j.retram.2016.01.006S2452-3186(16)00007-6"},{"key":"8892_CR450","doi-asserted-by":"publisher","unstructured":"Copland\u00a0I, Sharma\u00a0K, Lejeune\u00a0L, Eliopoulos\u00a0N, Stewart\u00a0D, Liu\u00a0P, Lachapelle\u00a0K, Galipeau\u00a0J (2008) CD34 expression on murine marrow-derived mesenchymal stromal cells: impact on neovascularization. Exp Hematol 36:93\u2013103.\u00a0[pii] S0301-472X(07)00575-9 https:\/\/doi.org\/10.1016\/j.exphem.2007.08.032","DOI":"10.1016\/j.exphem.2007.08.032"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08892-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-021-08892-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-021-08892-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T08:14:27Z","timestamp":1683706467000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-021-08892-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,15]]},"references-count":450,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["8892"],"URL":"https:\/\/doi.org\/10.1007\/s12016-021-08892-z","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,15]]},"assertion":[{"value":"24 August 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors alone are responsible for the content of this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}